Paediatric health related quality of life : a European perspective : instrument development, validation, and use in clinical practice by Baars, R.M.
Paediatric 
Health Related Quality of Life:
a European Perspective
Instrument development, validation, and use in clinical practice
Rolanda M. Baars
Th e DISABKIDS project described in this thesis was fi nancially supported by:
European Commission (QLG-CT-2000-00716).
Cover photo: R.M. Baars (Vietnam)
Lay-out and printing: Febodruk BV, Enschede
ISBN 90-9020393-1
© 2006 R.M. Baars, Leiden, the Netherlands 
All rights reserved. No part of this publication may be reproduced in any form or by any 
means without prior permission of the author.
Paediatric
Health Related Quality of Life: 
a European Perspective
Instrument development, validation, and use in clinical practice
Proefschrift
ter verkrijging van 
de graad van Doctor aan de Universiteit Leiden,
op gezag van de Rector Magnifi cus Dr. D.D. Breimer,
hoogleraar in de faculteit der Wiskunde en 
Natuurwetenschappen en die der Geneeskunde, 
volgens besluit van het College voor Promoties







Promotor: Prof. Dr. J.M.Wit
Co-promotor: Dr. H.M. Koopman
Referent: Prof. Dr. R.J.B.J. Gemke (Vrije Universiteit Amsterdam)
Overige leden: Prof. Dr. S.P. Verloove-Vanhorick
 Prof. Dr. A.A. Kaptein 
“Que sera, sera” 
For what the past has brought,
the present is,
and the future may bring.

Table of contents
Chapter 1  9
General introduction and outline of the thesis
Chapter 2 27
Clinicians' perspective on quality of life (QoL) assessment in paediatric clinical practice
Chapter 3 41
A child focus group methodology: experiences from the European DISABKIDS project
Chapter 4 55
Using cross-national focus groups to identify health related quality of life (HRQoL) 
aspects in children and adolescents with asthma and their parents: the European 
DISABKIDS approach
Chapter 5 73
Item selection after focus group research: the European DISABKIDS approach
Chapter 6 89
Th e European DISABKIDS project: development of seven condition-specifi c modules 
to measure health related quality of life (HRQoL) in children and adolescents 
Chapter 7 107
Th e European DISABKIDS health related quality of life (HRQoL) instrument for 
children and adolescents with a chronic medical condition: psychometric properties 
of the cross-national asthma sample
Chapter 8 131









General introduction and outline of the thesis
General Introduction and outline of the thesis
Th e DISABKIDS project is a European collaboration of clinicians and investigators that 
received funding from the European Commission in 2001. Over the last four years the 
DISABKIDS project's aim was to cross-nationally develop a new European health related 
quality of life (HRQoL) instrument for children and adolescents with a chronic medical 
condition 1(Box 1). Some of the steps taken during the developmental process of the 
European DISABKIDS HRQoL instrument for children and adolescents with a chronic 
medical condition are described in this thesis. Data from the asthma population is a 
recurring theme in most chapters as the Dutch DISABKIDS centre operated as asthma 
consultant. 
Four criteria must be met:
   •     If it occurs in children aged 0 to 18 years inclusively
   •     If its diagnosis is based on medical scientifi c knowledge and it can be diagnosed using reproducible and 
      valid methods or instruments according to the professionals
   •     If it is not (yet) curable
   •     If it has been present longer than three months or if it will very probably last longer than three months, or if  
       it  has occurred three times or more during the past year
Th is introduction will fi rst supply the readers with an informative background on HRQoL 
research. Th e general HRQoL principles will be explained together with the impact 
of paediatric asthma on the life of a child or adolescent. Th e development of HRQoL 
instruments is also explained and the aim and developmental steps of the European 
DISABKIDS project are described. 
Health related quality of life
In 1948 the World Health Organization (WHO) defi ned health as "a state of complete 
physical, mental and social well-being and not merely the absence of disease or infi rmity"3. 
Th is realisation has initiated the discussion on how to improve and measure health. At the 
same time the shift in mortality and morbidity rates of some chronic medical conditions 
(e.g. cystic fi brosis, cancer and metabolic disorders) have encouraged the discussion on 
how to improve quality of life (QoL) in patients. Th e fi rst hit on QoL in PubMed* dates 
back to 1966 and although QoL has become a general concept in research and daily life 
since then, it is still an elusive concept. 
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Th e goal of all medical interventions should be to promote the patient's health, and thus, 
to increase their health related quality of life (H.I. Brunner, 2003). 
* Th e National Library of Medicine's search service that provides access to an electronic database of over 
15 million citations in biomedical literature dating back to the 1950's.
Box 1. Criteria used to defi ne when a disease or condition is considered chronic in childhood 2.
Defi nitions of QoL often include aspects as: "the perceptions of physical, psychological, 
social, cognitive, functional and behavioural dimensions of well-being and function as 
perceived by the person concerned" 1. Th e World Health Organisation QoL (WHOQoL) 
group defi nes QoL as: "an individual's perception of their position in life in the context of 
the culture and value systems in which they live and in relation to their goals, expectations, 
standards and concerns. It is a broad-ranging concept, incorporating in a complex way 
individuals' physical health, psychological state, level of independence, social relationships, 
personal beliefs and their relationships to salient features of the environment" 4. When 
assessing the impact of health and illness on a person's life one hopes to measure the 
subjective perspective called health related quality of life (HRQoL) 5. HRQoL can 
be defi ned as: “a psychological construct which describes the physical, mental, social, 
psychological and functional aspects of well-being and function from a patient perspective” 
6. HRQoL assesses the patient's functioning from a broader scope than clinical measures 
alone to help understand the eff ects of a medical condition on a patient's well-being. Not 
only the objective aspects related to illness and treatment are assessed, but also the more 
subjective concepts surrounding a condition, for example the patient's perception of their 
emotional and social situation 7,8.
 
Over the last decades there has been an increase in publications on HRQoL assessment in 
children and adolescents, healthy or with a chronic medical condition 9,10. In general one 
can distinguish two main areas in which HRQoL assessment can be used: research and 
clinical practice. Most publications on paediatric HRQoL have psychometrically described 
the development and validation of questionnaires 11-17. Numerous evaluative studies of 
children and adolescents with chronic conditions have been published 18-25. Th ere is also 
an increased interest in implementing HRQoL assessment in paediatric clinical trials, for 
instance when choosing between medications or comparing benefi ts or impact of a certain 
treatment regime 26-31.
Th e latest challenge is to implement HRQoL questionnaires in paediatric clinical practice 
for individual assessment 32-34. Th ere is an awareness of the importance of not only treating 
a child's physical condition, but also incorporating the psychological and social aspects, 
acknowledging that the child's total well-being is aff ected by a medical condition 35. One 
reason for this awareness may be that objective measures of disease severity (e.g. pulmonary 
function) have shown modest correlations with how a patient feels and are thus seen 
as insuffi  cient determinants of health status. Th e HRQoL of one patient can also diff er 
extensively with another, even when their objective clinical parameters are similar 36-40. 
Th ere is evidence that HRQoL assessment can aid patient management in adults. Benefi ts 
include monitoring changes in patients, improving the clinician-patient relationship and 
communication, and potential screening for problems 41-48. While HRQoL assessment 
is on the rise in adult clinical practice this is not being imitated in the paediatric setting. 
Although investigators have suggested to assess HRQoL in paediatric clinical 
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practice, proven relevance of HRQoL implementation in paediatric clinical practice 
is unavailable and there are few indications that routine HRQoL assessment is being 
included in paediatric clinical practice 30,33,34,49-51. Th us it is only assumed that, as in adults, 
individual HRQoL assessment in paediatric clinical practice can improve the clinician-
patient relationship, facilitate communication, provide a complete impression of the 
child or adolescents health status, identify existing problem areas and initiate necessary 
intervention. Why HRQoL assessment is not widely included in paediatric clinical practice 
may depend on several factors. Some of these issues include the lack of valid and reliable 
questionnaires, minimal evidence of the benefi t to patient care, the limited availability of 
disease specifi c measures, limited self-completion questionnaires for children and adoles-
cents adapted to their age group, insuffi  cient information on interpretation and use of 
questionnaires, and cultural barriers 9,30,52. 
Th e clinician can add to these barriers through insuffi  cient knowledge of HRQoL, 
constraints on fi nancial and human resources, the belief that HRQoL assessment is 
unimportant, unawareness of available questionnaires or inexperience with questionnai-
res 32,42,47,53,54. Encouraging is the confi rmation that clinicians do consider their patient's 
HRQoL to be important and are interested in implementing HRQoL assessment in 
clinical practice 32,53-56. Th is is reason enough to further develop and improve HRQoL 
assessment and eliminate any obstacles that stand in the way of implementation in clinical 
practice. Moreover, the use of HRQoL questionnaires is likely to improve if clinicians 
have access to valid and easy to use questionnaires with clinical value in areas they fi nd 
important. 
HRQoL and asthma
Th e most common chronic medical condition among children is asthma. Its prevalence 
varies greatly between countries, with a high prevalence in Australia, New Zealand and 
Ireland (20-28%) and a low prevalence (mostly under 5%) in countries in South-East 
Asia and Northern and Eastern Europe 57. Th e majority of children develop their asthma 
before fi ve years of age 58,59. Asthma is a chronic infl ammatory disease of the airways. A 
diagnosis of asthma is mainly based upon clinical observations 60. In susceptible individuals 
infl ammation and airway narrowing can cause recurrent episodes of wheezing, chest 
tightness, coughing (typically nocturnal or exercise related) and shortness of breath 60,61. 
Th ese episodes are usually reversible either spontaneously or with treatment 60 and can 
arise spontaneously or can be triggered by factors such as pollen, cigarette smoke, house 
dust mite, viral infections, exercise or weather changes 61-63. In cases of acute asthma 
exacerbations symptoms can be more severe and in some cases even life threatening 
58,60. Asthma is linked to family atopy, and children with asthma are prone to allergies 
61,62. Asthma management consists of monitoring the course of the disease, avoiding or 
eliminating triggers (allergens, respiratory infections, irritants, chemicals, physical activity 
and emotional stress) that infl uence asthma symptoms or exacerbations, educating patients 
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and pharmacological therapy 60,63. Pharmacological treatment is focussed on suppressing 
infl ammation and reversing bronchoconstriction. Initial treatment usually includes inhaled 
bronchodilators as reliever and, if this is insuffi  cient, inhaled anti-infl ammatory agents as 
protector in daily doses 61,63.
Asthma can impact a child or adolescent's life in several areas 64. Children need to cope 
with taking their daily medication and some may be concerned about possible adverse 
eff ects. Th e symptoms they experience can lead to physical limitations, for example 
during sport or play. Nocturnal symptoms may disturb their sleep 60. Children might 
miss school days or experience poor school performance 60,65. Some may experience fear 
or panic due to the often sudden, life-threatening nature of the attacks 66,67. Th eir social 
activities may be limited due to the necessity of avoiding potential trigger factors (e.g. 
cigarette smoke, house dust mite) or as a result of physical limitations 14. Th e above 
factors can also add to the fear of being rejected by peers because of feeling "diff erent" 
68. Children can be troubled because they cannot integrate fully with their peers, making 
them feel isolated and left out. Any of these experienced limitations in physical, social and 
emotional functioning can cause feelings of anger, depression, anxiety, embarrassment or 
frustration 69-72. A study by Forrest et al. (1997) has also shown that teenagers with asthma 
experience more physical and emotional problems, lower perceived well-being, more 
activity restrictions and more negative behaviours that threaten social development than 
teenagers with no asthma 73. A meta-analysis by McQuaid et al (2001) shows that children 
with asthma have more adjustment diffi  culties and more internalising and externalising 
problems related to the severity of their asthma than healthy children 74. Asthma can 
disrupt the family routines and cause an increase in family stress 75 but can also be aff ected 
by family factors 76. Parents may overprotect a child with asthma, creating the possibility of 
restricting them in their normal daily activities 65,77. 
Overall, there are many factors that can cause extra stress and infl uence a child’s or 
adolescent's mental and physical behaviour. Th ese factors make it important for clinicians 
to become aware of the impact of asthma on a child or adolescent and their family. 
HRQoL questionnaires for children and adolescents are therefore likely to become 
increasingly important for the future of paediatric clinical practice and research. 
Developing HRQoL instruments
An increasing number of paediatric generic and condition-specifi c HRQoL questionnaires 
have been developed since the fi rst publications on paediatric HRQoL in the 1970's 5,9,78. 
Some of the more well-known generic questionnaires include the Pediatric Quality of Life 
InventoryTM (PedsQLTM4.0)79, the Child Health Questionnaire (CHQ)80 and the Child 
Health and Illness Profi le (CHIP)81. Frequently used measures of HRQoL in children 
or adolescents with asthma are the Paediatric Asthma Quality of Life Questionnaire 
(PAQLQ)36 and the Childhood Asthma Questionnaire (CAQ)13,82. 
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In general the development of each new HRQoL questionnaire follows similar phases 83. 
First, one should determine if there is a need for a new questionnaire 32. Secondly a basic 
consensus within the research group should be reached on the content and structure of the 
questionnaire 84. Choices include what one wants to measure, which group to test, their 
age range, their specifi c situation, and how long the questionnaire should be. Subsequently 
one should consider if a questionnaire is to be used for instance for individual assessment, 
group comparison or national screening surveys 85,86. Nowadays there is a preference 
for cross-national questionnaires for use in multi-national clinical trials or to enable 
comparisons between diff erent cultures or social groups 87. Decisions need to be taken 
on whether to develop the instrument in one country and translate it for use in other 
countries (sequential), or develop it cross-nationally (simultaneously)88. 
Th e next phase is to generate questionnaire items through a top-down or bottom-up 
developmental process. Items can be collected in an expert consensus meeting (top-down 
development) and include clinical experience, literature or available questionnaires 11,15,18. 
While the clinician's and even parent's opinion on HRQoL was regarded as suffi  cient, 
it is now known that their opinion can be diff erent to that of the child or adolescent's 
33,89-92. For this reason the bottom-up (patient-derived) process is often applied in which 
the group of interest (e.g. children with asthma) provide the aspects they fi nd important. 
Patient-derived methods can include interviews, focus group discussions or surveys 14,93,94. 
Th e statistical data on selected items, collected in a pilot test, can then help to reduce the 
items and test the domain structure for the fi nal instrument. 
As mentioned before, there have always been restrictions to the use and availability of 
paediatric HRQoL questionnaires. So, although there are several HRQoL questionnaires 
for children and adolescents, new questionnaires are still being developed or improved, 
either for new chronic conditions or for use in new situations. Another reason for the 
ongoing development of new questionnaires is the growing need for (translated) HRQoL 
instruments in cross-national multi-centre studies. Th e aim of the DISABKIDS project 
was to take existing limitations into account and cross-nationally develop a new European 
instrument through a bottom-up process, consisting of a chronic generic and several 
condition-specifi c modules, for use in children and adolescents with a chronic medical 
condition and their parents. 
DISABKIDS 
Th e DISABKIDS project is a collaboration of investigators from seven European countries 
(Figure 1) that set out to develop a new European HRQoL instrument for children and 
adolescents with a chronic medical condition 1. Included in the project were children 
and adolescents in three age groups (4-7, 8-12, 13-16) with one of the following chronic 
medical conditions: asthma, juvenile idiopathic arthritis (JIA), atopic dermatitis, cerebral 
palsy (CP), cystic fi brosis (CF), diabetes or epilepsy. Each country had a consulting role in 
one of the chronic medical conditions. Th e project was funded through the Fifth Frame
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work Research Programme ‘Quality of life and management of living resources’ of the 
European Community and was oriented towards three tasks: 
 1. Developing modules for assessing HRQoL in children and adolescents with 
  chronic medical conditions. 
 2. Psychometrically testing the instruments in diff erent countries. 
 3. Assessing the value of the DISABKIDS instrument by implementing and 
  evaluating it in paediatric clinical practice. 
Th e DISABKIDS project is unique due to the simultaneous cross-national development, 
the patient-derived bottom-up procedure, the modular design, the inclusion of seven 
chronic medical conditions, the wide age range (4-16 years) and the availability of a 
self-assessment and a proxy version. Th e instrument will be available in paper-pencil and as 
computer version in several languages.
Th e DISABKIDS project runs parallel to the KIDSCREEN project, which is an 
epidemiological research project that aims to develop and test a generic HRQoL 
questionnaire in primarily healthy children and adolescents 84,95. 
Th e DISABKIDS and KIDSCREEN projects have defi ned and developed a three level 
modular instrument (Figure 2) by combining the following modules: 
1. Th e KIDSCREEN generic module
2. Th e DISABKIDS chronic generic module






Figure 1. Participating countries in the DISABKIDS project
Figure 2. Modular design of the DISABKIDSα and KIDSCREENβ instrument.
Th e generic module consists of items that are applicable to all children and adolescents, 
healthy or ill. Th is module is capable of measuring HRQoL across patient populations 
and can compare the outcome to a healthy population. Th e chronic generic module, as 
defi ned bij the DISABKIDS group, is applicable to any child or adolescent with a chronic 
medical condition (Box 1). Items relate to areas of life that are aff ected by chronic medical 
conditions. Th is module can be useful in situations where it is important to be able to 
measure HRQoL across diff erent conditions and take into account common areas aff ected 
by chronic conditions. Th e condition-specifi c module assesses those aspects that are 
specifi c to patients with a certain chronic medical condition, often referred to as disease-
specifi c. It can only compare between groups of patients with the same chronic condition 
but has the potential to identify smaller changes important to research or clinical practice 
5,34,96,97. Th is three modular design is unique to the DISABKIDS and KIDSCREEN 
projects and can supply the investigator or clinician with the opportunity to assess HRQoL 
at diff erent levels.
International consensus was reached on the methodology of the questionnaire 
development. Th e procedure was derived from earlier experience of investigators in 
(international) instrument development 15,98-101 and consists of several work packages that 
refl ect a stepwise instrument development procedure (Box 2). 
WP 1: Literature review
WP 2: Focus groups 
WP 3: Item development
WP 4: Translations
WP 5: Pilot study 
WP 6: Analysis pilot study
WP 7: Field study 
WP 8: Analysis fi eld study 
WP 9: Implementation and fi nal results
DISABKIDS work packages
Literature Review (WP 1)
A literature search in Medline (1985-2000) was done for the identifi cation of abstracts 
concerning HRQoL assessment in children and adolescents with a chronic medical 
condition. Available assessment instruments and known HRQoL dimensions were 
reviewed for their use in the project.
Focus Groups (WP 2)
Children and adolescents with asthma, juvenile idiopathic arthritis, atopic dermatitis, 
cerebral palsy, cystic fi brosis, diabetes mellitus and epilepsy participated in focus groups or 
interviews. Statements were collected from the literal transcripts for the item generation. 




Box 2. Work packages (WP) within the DISABKIDS project
Item Development (WP 3)
Th e collected statements were used for the construction of the DISABKIDS instrument. 
Th e statements were divided into separate modules; a generic module, a chronic generic 
module and seven condition-specifi c modules. Th e statements underwent a reduction 
process to limit the amount of items for the pilot instrument. 
Translations (WP 4) 
Guidelines were established to harmonise the translations across countries. Two translators 
independently conducted a forward translation of the English pilot items into the target 
language. Th e translations were reviewed for conceptual equivalence and a single forward 
translation was decided upon. A backward translation was then performed, which was 
compared to the original item for the fi nal translation. Th is process was performed in all 
the participating countries and compared across languages.
 
Pilot Study (WP 5)
Data were collected for the psychometric analysis. Each condition was tested in at least two 
countries, while asthma was tested in all countries. Children and adolescents participated 
in a cognitive interview to determine the comprehensiveness, clarity and acceptance of the 
questions.
Analysis pilot study (WP 6)
Data were collected in an international SPSS† data fi le. Th e analysis was carried out at an 
international level using classical multi-scaling as well as modern psychometric methods. 
Th e fi nal domains were determined and item numbers reduced through quantitative 
psychometric analysis and the qualitative cognitive interview. 
Field study (WP 7)
Data were collected to test the psychometric performance of the pilot instrument in 
populations of children and adolescents with selected chronic conditions. Asthma was 
again tested in all countries.
 
Analysis fi eld study (WP 8)
Th e fi nal scale structure of the DISABKIDS instrument was tested, including the 
reliability, validity, retest-reliability and the construct validity. 
Implementation (WP 9)
Th e DISABKIDS instrument was implemented and tested in several settings. Analyses are 
still in progress. A paper and computer version was made available in several languages. 
† Statistical Package for the Social Sciences: software package used for conducting statistical analyses.
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Outline of this thesis
In this fi rst chapter we set out to explain some general principles related to HRQoL, 
asthma, developing a questionnaire and the DISABKIDS project (Chapter 1). Th e second 
chapter describes a survey done under the members of the Dutch Paediatric Association. 
Th e objective was to learn more about the perspectives of the paediatricians on HRQoL 
assessment in clinical practice. Knowing what the opinion of a future user group is helps 
to implement a new HRQoL questionnaire, like the DISABKIDS instrument (Chapter 
2). Th e third chapter describes the applied patient-derived methodology. Focus groups 
and interviews were used to identify the relevant aspects of HRQoL from children and 
adolescents with chronic medical conditions. Statements for the chronic generic and 
condition-specifi c modules were generated through this patient-derived method. Focus 
groups have proven to give a good indication of what the patient fi nds important and 
therefore emphasises the importance of the DISABKIDS bottom-up procedure (Chapter 
3). Th e results of the asthma focus groups and interviews, conducted in four European 
countries, are described in chapter four. Recurring themes are discussed and aspects related 
to living with asthma are described in a quantitative manner (Chapter 4). Qualitative 
data was collected from the cross-national DISABKIDS focus groups and interviews. Th e 
sequential reduction steps necessary to cut down the vast amount of collected statements 
for use in the pilot study are set out in chapter fi ve (Chapter 5). Th e development of 
the seven condition-specifi c modules is described in chapter six. A stepwise analysis 
was applied including the statistical results from the pilot and fi eld study, the cognitive 
interview and expert opinions (Chapter 6). Th e validation study of the asthma population 
is presented in chapter seven. Th e relationship between HRQoL, disease severity and 
existing questionnaires is evaluated (Chapter 7). Th e discussion is laid out in chapter eight 
in which limitations of questionnaire development and future suggestions for research are 
presented. Concepts regarding the implementation of individual HRQoL assessment in 
clinical practice are discussed, including limitations, necessary requirements and clinical 
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Abstract
Th is study was undertaken to investigate paediatric clinicians’ views on and use of quality 
of life (QoL) assessment in clinical practice. A survey was conducted among members 
of the Dutch Paediatric Association via e-mail. Over half of the 303 respondents (57%) 
believed that it was possible to use QoL questionnaires in clinical practice. Th e majority 
indicated that assessing QoL was benefi cial and that it was especially necessary to assess 
QoL in children with a chronic disease (82%). Although only a minority (17%) currently 
used QoL questionnaires, most respondents would want to use QoL questionnaires in 
the future (76%). Obstacles that prevent the use of QoL questionnaires are the extra time 
needed for assessment, the unavailability of standardized questionnaires and insuffi  cient 
knowledge about QoL. Th is survey shows that paediatric clinicians are positive towards 
QoL assessment, but that certain obstacles prevent the use of questionnaires. Th us, to 
facilitate future use, QoL questionnaires need to be developed from the perspective of the 
paediatrician. Th is means that they need to be developed for clinical use and brought to 
the attention of the paediatric health care community, demonstrating their validity to child 
health care. 
Introduction
Questionnaires designed to measure quality of life (QoL) have been developed and tested 
since the 1970s 1. Th ey are increasingly being used as assessment and outcome measures in 
clinical research trials in adults 2. Assessment of QoL has also improved in the paediatric 
fi eld. Th ere is an increase in the availability of generic and disease-specifi c questionnaires 
for use in children and adolescents 3-6. However, QoL is seldom included as an outcome 
measure in paediatric clinical trials or in clinical practice 7-9. 
Until recently most investigators have concentrated on the development and validation 
of QoL questionnaires for research. At present an increasing number of investigators have 
expressed their interest in using QoL questionnaires for individual assessment and see 
the implementation of individual QoL questionnaires into clinical practice as the current 
challenge in the fi eld of QoL research 1,10-12. In adult research QoL assessment has already 
proven to be helpful. Evidence has indicated that QoL assessment is benefi cial as an aid 
to patient management. Th is includes improving the clinician-patient relationship and 
communication, better monitoring changes in patients, screening for potential problems, 
and if necessary, referring to other professionals 11,13-18. Unfortunately, the paediatric fi eld 
lacks studies that provide proof that QoL assessment has similar benefi ts for the child's 
health.
If respondents do not believe that QoL information is clinically relevant, it appears 




Th ere is some information on the attitude of clinicians towards using QoL measurements 
for patient care. Th is research comes mostly from the adult oncology fi eld 14,19-25. Walsh’s 
survey (1988) showed that although clinicians believe that QoL can be measured, only 
a few used a specifi c method or were aware of available instruments 25. In the study by 
Taylor et al. (1996) the majority of respondents considered it important to collect QoL 
information from their patients but they tended to do this informally. Only 7% routinely 
assessed the QoL of their patients in a structured manner 24. Identifi ed obstacles for QoL 
assessment were: time and resource constraints (money and human resources), lack of 
evidence-based intervention studies on their benefi t to patient care, a perceived lack of 
appropriate instruments, lack of knowledge, unavailable interpretation guidelines and a 
belief that QoL assessment is unnecessary 15,18,22,24. No literature was found on paediatrici-
ans’ views on QoL assessment in clinical practice, and there is no indication that paediatric 
health care professionals implement available QoL questionnaires on a regular basis. Th e 
objective of this study is to assess the use of QoL questionnaires and the perspective of 
paediatric clinicians towards QoL assessment in paediatric care. 
Material and methods
Th e aim was to evaluate (a) the paediatric clinicians' perspectives on quality of life 
and QoL questionnaires in clinical practice, (b) their willingness to assess QoL and (c) 
the obstacles preventing the use of QoL questionnaires. As the familiarity with QoL 
questionnaires and their terminology was assumed to be minimal, we did not use a specifi c 
QoL concept but referred to QoL in general. We designed a questionnaire (see appendix) 
based on earlier studies 22-25. Questions regarding the clinicians’ gender, age, profession, 
years of working experience, sub-specialization and hospital affi  liation were included. A 
pilot test was carried out among clinicians for comprehension, ease of use and completion 
time. 
Th e registry of members of the Dutch Paediatric Association (n=1780) was used to 
identify the study group. Members mainly include house-offi  cers, paediatric registrars, 
paediatricians and retired paediatricians. Between May and July 2002, the self-
administered questionnaire was emailed to those members for whom an email address was 
available (n=1036). A reminder was sent a month after the fi rst mailing. Th e electronically 
returned questionnaires were directly converted into a format of the Statistical Package 
for the Social Sciences (SPSS), the input of the mailed questionnaires was done by hand. 
Descriptive statistics were generated with the SPSS 10.0. Th e Pearson Χ2 test was used to 
calculate the statistical diff erence within the population.
Th e heads of the paediatric departments of each of the eight university hospitals in the 
Netherlands were also contacted and asked to participate in a semi-structured interview 





Of the 1036 emailed members, 362 replied (35 %), either by email or mail. A total of 303 
questionnaires were used for the analysis. Th e other 59 responses were excluded, mostly 
because the questionnaire was not attached to the email or an empty questionnaire form 
was returned. Some of these respondents indicated that they thought the questionnaire was 
not applicable to them or did not want to participate. 
Demographics
Th e demographic characteristics of the study group are listed in Table 1. Th e studied 
population had a larger proportion of paediatricians and more respondents from university 
hospitals. 
Th e respondents' perspectives on quality of life and QoL questionnaires
Sixty-nine percent of the respondents were familiar with the existence of QoL 
questionnaires for children. Most had heard of them through the literature (40%) and 
from conferences (32%). Aspects that were seen as most important for QoL were physical 
functioning, social contact, pain, self-respect and daily life activities. Th e majority of the 
respondents (72%) thought it was possible to assess QoL in a research setting, only 57% 
thought this was possible in a clinical setting. Sixty-one percent of responders indicated 
that they always assessed the patient's QoL informally during their consultation. Most 
clinicians did not use any formal method to assess QoL, only a few indicated ever using 
a paper (17%) or a computer-aided (6%) QoL questionnaire. If valid and reliable QoL 
questionnaires would be available to them in the future, 76% would fi nd them useful. 















































Table 1. Demographics of the studied population (n = 303) compared to the remaining 
members of the Dutch Paediatric Association (n = 1477).
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Th e majority (71%) indicated that a specialized nurse could be primarily responsible for 
the assessment of a patient’s QoL. Th e paediatrician, the psychologist and the hospital 
play specialist were also seen as suitable assessors of QoL by 58%, 56% and 50% of the 
respondents, respectively. Ideal methods of assessing QoL (formally and informally) were 
found to be the doctor’s consultation (64%), a paper QoL questionnaire (53%) and a 
computer-aided QoL questionnaire (50%). 
Willingness to assess QoL 
Although 76% of the respondents indicated that they would want to use QoL 
questionnaires in the future, only 60% expected to actually do this. QoL assessment was 
found relevant for use in paediatrics, clinical research and especially for children with a 
chronic disease. Eighty-two percent of the respondents think it is necessary to formally 
assess QoL in children with a chronic disease (Table 2). 
Patient group Not necessary In some cases Necessary




















Obstacles preventing the use of QoL questionnaires
Respondents were asked which main obstacles would prevent them from using QoL 
questionnaires in the future. Th e main obstacles were the extra time needed for assessment, 
the unavailability of standardized questionnaires and their insuffi  cient knowledge about 
QoL (Table 3). When asked whether they think they now have the skill and knowledge to 
use QoL questionnaires, 70% answered negatively.
Perceived obstacles Percentage of respondents
Extra time needed for assessment
Unavailability of standardized questionnaires
Insuffi  cient knowledge about QoL
No assistance in administering questionnaires
Inexperience with questionnaires
Needed training in interpretation
Insuffi  cient information on questionnaires
Needed training in administration
Resistance from child or parents
Own priorities are diff erent













Table 2. Opinions on the necessity to measure QoL in diff erent patient groups (%).
Table 3. Perceived obstacles preventing paediatricians from using QoL questionnaires (%).
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Subgroup analysis
Th e respondents who were familiar with the existence of QoL questionnaires (n=206) were 
signifi cantly more positive about their use. Th ey were more likely to see the possibility 
of their use in a clinical setting (p=0.00) and in research (p=0.023) and were also more 
positive about using QoL questionnaires in the future (p=0.049) than the respondents 
who were not familiar with QoL questionnaires. Th ey also scored signifi cantly higher on 
the feeling that they had the skill and knowledge to use QoL questionnaires (p=0.033). 
However, they saw the unavailability of standardized questionnaires as a larger obstacle 
(p=0.038). Respondents who worked at a university hospital (n=171) were signifi cantly 
more familiar with the existence of QoL questionnaires than the group working in a 
community hospital (p=0.007). Respondents with less than 10 years of work experience 
(n=147) and registrars (n=58) were signifi cantly less familiar with the existence of QoL 
questionnaires (p=0.03 and p=0.019, respectively). Th ey also scored signifi cantly higher on 
the obstacle: 'inexperience with questionnaires' (p=0.001 and p=0.008, respectively).
Interview with heads of the paediatric departments
Seven of the eight heads of the university paediatric departments participated in an 
individual semi-structured interview. Th ey believed that most paediatricians were 
aware of the existence of QoL questionnaires, but suspected that most of them see 
QoL questionnaires primarily as a research instrument and that they perceive the use of 
QoL questionnaires to be subjective and unreliable for clinical use. Th ey propose that 
paediatricians are only open to innovation when they can see the benefi t and eff ectiveness 
of a new method. Th ey stated, therefore, that it was important to further validate 
existing questionnaires and demonstrate their benefi t in clinical practice. Th ey indicated 
that implementation of QoL questionnaires in clinical practice would be prevented 
by the following problems: limited time and manpower, insuffi  cient fi nances, lack of 
standardization, insuffi  cient knowledge and unproven benefi t. For these reasons, it was 
implied that paediatricians would probably not administer the questionnaires. Th ey said 
that the professionals who could facilitate the assessment, analysis and interpretation of 
QoL questionnaires were registrars, specialized nurses and psychologists. 
Discussion 
Th e aim of the current study was to explore the clinicians’ view on QoL assessment in 
paediatric clinical practice. Similar to earlier studies, we found that clinicians are positive 
towards the use of QoL questionnaires, but that assessing QoL formally is uncommon 
23,24. Th e respondents saw the assessment of QoL in children with a chronic condition as 
especially important, and they believed that assessment should mainly be a task for the 
specialized nurse. It was stressed both by the survey and semi-structured interviews with 
the heads of paediatric departments that greater acceptance of QoL measurement is reliant 
upon evidence-based research that shows that QoL questionnaires are valid, reliable and 
benefi cial and that standardized questionnaires should be easily accessible and provide 
ample information on interpretation and use. 
chapter 2
While the majority of the respondents indicated that they would be interested in using 
QoL questionnaires, only a few currently used them and a small majority expected 
that they would actually use them in the future. Th is can be explained by the number 
of obstacles that they expect to encounter, such as the unavailability of standardized 
questionnaires, limited time for assessment and insuffi  cient knowledge about QoL. Th ese 
obstacles were similar to those found by others outside the paediatric fi eld 18,19,22,24. To 
stimulate clinical implementation, it is thus important to do more research on validating 
questionnaires and provide evidence of their benefi t for clinical practice. If, in the future, 
paediatricians have access to valid questionnaires in areas they indicate are important, such 
as the QoL assessment of children with a chronic disease, this is likely to substantially 
increase their use.
Limited time for the completion of the questionnaires in the clinical setting is a major 
problematic aspect. Administering QoL questionnaires and scoring them takes extra time. 
A possible solution would be to further develop computerized questionnaires that can 
be used in the clinical setting. Th ese can easily be administered, supply automatic data 
analysis and give instant results with a possibility to compare them to earlier measurements 
or a norm population 16,26,27, thus eliminating one of the major obstacles to questionnaire 
use. Being familiar with QoL questionnaires was associated with a more positive attitude 
towards their use. Th us, steps need to be taken to inform clinicians and other professionals 
about available questionnaires and the possibilities for their use in clinical practice. Th is 
is especially important for clinicians who have just started their careers and clinicians 
working in community hospitals. Th is indicates the importance of QoL data being 
reported in journals familiar to paediatric clinicians. It was also indicated how important it 
is to introduce a more multidisciplinary approach towards QoL assessment, as respondents 
noted the specialized nurse as someone who would be an appropriate person to administer 
QoL questionnaires. 
Th e major limitation of this study is that the fi ndings are related to a sample, which 
represents the opinion of only 17 % of the Dutch Paediatric Association. However, the 
response rate in our study (35%) was higher than the percentage (26%) achieved in a 
recent study by McMahon et al (2003). Th ey compared a fax, post and email survey of 
paediatricians and found that their response rate, after 2 mailings, was 26% for email, 
41% for post and 47% for fax 28. Our response rate might have been improved if we had 
sent reminders by postal mail; however, time and fi nancial factors prevented this at that 
time. Another aspect infl uencing the response rate was that there was no possibility to 
check whether the email addresses were actually being used. We also found that some of 
the respondents were inexperienced in opening, completing and returning an attached 
fi le via email. Th eoretically, members already interested in QoL issues might be more 
likely to return the questionnaire, which would lead to a more positive attitude towards 
QoL assessment. However, we propose that the representativeness of the sample might be 




departmental heads and the survey group, correspond. Th e survey also consisted of a large 
number of respondents who were not familiar with QoL questionnaires (30%) or found it 
was not (yet) possible to use QoL questionnaires in clinical practice (37%), indicating that 
the group represented a wide range of experience with QoL measurement.
Conclusion
Th is study demonstrates the necessity of taking the clinicians' perspective into account in 
the development of QoL questionnaires for clinical practice. Th e paediatric clinicians in 
this survey were interested in QoL assessment and felt that this was especially necessary 
in the treatment of children with a chronic disease. However, they identifi ed a number of 
obstacles for the use of QoL questionnaires. Th us, if QoL questionnaires are to become 
an important part of the patients' assessment, more consideration needs to be given to the 
obstacles, to their use in the clinical setting, and to promoting the questionnaires to the 
health care community. 
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In this questionnaire you will fi nd questions on the use of quality of life (QoL) measures within paediatrics. 
Each part of the questionnaire will be clarifi ed with explanatory text. For the question you can tick that box that 
in your opinion is most appropriate. Th ere are no right or wrong answers. What you think is of importance. 
Completing the questionnaire will take 10 minutes.
It is diffi  cult to give an exact defi nition of quality of life (QoL) . Th rough the years several defi nitions have been 
presented. We have selected several subjects. Which of the following subjects are according to your opinion most 
important for QoL? (maximal 5 answers possible)
❏ Physical functioning ❏ Body image
❏ Vitality ❏ Mobility
❏ Treatment load ❏ School functioning
❏ Pain ❏ Satisfaction 
❏ Limitations ❏ Emotions 
❏ Autonomy ❏ Cognition 
❏ Home situation ❏ Social contacts 
❏ Daily life activities ❏ Illness load
❏ Future ❏ Creativity
❏ Religion ❏ Coping
❏ Self respect ❏ Other.......                           
We are curious about your opinion on measuring QoL with the help of questionnaires. 
Do you think QoL can be....
Yes Not yet No No opinion
Defi ned? ❏ ❏ ❏ ❏
Objectifi ed? ❏ ❏ ❏ ❏
Validly measured? (measure what it should measure) ❏ ❏ ❏ ❏
Measured reliably? (continuously measure the same) ❏ ❏ ❏ ❏
Used in the clinic? ❏ ❏ ❏ ❏
Used in research? ❏ ❏ ❏ ❏
In what way do you currently form an opinion on the child and parents QoL during (outpatient) consultation?
   
 Never Sometimes Always
Intuition ❏ ❏ ❏
Clinical experience ❏ ❏ ❏
In your consultation ❏ ❏ ❏
From another health care workers consultation ❏ ❏ ❏
A paper questionnaire ❏ ❏ ❏
A computerised questionnaire ❏ ❏ ❏




What, in your opinion, would be the ideal way to form an opinion of a child and parents QoL?
Not Sometimes Useful
Intuition ❏ ❏ ❏
Clinical experience ❏ ❏ ❏
In your consultation ❏ ❏ ❏
From another health care workers consultation ❏ ❏ ❏
A paper questionnaire ❏ ❏ ❏
A computerised questionnaire ❏ ❏ ❏
Other .......                                 
Several questionnaires to measure QoL in children have been developed in the last years 
Are you familiar with the existence of these questionnaires? 
❏ No
❏ Yes,  (more answers possible) 
❏ While at university 
❏ While specializing 
❏ From literature
❏ During courses
❏ At a conference
❏ Other                            
In this next part we are curious about your opinion on the importance of quality of life questionnaires in the 
care for children and their parents. How relevant do you fi nd the use of QoL questionnaires for:
Not Hardly A little Considerable Very
Routine treatment ❏ ❏ ❏ ❏ ❏
Treatment of the child with a chronic disease ❏ ❏ ❏ ❏ ❏
Treatment of a child with unexplainable complaints ❏ ❏ ❏ ❏ ❏
Clinical research ❏ ❏ ❏ ❏ ❏
Improvement of the general health of a child ❏ ❏ ❏ ❏ ❏
Certain choices in your treatment ❏ ❏ ❏ ❏ ❏
Paediatrics ❏ ❏ ❏ ❏ ❏
Paediatricians in Holland:
Never Seldom Sometimes Often Always
Th ink that questionnaires need to be included in the treatment ❏ ❏ ❏ ❏ ❏
Find it praiseworthy/commendable when I use QoL questionnaires ❏ ❏ ❏ ❏ ❏





It is completely my own choice whether I use QoL questionnaires ❏ ❏
I have the skill and knowledge to use QoL questionnaires ❏ ❏
Assuming that valid and reliable QoL questionnaires will be available in the future what would you in general 
think about using these QoL questionnaires your self?
1 2 3 4 5
Not useful ❏ ❏ ❏ ❏ ❏ Very useful
Very time-consuming ❏ ❏ ❏ ❏ ❏ Very time-saving
Very uninteresting ❏ ❏ ❏ ❏ ❏ Very interesting
Can you indicate what aspects would keep you from using QoL questionnaires in clinical practice? (several 
options)
❏ Your own priorities are diff erent ❏ Availability of extra working space for assessment
❏ Insuffi  cient knowledge about QoL ❏ Extra time for assessment of the questionnaire
❏ Inexperience with questionnaires ❏ Training in administering the questionnaire
❏ Resistance from child and parents ❏ Training in the interpretation of the questionnaires
❏ Insuffi  cient information on questionnaires ❏ No assistance in administering the questionnaire
❏ Availability of standardized questionnaires ❏ Other.......                        
Do you think it is necessary to formally measure QoL through standardized questionnaires in … 
Not necessary Necessary in some cases Necessary
Children at the outpatient clinic ❏ ❏ ❏
Admitted children ❏ ❏ ❏
Acutely ill children ❏ ❏ ❏
Chronically ill children ❏ ❏ ❏
Children with unexplainable complaints ❏ ❏ ❏
Other .......                                          
What discipline should, according to you, be primarily be responsible for the administering QoL questionnaires 
from children and their parents. (more answers possible)
❏ Paediatrician ❏ “ Well baby” health clinic
❏ General nurse ❏ Teacher
❏ Specialised nurse (e.g. diabetes nurse) ❏ Psychologist
❏ General practitioner ❏ Hospital play specialist 
❏ Social worker ❏ Other.......                                          
Clinicians’ perspective
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Assuming that in the near future valid and reliable quality of life questionnaires (paper or computer) will be 
available in paediatrics.
Would you want to use QoL questionnaires in your treatment?
❏ Certainly not ❏ Probably not ❏ Maybe ❏ Probably will ❏ Surely will
Do you plan to use QoL questionnaires in your treatment?
❏ Certainly not ❏ Probably not ❏ Maybe ❏ Probably will ❏ Surely will
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Abstract
A cross-national patient-derived methodology was applied during the development 
of the European DISABKIDS health related quality of life (HRQoL) instrument to 
identify relevant HRQoL statements. Focus groups were used in the DISABKIDS 
project to include the child and adolescent's own concepts, language and culture, 
and to acknowledge the patient as the expert in their own lives. Participants included 
children and adolescents with a chronic medical condition, their parents and health care 
professionals. Focus groups were monitored by two moderators and facilitated by a series 
of semi-structured questions and probes. HRQoL statements were identifi ed from the 
literal transcripts for the development of the European DISABKIDS instrument. Th e 
DISABKIDS manual served as a guide to assure that a similar method was used in all 
countries. Th e focus groups and interviews were conducted in eight institutions in seven 
European countries. Participants included 154 children and adolescents with a chronic 
medical condition, 142 family members and 26 health care professionals. Focus group 
progress was related to the developmental abilities of the child. A total amount of 3515 
HRQoL statements were collected. Th ese statements have subsequently been used for 
the development of the DISABKIDS instrument. Th is patient-derived procedure made 
it possible to refl ect on aspects that are important to the patient group and phrase items 
in their own words. However, a number of issues need to be considered when adapting 
the focus group methodology for use in children and adolescents, which include the 
developmental abilities of the participants. 
Introduction
In the past children and adolescents have often been treated as passive receivers of medical 
services and health care. Even paediatric health related quality of life (HRQoL) was 
often assessed by the parent instead of the child 1-3. As proxy measures are not necessarily 
representative of how the child or adolescent feels the focus is currently directed towards 
the child and adolescent 4-7.
Including the young patient's opinion is now recognised as important, not only for the 
assessment of their HRQoL but also during the questionnaire's developmental process 8-12. 
As HRQoL is inherently an attribute of the patient, the questionnaire should refl ect the 
concerns and opinions that are important to the patient. Using only expert opinions for 
the development of a questionnaire is thought to lead to investigator bias and poor face 
and content validity 13. Th erefore the patients should be involved in the development of 
a questionnaire 13,14. As a consequence patient-derived methods are being used as an aid 
in the development of HRQoL questionnaires. Th e focus group methodology is such a 
Without including children in the main stage of HRQoL research, we believe that 
children's fundamental beliefs, feelings and understanding of their disorders and their 
interface with society might not be revealed (G.M. Ronen, 2001).
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patient-derived method, which is regularly used in de development of paediatric HRQoL 
questionnaires 10,11,15. 
Focus groups have been defi ned as "a research technique that collects data through group 
interaction on a topic determined by the researcher" 16. It is a qualitative research method, 
which helps to understand beliefs, views, knowledge, ideas, attitudes and experiences in 
a certain group in relation to a certain topic. It gets its advantage from group interaction, 
which can deepen and clarify topics within a group 17-19. Th e communication and 
interaction between the participants can generate useful data and allows the investigator 
to learn about the participants’ perspectives. Focus groups were fi rst used as a marketing 
research tool but are now more widely used for health care research and services. Within 
a focus group, one can address clinical questions, identify problems or learn how patients 
experience illness or health care services. Focus groups are also found to be useful in a 
preliminary phase of a study to identify important research issues or develop suitable items 
for a new questionnaire 8,14,18,19.
Th ere is however little information available on the methodological adaptations that are 
necessary to run focus groups with children and adolescents 8,17. One can assume that 
there is a need to consider issues related to the child and adolescent's developmental 
level. Such issues include the child and adolescent's verbal comprehension, their ability 
to report back on a specifi c time period, and the age appropriateness and changing 
importance of HRQoL issues 20. When conducting focus groups or interviews with 
children and adolescents one especially needs to consider that their communication and 
social skills depend on their age and attained cognitive level 17,20,21. Although their skills 
and developmental level may form a challenge in focus group research, the developmental 
variability of the child and adolescent is also an advantage. Focus groups can provide 
investigators with the child and adolescents own ideas, supplied in their language and 
including their view of health, which can help to adapt the questionnaire to their level of 
understanding.
Th is paper describes the cross-national patient-derived method that was applied in the 
European DISABKIDS project. Focus groups and interviews were conducted with 
children and adolescents with chronic medical conditions, their parents and health 
care professionals to capture their view on HRQoL. A description will be given of the 
methodology used in this large cross-national project. Positive and negative aspects will be 
discussed, which will help in the application of the focus group methodology with children 
and adolescents in the future. 




Th e DISABKIDS project
Th e DISABKIDS project is a European collaboration, which consists of eight partner 
institutions in seven countries (Austria, France, Germany, Greece, the Netherlands, 
Sweden and the United Kingdom). Th e aim was to cross-nationally develop a new 
European HRQoL instrument for children and adolescents with a chronic medical 
condition in several countries simultaneously 22. Chronic medical conditions included 
in the project are asthma, juvenile idiopathic arthritis (JIA), atopic dermatitis, cerebral 
palsy (CP), cystic fi brosis (CF), diabetes and epilepsy. Th e DISABKIDS project intends to 
provide for the growing need of multilingual cross-nationally validated paediatric HRQoL 
instruments for use in (international) clinical trials and clinical practice 23. Th e fi nal 
instrument has a modular build-up, with a chronic generic module that is applicable to all 
children with a chronic medical condition, and seven condition-specifi c modules.
Th e items for the DISABKIDS instrument were collected through a patient-derived 
(bottom-up) procedure based on focus groups and interviews with children and 
adolescents with a chronic medical condition. Th is child focused research method was 
applied in each of the DISABKIDS centres and provided the opportunity to capture the 
child’s perspective on HRQoL. Th e identifi ed HRQoL statements comprised the data 
pool from which the fi nal instrument items were constructed. Focus group discussions 
and interviews were also conducted with parents and health care professionals in order to 
incorporate their views into the DISABKIDS instrument. 
Th e DISABKIDS focus group methodology
To assure that a similar method was used in all countries a manual was developed which 
included the outline of the focus groups and the semi-structured questions. In view of 
time and resource constraint and if participants were unable to attend a planned focus 
group there was the option of participating in an individual interview. Each centre was 
responsible for training the moderators and recruiting participants for the focus groups 
and interviews. 
Each of the eight DISABKIDS partners aimed to run focus groups for at least two to three 
chronic conditions. Separate focus groups were conducted for each chronic condition and 
were divided by age (4-7, 8-12 and 13-16). Each focus group did include a mixture of 
disease severity and gender. Th e general aim was to have between 4 and 8 participants in a 
focus group 17. Parents and health care professionals participated in separate focus groups 
or interviews. 
Two moderators ran the focus group discussions. Both moderators were familiar with 
group discussions as well as working with children. While the fi rst moderator led the 
discussions the task of the second moderator included the technical aspects of tape-
recording, observing the group and writing down content and non-verbal behaviour 
during the session. 
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At the start of each focus group the aim, duration and confi dentiality was explained to 
the participants. Permission for the audio-taping was also asked. Th e moderators used the 
semi-structured focus group questions supplied in the manual (Box 1). Th e discussion was 
led in a non-directive fashion. Th e questions were chosen in order to lead the participants 
from a general discussion to more specifi c information about their quality of life. If 
necessary probe questions were used to stimulate conversation.
Semi-structured questions:
What do you like about your life?
What do you like best about your life?
What makes you happy?
What bothers you most in your life?
What kind of things keeps you healthy? (coping styles / activities)
If you could make a wish, what would you wish for in order to be happier or more satisfi ed?
Tell me about condition. (e.g. epilepsy / diabetes / asthma etc.)
Apart from yourself, do you know any other children with this condition?
How does their condition aff ect them at school / home? 
How does your condition aff ect you at school / home?
What would you like people to say at school / home / hospital to help?
What would you like people to do at school / home / hospital to help?
More specifi c questions:
What do you think of your condition?
What do you think of your medication / treatment / hospital / the doctors.
What are the disadvantages of having your condition? Are there advantages?
Do you know what other kids think of you having this condition? 
Are you diff erent compared to children without this condition?
Th e focus groups were organised into two parts (Table 1). Part one was intended to discuss 
various health and illness related topics. Part two allowed the children and adolescents to 
write down questions that would give a clinician a good impression of their HRQoL. Th ey 
also listed which questions they found most important and possible question formats and 
response categories were discussed. 
Th e focus groups and interviews were tape-recorded and transcribed verbatim to conserve 
the exact expressions used by participants. Statements related to HRQoL were identifi ed 
from the literal transcripts to form a pool from which the fi nal items were constructed. 
Phase Time frame Purpose
Part 1 Introduction 5 min Warm up
Discussion 35 min Discussing perceived HRQoL issues
Break 10 min
Part 2 Question construction 30 min Writing individual questionnaire items 
Debriefi ng 10 min Group evaluation and any missing topics
A child focus group methodology
Box 1. Prepared semi-structured questions included in the focus group and interview manual.
Table 1. Focus group structure.
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Participants
Th e participants (children, adolescents and their parents) were chosen via the hospital 
register or patient associations and had a confi rmed diagnosis of one of the seven chronic 
medical conditions included in the project protocol (asthma, JIA, atopic dermatitis, 
CP, CF, diabetes or epilepsy). All potential participants were contacted by letter with an 
explanation of the project and details of what they would be asked to do. Families willing 
to participate returned a form agreeing to the study and were contacted via telephone in 
order to co-ordinate a date suitable for all focus group participants to meet. All participants 
had inclusion criteria to comply to (Box 2). Th ere was no requirement that the participants 
should be unknown to each other. Th e participants completed a standardised consent 
form prior to entering the focus groups and interviews. Where possible the location of 
the groups was outside the hospital premises. Th e focus groups were divided by chronic 
condition and stratifi ed by age (4-7, 8-12 and 13-16 years). Each focus group consisted 
of a mixture of disease severity and gender. Parents were invited to participate in separate 
focus groups (grouped according to the chronic condition and age of their child). If 
participants were unable to attend a planned focus group they could take part in a personal 
interview. Health care professionals were contacted directly by the investigators and were 
often affi  liated to the research centres. Th e European commission approved the study as 
well as each of the Medical Ethics Committees in each study centre. 
Inclusion criteria:
• Consent to participate in the study 
• Between 4 and 16 years of age
• Have one of the seven chronic conditions
• No other chronic medical condition
• Suffi  cient knowledge of language and able to express themselves
Results
Focus groups and interviews were conducted in each of the DISABKIDS centres: the 
University of Vienna in Austria, the University Hospital of Marseille in France, the 
University Hospital of Hamburg in Germany, the Medical University of Lüebeck in 
Germany, Th essaloniki University Paediatric Clinic in Greece, Leiden University Medical 
Center in the Netherlands, the University Hospital of Lund in Sweden and the Royal 
Hospital for Sick Children in Edinburgh the United Kingdom. Th e University of Verona 
in Italy participated in the focus group research as an affi  liated centre. Moderators were 
members of the research teams. Each centre included one to three chronic conditions 
(Table 2), which included separate focus groups for the diff erent age ranges and parent 
groups. 
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Country Condition A Condition B Condition C
Austria Diabetes mellitus
France Epilepsy
Germany (H*) Atopic dermatitis
Germany (L†) Juvenile idiopathic arthritis Cerebral Palsy
Greece Cystic Fibrosis Asthma
Italy Asthma
Netherlands Asthma Juvenile idiopathic arthritis 
Sweden Diabetes Mellitus Epilepsy Asthma
United Kingdom Cerebral Palsy Epilepsy
A total number of 322 participants contributed to the DISABKIDS focus groups and 
interviews. Of these 154 were children and adolescents, 142 were family members and 
26 health care professionals. Th e data output consisted of the focus group and interview 
tape-recordings, notes from the moderators and cards or fl ipchart pages with suggested 
questions written by the children and adolescents. Th e group size ranged from three to six 
persons in each country and the time to complete the focus groups was between 60 and 90 
minutes.
Th e Greek centre used videos as 'warming-up' activity at the start of the focus groups. Th is 
helped to relax the children. Others applied a general introduction round. Th e moderator's 
task was to stimulate new topics and guide the discussion, which was sometimes 
experienced as diffi  cult, especially with the youngest age group. Young children were 
not always able to express their opinion or feelings in more than a few words. Answers 
were short and it was hard to stimulate group discussions. From the age of 6 there was a 
noticeable increase in their ability to express themselves. Interaction with group members 
was apparent from the age of 10 years. In some instances one speaker dominated the dis-
cussion while another child hardly spoke. Th e large age variation in the adolescent groups 
presented a few problems, for example the life experience of a 13 yr old boy can be very 
diff erent to that of a 16 yr old girl. Th e amount of time children could focus on the topic 
increased by age and reached a maximum of 90 minutes in the adolescent groups. Parents, 
on the other hand, were reluctant to stop at the end of the sessions. In the parent and 
health care professional groups the discussions developed automatically. Th ere was group 
interaction with participants discussing topics with each other and not just answering the 
moderator's questions. On the whole all the participants indicated that they welcomed this 
opportunity to talk to others in a similar situation, felt they where acknowledged as experts 
and would volunteer to participate in similar exercises in the future.
A child focus group methodology




Th e tape-recordings were written or typed out literally, and included the notes and 
observations from the second moderator. Th is process was time consuming and took 
between 6 to 10 hours. Each country selected relevant HRQoL statements from their 
national focus group or interview transcripts. Th is resulted in a total amount of 3515 
statements. Collected statements showed various similarities between countries. Medical 
aspects such as treatment and symptoms were discussed in all countries. Other recurring 
topics included experienced limitations, school, relationships with peers, and emotional 
reactions to having a chronic medical condition. Th e parents often discussed the health 
care system extensively. Th e collected statements, clustered by condition, were divided into 
three modules (generic, chronic generic and condition-specifi c). All the statements that 
were not directly related to health or a chronic medical condition (n=488) were merged 
to form a generic module. Th e statements that were applicable to any chronic medical 
condition (n=1647) were merged to form the chronic-generic module. Th e statements that 
were specifi c to each of the medical conditions (between 340 and 66 statements) formed 
the seven condition-specifi c modules (Table 3). 
Th is division was the basis of the three-modular structure; the generic, chronic generic 
and condition-specifi c modules. From this point onwards the statements in each module 
underwent a reduction process for the development of the pilot instrument. Th ese results 



















Th e focus groups and interviews enabled a bottom-up procedure for the development 
of the DISABKIDS instrument. Although focus groups and interviews have been used 
previously for the development of paediatric HRQoL questionnaires this has not been 
done simultaneously in several countries and for several chronic medical conditions. 
Th e applied patient-derived method has proven to be eff ective for data collection in the 
DISABKIDS project. All centres reported that there were many spontaneous responses, 
which suggests that participants were using their own way of expression and ideas. 
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Th ere are some issues specifi cally related to running focus groups and interviews with 
children and adolescents that should be discussed. Th e methodology must be adopted 
to create the right kind of environment where the child can be open and motivated to 
participate. Being successful at child focus groups depends on the skills of the moderator 
and requires attention to several factors 16,25. It cannot be emphasised enough that the 
moderators must be trained and aware of the cognitive and social capacities of children of 
diff erent ages, and must be aware of their communication ability and attention span. Th e 
experienced age dependent change in ability to express themselves, interact with the group 
and stay focussed coincided with earlier described changes in childhood development 
8,17,26,27. As the quality of the supplied data is tied to the skills of the moderator we 
emphasise the importance of (international) training in this skill, especially for future 
cross-national studies. 
Other problem areas concern group processes: the discussion may lack spontaneity, one 
participant can dominate the group and some participants may not join in the discussions 
or show disrespect. Th ere are several guidelines to apply in such situations of which most 
were provided in the DISABKIDS manual (Box 3)17. We were also confronted with various 
developmental levels and diff erent gender priorities in the adolescent groups 8,17,21. For this 
reason we would choose to divide the adolescent group by gender and into two age groups 
in the future. Overall, one needs to keep in mind that focus groups are a time consuming 
method that needs careful planning and adaptation to the group of participants. It can also 
be diffi  cult to recruit participants due to practical (previous appointments, summer time, 
travel distance) or personal reasons (shy, refusing to talk about medical condition).
Th ere are limitations related to collecting data through focus groups and interviews. 
Th e generalisation of the collected data can be questioned as only a limited number of 
children, adolescents, parents and health care professionals participated (154, 142 and 26 
respectively). Selection bias is also a limitation and creates the risk that the participants do 
not represent the general population of interest. It was also not possible to check that all 
relevant HRQoL aspects were discussed. Participants may have found it diffi  cult to talk 
about certain (sensitive) issues, or topics were not thought of at the time. Other studies 
have continued conducting focus groups till no new data were presented 28,29. However, 
this was not possible in the DISABKIDS project due to time constraints. Reassuring is that 
overall the number of participants was relatively large for focus group research and that 
a considerable amount of HRQoL statements were collected. Th e simultaneous setup in 
diff erent countries supported the cross-national developmental process and demonstrated 
that various issues were relevant in all countries. 
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Other issues concern the construction of the statement pool and what data to use from 
the focus groups and interviews. Qualitative patient-derived methods, like the focus 
group or interview, do not provide statistical data 29. Th ere is no statistical or standardised 
method to apply to the selection of HRQoL statements from the national focus group and 
interview transcripts. As the statement selection was a subjective process, based on general 
content analysis, it can be infl uenced by personal interpretations, interests and subjective 
factors 30. Previous investigators have used the computer to facilitate this step, however 
as the qualitative data were in several diff erent languages this was not applicable to the 
DISABKIDS project 31,32. 
Conclusion
Th e applied child-focused patient-derived methodology aided in the collection of HRQoL 
statements for the development of the European DISABKIDS HRQoL instrument. Th e 
focus group and interviews were successful in embracing the child and adolescent's own 
point of view, concepts, culture and have acknowledged the child as the expert in their 
own lives. Th e described cross-national focus group and interview methodology made it 
possible to refl ect on aspects that were important to the patient group, compare 
cross-national data and provided HRQoL statements for use in the DISABKIDS 
instrument. Being successful at focus group research does require attention to several 
factors (Box 4). In addition, suffi  cient consideration needs to be given to the organisational 
aspects related to focus group research, the developmental level of the participants and the 
method of processing qualitative data. 
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• Supply a good introduction and an opportunity to get to know the group
• Introduce some general rules on confi dentiality and respect
• Let the children know that they are the experts and the investigator needs their input
• Consider the developmental age of the child and their ability to take part in the discussion
• Allow the children some control over the discussion
• Let them express themselves as freely as possible, listen attentively and don't interrupt
• Gather the information as objectively as possible
• Encourage descriptions of events by getting them to tell a story of their day or anecdotes
• Be relaxed during the interviews as this will relax the children as well
• Be sensitive to the mood of the group
• Do not insist on discussing painful themes
• Avoid making participants feel that they have failed if they can't answer the questions
• If you think the participants are telling lies then DO NOT press them for the truth
• Always end a focus group with a debriefi ng
Box 3. Aspects a moderator should apply during focus group work with children and 
adolescents.
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Preparations Determine your goal and target population
Agree on an available budget and timeline
Get approval of the ethical committee
Recruit at least two moderators
Focus group manual with guidelines and questions 
Find suitable locations (avoid a hospital setting when possible)
Send letters to potential participants
Inclusion criteria Consent to participate in the study
Fit the age requirements of the study
Fit the group description (e.g. chronic medical condition) 
Suffi  cient language skills
Materials Focus group manual
Tape recorder and tapes with labels
Pencils and paper or fl ipcharts
Refreshments
Token of appreciation
Moderator qualities Familiar with group discussions 
Experience with children's cognitive and social capacities
Aware of children’s communication abilities and attention span
Non-authoritarian and patient 
Basic data Participants' names
Age and gender
Type of school / grade
Health Status
Medication 
Output Literal transcription from tapes (takes 8-12 hours)
General outline from tape (takes 4-8 hours)
Data from notes (2-3 hours)
Data from memory (1 hour)
Moderator debriefi ng Did the moderator keep to the rules and suggested interview structure?
Did the children understand the instructions?
Did the discussion fl ow smoothly?
Where there problems?
What was the general atmosphere of the session?
How did the session end?
A child focus group methodology
Box 4. General guidelines for focus group research.
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Using cross-national focus groups to identify health 
related quality of life (HRQoL) aspects in children 
and adolescents with asthma and their parents: the 
European DISABKIDS approach




Focus groups and interviews were conducted to support the bottom-up developmental 
process of the DISABKIDS health related quality of life (HRQoL) instrument for 
children and adolescents with a chronic medical condition and their parents. Th e 
HRQoL statements which were identifi ed through focus groups and interviews were 
used to develop the European DISABKIDS HRQoL instrument. Participants included 
children and adolescents with a chronic medical condition, their parents and health care 
professionals across Europe. Th e asthma results are presented in more detail. Th e asthma 
focus groups and interviews were conducted in four European countries (Greece, Italy, the 
Netherlands and Sweden). A total of 43 children and adolescents with asthma, 33 family 
members and 7 health care professionals participated in the focus groups and interviews. 
Asthma symptoms and related medical aspects were discussed in all groups. Additional 
issues related to asthma included physical limitations in the youngest groups and social 
issues in the adolescent groups. Parents were worried about prevention, long-term eff ects, 
medication and school. Th e discussed topics were similar between countries. A total of 
637 HRQoL statements were collected from the asthma focus groups and interviews for 
the development of the European DISABKIDS instrument. In addition to having to live 
with the medical implementations of asthma, children and adolescents are also eff ected in 
social and physical areas. Th e children and adolescents discussed the current limitations 
they experienced while parents concentrated on the long-term consequences. A greater 
understanding of the impact of asthma on the lives of children and adolescents was 
achieved. Th e focus group discussions were also a useful tool in generating statements from 
children and adolescents with a chronic condition like asthma for the development of the 
DISABKIDS HRQoL instrument. 
Introduction
Th ere are several aspects that need to be considered during the development of a paediatric 
health related quality of life (HRQoL) questionnaire. Ideally a HRQoL questionnaire 
should give an accurate representation of the aspects in life that are aff ected by an illness. 
Choosing which issues should be included in a questionnaire and how to generate 
these items are important decisions. Th ere is no standard procedure for developing a 
HRQoL questionnaire for children or adolescents. Existing questionnaires have been 
constructed in several ways, they vary in their defi nition of HRQoL, they consist of 
diff erent multidimensional constructs and diff er in the content of the domains 1-7. Selected 
items are often derived from one or more sources including relevant literature, existing 
questionnaires, health care professionals' opinions, investigators' opinions and the views of 
the child, adolescent or the parent 8-18.
Th e need to incorporate patients’ values and preferences is what distinguishes quality of 
life from all other measures of health (T.M. Gill, 1994). 
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To make sure that a paediatric HRQoL questionnaire accurately represents the child or 
adolescent's HRQoL, it is important that the items are appropriate to the representation 
of their illness. Numerous studies have shown that using the expert or parent opinions to 
construct a paediatric questionnaire can lead to bias and poor face and content validity 
as their opinions can diff er from those of the child or adolescent 19-25. As HRQoL is an 
attribute of the patient emphasis should be on the child and adolescent's perception of 
HRQoL. To accomplish this, the child and adolescent should be directly involved in the 
development of any paediatric HRQoL questionnaire by defi ning and identifying the 
issues that are important to them 26-28.
Th ere are various ways of involving children and adolescents in the development of a new 
questionnaire. Th eir opinion can be collected through surveys, interviews or focus groups. 
A focus group is a qualitative research method, which allows the investigator to explore the 
opinions, attitudes, knowledge, concerns and experiences of a group 29-31. Within HRQoL 
research focus groups can be used to explore the health care perception of a particular 
population, to study research questions or to support the development of a questionnaire 
31,32. Focus groups are also useful in generating questionnaire items as participants can 
determine the topics and identify HRQoL issues that are important to them 30,33. Th is in 
contrast to having health care professionals, investigators or family members judge the 
importance for children and adolescents 26,34. 
Th ere are several publications on how a focus group can be used as an appropriate method 
to explore HRQoL issues in children and adolescents with a chronic medical condition 
34-38. Th e European DISABKIDS project included seven chronic medical conditions in the 
development of the paediatric HRQoL instrument. Th e fi ndings reported in this paper are 
part of the larger DISABKIDS focus group study. We will only elaborate on the asthma 
results generated from the focus groups and interviews with children and adolescents 
with asthma, their parents and health care professionals. First, a qualitative description 
of the cross-national asthma focus groups and interviews is given. Secondly, the collected 
HRQoL statements will be described in a quantitative manner. 
Method
Th e DISABKIDS project 
Th e DISABKIDS project is a collaboration of eight research centres in seven European 
countries. Th e aim of the project was to develop a new HRQoL instrument for children 
and adolescents with a chronic medical condition and their parents 39. Seven chronic 
conditions were included in the project: asthma, juvenile idiopathic arthritis (JIA), atopic 
dermatitis, cerebral palsy (CP), cystic fi brosis (CF), diabetes and epilepsy. Th e instrument 
aims to consist of aspects that are important to the patient, be multidimensional, cross-
nationally applicable, valid, reliable and sensitive 40. Th e developmental process followed 
predefi ned steps (Box 1). Th e fi nal HRQoL instrument consists of two modules: a 
chronic generic module that is applicable to all children or adolescents with a chronic 
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medical condition and condition-specifi c modules for each of the seven included chronic 
conditions. Central to the DISABKIDS methodology was the ‘bottom-up’ construction 
or patient-derived method. Relevant HRQoL aspects were identifi ed from the perspective 
of the child, the adolescent, their parents and health care professionals. Unique to this 
project is that focus groups were run cross-nationally. Subsequently the collected HRQoL 
statements are formulated into items and incorporated into the chronic generic or a 
condition-specifi c module 41. 
Participants
Children (aged 4-7 and 8-12) and adolescents (aged 13 -16) with a chronic medical 
condition and their parents were invited to participate in the focus groups. Families 
were identifi ed through patient associations or their hospital clinicians. Th ey received an 
invitation by mail and were phoned to ask whether they would participate. Patients with 
additional chronic conditions or who did not verbally master the national language were 
excluded. Th e focus groups were divided by chronic condition and stratifi ed by age (4-7, 
8-12 and 13-16 years). Each focus group consisted of a mixture of disease severity and 
gender. If participants were unable to attend a planned focus group they could take part in 
a personal interview. Parents were invited to participate in separate focus groups (grouped 
according to the chronic condition and age of their child). Health care professionals were 
contacted directly and where often affi  liated to the research centres. Th e responsible local 
Ethics Committees approved the study and all participants signed a consent form. 
Focus groups
To insure that a similar method was used in all participating countries a manual was 
written which included the outline of the focus group process and the question structure. 
A moderator led the focus groups and asked the questions, while an assistant observed, 
wrote minutes and operated a tape recorder. At the start of the focus groups the aim, 
duration and confi dentiality was explained. Permission was also obtained for audio-taping. 
Th e moderator started with the semi-structured questions, given in the manual, and 
allowed the participants to direct the discussion. During the session the questions were 
directed towards more illness related topics. Th e moderator made sure to create a safe 
environment, encouraged involvement and probed for comments. As a closing exercise 







6: Analysis pilot study
7: Field study
8: Analysis fi eld study
9: Implementation 
Box 1. Developmental steps within the DISABKIDS project.
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clinician a good impression of their HRQoL. Approximately 90 minutes was planned 
for each session. At the end, all participating children and adolescents received a gift. 
Th e focus groups and interviews were transcribed verbatim. Th is raw data was used for 
two purposes. Firstly, the transcripts were used to illustrate the discussed themes and the 
perceptions of the participants. Secondly, statements related to HRQoL were identifi ed 
from the national transcripts by investigators in each country. Th ese statements were 
entered into a database and used for the development of the DISABKIDS items 41. 
Results
Population
Asthma focus groups and interviews were conducted in Greece, Italy, the Netherlands 
and Sweden from June to August 2001. A total of 9 child/adolescent focus groups and 8 
parent groups were conducted, with an average of two of each in every country. In total, 
43 children and adolescents with asthma (6, 23 and 14 in the age group 4-7, 8-12 and 13-
16, respectively) and 33 family members participated in the focus groups and interviews. 
Generally the focus groups consisted of 3-6 participants. Th e Dutch centre also included 
two focus groups with experts (4 asthma nurses and 3 paediatricians), in order to collect 
their opinions and to enable comparison with the child or parent's view. 
Qualitative focus group results
Child and adolescent
Children and adolescents indicated that it was bothersome to take medication on a 
daily basis. Th ey often forgot to take the medication and some felt that they didn't need 
medication when they had no complaints. It was noted that those who discussed non-
compliance to the medical regimen were also uncertain about how the medication worked 
or how it aff ected them (Box 2). Some found that they were insuffi  ciently informed about 
side eff ects, worried about taking prednisolon or had an aversion to frequently changing 
their medication. Th e younger children complained about the taste of the medication. 
Most said that they did not mind taking medication in front of others but they tended to 
avoid this as much as possible. When discussing their relationship with the clinician some 
indicated that they would prefer the clinician to talk to them on a more personal level. 
Others were happy with the ways things were and felt understood. Especially the younger 
children disliked specifi c procedures such as getting injections, blowing peak fl ow or lung 
function tests. Hospital admittance generally had a negative impact on the child and 
adolescent. 
Th e children and adolescents experienced several physical symptoms related to having 
asthma. Th ey complained about their cough, feeling short of breath or feeling like they 
are breathing through a straw. Symptoms were infl uenced by cigarette smoke, dust, sports, 
weather seasons or emotions. Th ey indicated that they got tired easily, had less energy than 
their peers and experienced limitations during physical activities. Sport is a recurring topic 
in the focus groups. Th e majority had experienced the need to stop during sport because 
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they were out of breath or didn’t have enough energy to keep up with the rest of the group. 
Th is is troublesome because they feel left out of the group. Children and adolescents with 
allergies to pollen, dust or animals experienced even more limitations. Th ese irritants are 
infl uential in classrooms, at a friends place and on school trips. Having to avoid certain 
places and activities has an impact on everyday life in terms of encountered limitations. 
Th e younger children often spoke about not being allowed to play with pets or missing 
their cuddly toys. Th e adolescents knew that they needed to avoid cigarette smoke but 
found it hard, as going to a friend's place or going out sometimes makes this unavoidable. 
Non-compliance:
• Th e teacher said that medication is bad
• I shake because of the side eff ects …... so I don’t take my medication on the days I have a school-test
• I don't take medication ………to forget that I have asthma
Medical care:
• I am bothered by having to visit the hospital when I have an asthma attack
• I don't like going to the doctor to do injections for the allergy
• Lying in the hospital, that is most bothersome
• Family doctor never lets you fi nish talking
Limitations:
• Having asthma is not so nice, because you can't join in so many games
• I dislike the fact that I have to have a rest when I run
• Cannot go to parties at homes with pets
Social: 
• Th e kids at school don't know that I have asthma
• Others go and tease you with it
• School parties are unpleasant because of the smoking
• Th ey don't understand that you're short of breath
• I don't talk with my friends about my problem
• X understands that he is diff erent from the other children and is worried about it
Children and adolescents don't want to feel any diff erent from their peers. Th ey fi nd it 
important to belong to a group and to go out with friends. However, especially in the 
adolescent groups we found that due to the asthma they often felt diff erent and left out of 
school activities. Experienced physical limitations made it harder to keep up with peers. 
Being ill, missing school or being behind in schoolwork sometimes prevented them from 
participating in social activities. 
Some become angry when they are restricted in what they want to do. Others worry about 
getting teased because they cannot keep up with sports or need to take medication at 
school. For this reason some avoid mentioning that they have asthma. Most have come 
across not being understood by others, not only with peers but also with teachers or adults. 
School was not mentioned much by the younger group. Adolescents found it frustrating 
to miss school or school tests due to asthma complaints, hospital check-ups or admissions. 
Th is made it harder to keep up with the school's learning schedule. Th ey indicated that it 
is important that the teachers understand the implications of having asthma.
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Parents
Th e main issues discussed by the parents' concerned medication and emotional eff ects of 
asthma. Most parents indicated that there were frequent arguments because of their child 
not wanting or forgetting to take their medication. Parents worry about possible side 
eff ects from the asthma medication, especially about any long-term eff ects and whether 
their children can lead a healthy life in the future. Parents frequently discussed health 
care and the treatment they receive from clinicians. Th ey want more information about 
health care facilities and medication. Having a doctor who listens and explains this is very 
important to them. 
Parents know that their children are not able to participate in all activities. Th ey 
acknowledged that their children get tired easily, cannot compete as well in some sports 
and avoid extreme activities. Th ey also mentioned that their child misses out on certain 
activities as playing at a friend's house or having sleepovers. Th ey believe that this makes 
it harder for them to make friends and may make them feel diff erent from their peers. 
Parents also acknowledged that some children try to hide their asthma from friends. Some 
worry about their children being ashamed of having asthma. Th ey fi nd it hard to fi nd out 
how their child really feels and how they cope with their asthma.
A few parents think that their children are more grown up, tougher, have more drive 
to prove themselves because of the asthma. Others parents worry about the amount of 
responsibility a child can have. Th ey are constantly checking on their kids, what they can 
and can't do. Parents are concerned about their child’s vulnerability and try to protect 
them from exhaustion and irritants (i.e. limiting activities, keeping their home clean, 
getting rid of pets or cuddly toys). Th eir main aim is to prevent their child from getting 
asthma symptoms. Th e downside is that this sometimes restricts their child, for instance in 
developing social contacts. School performance was also a frequently discussed topic. 
Parents worry about the eff ect asthma had on the child's schoolwork due to getting tired 
easily, missing school or redoing tests. Th ey try to inform the school on the impact of 
asthma and the importance of avoiding irritants. However, not all teachers understand the 
implications of asthma. 
Country specifi c issues
In general similar topics were discussed in all four countries. Th ere were some country 
specifi c aspects like riding a bike in the Netherlands, going to the beach in Greece and into 
the mountains in Italy. Greece was the only country where allergies, pets and diffi  culty to 
visit friends were not discussed in the focus groups. 
Age diff erences
Children in the age group 4-7 did not spontaneously speak about their illness. Th ey 
discussed basic things like what games they liked. Some discussed getting tired when 
running or playing. Th ey often spoke about wanting pets. Children aged 8-12 talked about 
Asthma focus groups
61
the more practical aspects as needing to use medication, not being able to do as well as 
other kids in sports or physical activities, about their symptoms bothering them and about 
not wanting to take medication. Some also discussed wanting a pet but not being allowed 
to have one. Next to the practical implication of using medication the teenaged group 
(aged 13-16) discussed more topics related to social activities. Th ey discussed being less 
able to join in sports and physical activities or that some social activities were a problem 
(school parties, going out, disco, staying at a friends place, family gatherings). Most issues 
related to trying not to be any diff erent from others and fi tting into the peer group. 
Health care professionals
Th e Dutch paediatricians and specialised asthma nurses that participated in the focus 
groups reported that it is diffi  cult to understand the child's perspective. Current emphasis 
is on the presentation of symptoms and objective measurements of the disease. Th ey try 
to specifi cally ask the child for their views as they realise that there might be a discrepancy 
between what parents tell them and what the children and adolescents experience. Th e 
problem as they see it is asking the right questions. Th ey generally ask questions about 
sports and use of medication, but know that the answers may not refl ect the actual 
problem the child is experiencing. Adolescents rarely talk about problems spontaneously. 
Th e clinicians and nurses acknowledge this as a problem as they know that they might miss 
valuable information about aspects in the adolescents' live, such as associated problems at 
school or in their social life. However, especially the clinicians feel limited by the time they 
have available when running a busy outpatient clinic. 
Quantitative asthma focus group results
Item pool description
A total of 637 statements related to HRQoL were identifi ed from the asthma focus 
group and interview transcripts and pooled in an asthma data bank. Th ree hundred and 
four statements were recognized as being specifi cally asthma related (condition-specifi c). 
Th ese statements were used to develop the asthma specifi c module of the DISABKIDS 
instrument. Th ree hundred and thirty three statements could be appropriate to a child or 
adolescent with any chronic medical condition (chronic generic) and were not specifi c to 
having asthma. Th ese chronic generic statements, collected from the asthma transcripts, 
were merged with the chronic generic statements collected from the focus groups and 
interviews of the other chronic medical conditions. 
Th e statements collected from the asthma focus groups and interviews were given domain 
names by two investigators (RMB and JEC). Th eir interrater reliability was 0.52 (Cohen's 
kappa). When the given domain diff ered a third investigator (HMK) assigned the fi nal 
domain name (Table 3). Most collected statements entered into the database were related 
to symptoms, treatment or medical care (35%). Statements related to limitations and 
restrictions mostly originated from the younger children and their parents. Th e children 
and adolescents generated most of the social statements. Th e adolescent's parents generated 







Percentile distribution of statements per group*
Child            
(8-12 yr)
Parent          
(8-12 yr)
Adolescent   
(13-16 yr)
Parent        
(13-16 yr)
Medical/hospital/doctor 20 20 19 18 18
Symptoms/complaints 15 21 12 15 11
Psychological / emotion 14 11 19 16 14
Limitations / restrictions 13 13 16 7 9
Social (friends/peers) 8 10 4 14 6
Physical / sport 7 8 5 6 7
School 7 4 7 8 13
Coping 7 5 11 6 11
Family / home 6 7 3 5 5
Health care 3 1 4 5 6
Discussion 
Th is study describes the qualitative patient-derived research method applied in the 
DISABKIDS project to explore the patient's view on the infl uence of asthma on their 
daily life. As stated earlier there are several advantages to using cross-national focus groups 
for item generation. Collected statements come directly from the target population and 
provide access to the child and adolescent's own language. In addition the probability of 
cultural bias will be reduced as a result of the cross-national setup where uniformity of the 
items between countries was sought after.
We found that focus groups with children and adolescents were more diffi  cult compared 
to adult groups. Especially the youngest children (aged 4-7) were not really capable 
of expressing their opinions or feelings in more than a few words. Overall, children 
often preferred to wait until someone else had answered a question or the question was 
directed to them personally. Th is in contrast to the groups with parents and health care 
professionals were the conversations went almost automatically. Even for the adolescents, 
90 minutes turned out to be the maximum time they could focus on the topic. Like others 
we found that near the end the motivation declined, the responses were less extensive 
and more irrelevant topics were raised 27. In general the children and adolescents did feel 
acknowledged as being the experts and expressed that they would volunteer to participate 
again. Th e parents appreciated the chance to talk about their experiences and found it 
especially valuable to hear from others in a similar situation.
During the focus groups the children and adolescents admitted their non-compliance, 
they said that they forgot to take their medication, believed that it did not work, thought 
it was not necessary or wanted to avoid any side eff ects. Similar aspects related to non-
Asthma focus groups
Table 3. Domain distribution of the collected statements, from children, adolescents 
and their parents in the asthma focus groups and interviews (%).
*Th e collected statements from children in the 4 -7 age group, their parents and health care professio-
nals are not shown due to the small numbers.
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compliance have been found in previous studies 42-45. Social issues were found to be a 
dominant theme, especially for the adolescent, which was similar in other studies, even 
in other chronic conditions 34,35,46,47. Th e impact of physical limitations and prevention 
measures on a child or adolescent's social life has also been illustrated before 45. Adolescents 
indicated that they did not want to be seen or be treated as diff erent and wished to be 
accepted by their peers. Younger children were more concerned with the actual physical 
limitations they experienced (running, riding a bike, sports). Parents were mostly troubled 
about medical aspects concerning insuffi  cient confi dence in medication, side eff ects, 
little knowledge of the medication or the treatment plan and fear of any long-term 
consequences. Similar outcomes have been discussed in other studies reporting that the 
children found the symptoms and limited physical activities most bothersome and that 
parents were worried about the medication, long-term eff ects of the illness and feeling 
helpless when a child has an asthma attack 11,46,48-50. Not all topics were discussed in each 
country. For example allergy, pets and diffi  culty to visit friends were not discussed in 
Greece. Th is might be related to the fact that their living conditions are diff erent from 
other countries and can be a refl ection of selection bias as most of these children had 
exercise-induced asthma.
Th e focus groups with the health care professionals illustrated that parents and clinicians 
have diff erent aims. While the parents and children often aim at limiting the use of 
medication as much possible, health care professionals accept a higher dose of medication 
to accomplish minimal physical limitations. Th is can cause a confl ict in aims and infl uence 
non-compliance. Health care professionals indicated that they fi nd it hard to recognise 
issues that are of importance to the patient, and that they mostly concentrated on the 
functional ability. Th e health care professionals do realise that if a child is not happy about 
using medication the chances increase that they will not use the medication properly. 
Th ey also understand that they should explain their decisions more clearly to the child 
and parents to enhance compliance with medication. Th e risk of a child or adolescent 
becoming socially isolated or not being able to join in all activities was acknowledged. 
However, health care professionals suggest that this might also relate to a child's 
personality.
On the whole, asthma has a major impact on the child and adolescent's life. Keeping 
up with aspects important to the child or adolescent’s HRQoL is important to facilitate 
and improve clinical practice. Recognition and knowledge of any problems can enable 
clinicians and nurses to help and support these families. Another aspect illustrated by the 
focus groups discussions was that children and adolescents concentrate on the 'here and 
now'. Th eir focus is on the present limitations they experience and how this infl uences 
them in daily life. Th e parent's centre of attention is on the future (schooling, future jobs) 
and they aim for the lowest possible medication doses for fear of long-term consequences. 
Clinicians concentrate on the physical function, reducing the current symptoms, aiming 
for the best possible lung function and optimising treatment compliance.
chapter 4
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Some methodological issues need to be discussed. One issue concerns selection bias. 
Participants may not be representative for the population of interest as the more confi dent 
individuals can be more willing to participate. Th ose who did not join may have a diff erent 
view on their illness and the eff ect it has on their lives. Another point is that the total 
group of children, adolescents and parents was also relatively small. On the other hand the 
discussed topics were widespread and showed similarities between countries. As a result the 
collected statements were acknowledged as important to our research population. While 
some investigators have conducted focus groups or interviews till no new issues were pre-
sented, this was not possible in the DISABKIDS project due to time constraints 35,37,51. 
Despite the fact that dynamic group interaction can stimulate additional information, 
interaction can also be inhibited. One person's opinion can prevail in the group by 
silencing less confi dent participants or by constantly changing topics 31,52. Personal 
expectations of participants, group incompatibility or lack of respect may also cause 
problems, as can mixed gender groups 32,53-55. In our focus groups the moderator needed 
to deal with limited interaction between participants, the more dominant child, the quiet 
child and, sometimes diff erent priorities between the girls and boys. 
Collected focus group data can only be interpreted or reported in a qualitative manner, 
with selected phrases and quotes as outcome. Th e strength of a certain viewpoint cannot 
be measured by counting the number of collected statements or by the intensity in which 
it is expressed 31. Firstly, the amount of collected statements within a group can depend on 
the number of conducted focus groups and interviews. Secondly, the discussed issues can 
be biased as a result of the questions asked by the moderators or the interaction within the 
group 31. Additionally, the selection of HRQoL statements from the transcripts depends on 
the investigator. Th e distribution of the collected statements (Table 3) therefore functions 
solely as illustration. Nevertheless, the fact that major topics were discussed in all four 
countries and that obtained results were similar to earlier studies helps to strengthen the 
validity of the fi ndings.
Th ere was no objective method for extracting the HRQoL statements from the literal 
transcripts. One DISABKIDS member identifi ed the appropriate statements in each 
country. Th e quality of individual content analysis has been questioned, as the agreement 
between raters can be low and individual raters may not extract all information 56. 
However, other investigators have suggested that individual judgement is valid and they 
fi nd external or group ratings unnecessary as the context in which the data were conducted 
may be missed 57,58. A computer program can also be used to code and analyse the 
transcripts but has its limitations and was not applicable in the DISABKIDS project due 
to the diff erent languages of the transcripts 58,59. 
Appointing domains to the statements also included a subjective element, with the fi rst 
two raters disagreeing on quite a number of the statements. However, this does not 
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indicate that one or the other is incorrect, as some statements can be applicable to several 
domains. Th e most frequently mentioned domains included the medical, symptoms, 
psychological and limitation domains, which is similar to the domains incorporated in 
most current paediatric questionnaires 60. Th is means that these topics are either important 
or we recognised these HRQoL statements because we are familiar with these topics from 
earlier research 40.
Th e need to assess HRQoL in diff erent countries and cultures is increasingly being 
discussed 61-63. However, when a HRQoL questionnaire is developed in one country and is 
translated into another language this might cause cultural obstacles and true comparability 
may not be achieved 64-66. Developing a HRQoL questionnaire cross-nationally can limit 
cultural and socio-economic infl uences. Th is brings us to the advantage of the cross-
national method within the DISABKIDS project. Th e focus groups and interviews 
were an eff ective way to gather topics that were important and appropriate to children 
and adolescents in several countries. Th is benefi ted the international consensus that 
was achieved within the DISABKIDS group by selecting those items that refl ected the 
universal concerns of our research population. Only a few HRQoL questionnaire have 
been developed in simultaneous collaboration with diff erent countries 16,62,64,67. One 
well-known project is the World Health Organization Quality of Life (WHOQOL) 
project, which works in collaboration with several countries around the world. However, 
this concerns adult research 68. 
Conclusion
Overall, the focus groups and interviews gave insight into a range of important issues 
and viewpoints, identifi ed recurring themes between groups and generated items for 
the new DISABKIDS instrument. It provided an impression of the HRQoL of children 
and adolescents with a chronic medical condition like asthma and ensured that aspects 
found important to the patients were included. However, one must keep in mind that a 
substantial amount of time and eff ort does need to be put into the organisation of focus 
groups and that there are special demands in moderating, transcribing and analysing the 
data. Th e information we have gathered is not only of importance to the DISABKIDS 
project but also for those who work with young patients in clinical practice or research. 
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Item selection after focus group research: the European 
DISABKIDS approach
R.M. Baars, S. Schmidt, M. Bullinger, A.H. Zwinderman, J.M.Wit, H.M. Koopman and the 
DISABKIDS group.
Abstract 
A description is given of how items were selected for the DISABKIDS pilot instrument 
from a pool of health related quality of life (HRQoL) statements. To insure a bottom-up 
procedure the collected statements were generated from simultaneous cross-national focus 
groups and interviews with children and adolescents with a chronic medical condition, 
their parents and health care professionals. Th e DISABKIDS approach included a 
sequence of reduction methods. Steps included a redundancy scoring to delete the double, 
unclear and irrelevant statements. Secondly, experts rated the statements for importance. 
Th e statements were then rewritten into an appropriate questionnaire format. A fi nal card 
sorting method was applied to select domains and dimensions. Last refi nements were made 
to remove any further unethical, unclear or similar items. Th ree hundred and twenty-two 
participants contributed to the focus groups and interviews. A total of 3515 HRQoL 
statements were identifi ed from the literal transcripts. Th ese included generic quality of 
life statements (n=488) not related to any medical condition, chronic generic statements 
(n=1647) related to any chronic medical condition and condition-specifi c statements 
(n=66 to 340) that related to one of the seven included chronic medical conditions. After 
the applied redundancy steps a 100 chronic generic items and 26 to 44 condition-specifi c 
items were retained for testing in the DISABKIDS pilot study. Several sequential reduction 
steps were necessary to cut down the vast amount of collected statements from the 
DISABKIDS focus groups and interviews to develop our pilot instrument. Th ese steps 
determine the fi nal construct of a questionnaire. In our case it was found that the card 
sorting method was the most comprehensive and straightforward method to reduce the 
statements and divide the items into domain groups.
Introduction
A fundamental process in the development of health related quality of life (HRQoL) 
questionnaires is the selection of items. Qualitative patient-derived research methods, 
as the focus group and interview, have increasingly been used to collect items for new 
HRQoL questionnaires 1-6. Organisational aspects related to running focus groups and 
the resulting qualitative data (i.e. discussed themes) have also been regularly described 7-13. 
However, we found that existing literature gives no standard criteria or clear description on 
how to select questionnaire items from the collected qualitative data 14-16. Processing raw 
qualitative data to form an item pool seems to be a variable and possibly subjective process. 
Steps for selecting the item pool should be objectively described, as failure to explain this 
process results in a diffi  culty to understand how selection choices were or can be made 17. 
Applied development and selection methods can also infl uence the outcome of the fi nal 
questionnaire 18. A clear description of the development and processing of qualitative data 
is thus required to improve the quality of qualitative research 16,19,20.




Investigators have used patient-derived methods, as the focus group and interview, to 
generate items for new questionnaires but have not described or are unclear about the 
item selection process from their raw qualitative data 1,3,5,21-25. If item reduction methods 
were described these concerned limited item pools or the selection of items after the pilot 
or fi eld testing of a questionnaire. Described methods include clinicians or investigators 
selecting items, principal components analysis, criterion keying or asking patients to score 
items on importance, frequency or severity 1-3,23,26,27. Th e clinimetric technique or "clinical 
impact" method is commonly used and provides an item rank order based on item 
importance, frequency or severity ratings provided by patients 28. Scores of the individual 
patient or the means of the patient group are either multiplied or added to establish 
an item rank order (Box 1). Th e applied clinimetric technique does not seem to aff ect 
the general result of the item reduction 28. Th e top ranking items are rated as the most 
important as they represent the highest experienced burden or impact. 
*Multiplication or addition of the individual's importance score (I) on an item with the individual's severity (S) 
score of that item. Th e resulting product is an individual item importance-severity (M) or importance-plus-severity 
(P) score, which can be averaged over the group. 
Formula: I x S =M    or    I + S = P
*Th e mean importance score of the group (Im) can be multiplied with or added to the mean severity value for the 
entire group (Sm). Th e resulting overall group importance-severity score (M) or importance-plus-severity score (P) 
can be used to rank the items.
Formula: Im x Sm = M    or    Im + Sm = P
*Multiplication or addition of the individual's importance score (I) on an item with the individual's frequency (F) 
score of that item. Th e resulting product is an individual item importance-frequency (M) score or importance-plus-
frequency score (P), which can be averaged over the group.  
Formula: I x F =M    or    I + F = P          
*Th e mean importance score of the group (Im) can be multiplied with the frequency (F%) of which an item occurs in 
a group. Th e resulting overall group importance-frequency score (P) can be used to rank the items.
Formula: Im x F% = P  
I =importance, can be scored on a Likert scale (not important to very important)
S =severity of the complaint, can be scored on a visual analogue or ordinal scale
F = frequency, can be scored on a Likert scale (never, sometimes, often etc.)
F% = proportion of patients that report the item as troublesome (max = 100%)
Im = mean importance score given to an item by a group of patients who fi nd this troublesome 
Above selection processes all assume that there is a limited list of items. Th e process of 
selecting items from a large statement pool generated from qualitative patient-derived data 
as in the DISABKIDS project has rarely been described 14,16. Th e aim of this paper is to 
describe the stepwise item reduction process that was performed to develop the European 
DISABKIDS HRQoL instrument for children and adolescents with a chronic medical 
condition and their parents. Item selection, reduction steps and encountered problems are 
discussed. 
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Method
Th e DISABKIDS project
Th e DISABKIDS project is a collaboration of eight research institutions in seven European 
countries (Austria, France, Germany, Greece, the Netherlands, Sweden and the United 
Kingdom). Th e project's aim is to develop a European HRQoL instrument for children 
and adolescents with a chronic medical condition and their parents 29. Th e project followed 
a cross-national approach, which combined a bottom-up and top-down strategy and 
where items were produced simultaneously in diff erent countries. Only a few HRQoL 
questionnaires have been developed through such a strategy 30-32. 
Th e fi nal DISABKIDS instrument aims to include aspects that are of importance to 
the patients and is multidimensional, multilingual and cross-nationally applicable in 
several countries. Unique is that the DISABKIDS project developed a core chronic 
generic module, which is applicable to all children or adolescents with a chronic medical 
condition, supplemented by a condition-specifi c module, which is specifi c to a certain 
medical condition. Th ese two modules make comparative clinical studies possible (i.e. 
comparison between illness samples) and also provide additional information on a specifi c 
disease 33. Chronic conditions included in the project are asthma, juvenile idiopathic 
arthritis (JIA), atopic dermatitis, cerebral palsy (CP), cystic fi brosis (CF), diabetes and 
epilepsy. Existing questionnaires and literature were reviewed to support the framework 
of the instrument. In order to focus on the child’s perspective, statements for the 
DISABKIDS instrument were collected through a bottom-up procedure based on cross-
national patient-derived methods, including focus groups and interviews. Th ese procedures 
made it possible to refl ect on aspects that are important to the patient group and adapt 
item phrasing to the child's level. Th e development of the DISABKIDS instrument 
followed consecutive work packages alternating inductive and deductive steps (Table 
1) 31. Patients and investigators were alternately seen as the appropriate experts during 
the instrument's construction phases. Th e DISABKIDS project is closely linked to the 
KIDSCREEN sister project. Th is project has developed a generic quality of life (QoL) 
questionnaire for children of the general population through similar methodology 34,35. 
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Collected statements from the focus group and interview transcripts functioned as the 
main item source. Children and adolescents between 4 and 16 years old with one of the 
seven chronic conditions, their parents and health care professionals participated in 
the focus groups and interviews. Separate focus groups were organised for children 
and adolescents with each of the included chronic conditions and their parents. Each 
group was divided by age and consisted of a mixture of severity and gender. Health care 
professionals also gave their opinion on relevant HRQoL aspects through focus groups or 
interviews. Each of the eight DISABKIDS centres planned focus groups: Edinburgh (UK), 
Hamburg (DE), Leiden (NL), Lübeck (DE), Lund (SW), Marseille (FR), Th essalonica 
(GR) and Vienna (AU). Verona (IT) participated in the DISABKIDS focus group work 
package as an affi  liated centre. Some participants were unable to attend the planned focus 
group and participated in individual interviews. To assure that a similar method was used 
in all centres a manual was developed which included the outline of the focus groups, the 
structured questions and general guidelines. Th e responsible Ethics Committees approved 
the study and all participants signed a consent form. 
Item selection
Th e focus group discussions and interviews were literally transcribed. From these 
transcripts each country selected statements related to HRQoL. Th ese statements were 
then translated into English and pooled into an ACCESS database grouped per condition. 
Th e ACCESS database was used to reproduce the taken steps, protect the input data with 
a password and give a clear overview. Th e statements per chronic medical condition were 
subdivided into three groups and a general domain name was designated to each statement 
by the investigator. One group consisted of generic statements, which could be applicable 
to all children, healthy or with a chronic medical condition. Th e generic statements from 
each condition were merged and transferred to the KIDSCREEN project. Merging those 
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Table 1. Work packages (WP) within the DISABKIDS project.
*Inductive versus deductive processes are named as bottom-up and 
top-down approaches, respectively. 
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statements that were applicable to children with any chronic medical condition formed the 
second group; the DISABKIDS chronic generic module. Th e third division of statements 
formed the seven DISABKIDS condition-specifi c modules. Th e statements in each 
condition-specifi c module originated from the transcripts of a specifi c chronic medical 
conditions and refl ected specifi c aspects related to that medical condition. Th ese three 
groups were the basis of the modular build-up of the DISABKIDS and KIDSCREEN 
instrument.
Th e reduction of the statements was done per module and combined diff erent methods in 
four steps (Figure 1). All steps have been documented and the fi nal items can be retraced 
to the original source.
Step 1: Redundancy scoring
Th e fi rst step was aimed at limiting the excessive amount of statements. A DISABKIDS 
member from Scotland, Germany and the Netherlands each scored the collected 
statements derived from the focus groups and interviews on forms in a protected ACCESS 
database. Th e reduction of statements was based on criteria presented in the European 
Health Interview Survey (EUROHIS) study protocol 36. Th ree independent raters marked 
the statements when they were redundant, semantically equivalent or unclear. Statements 
that did not meet the criteria of the project, like aspects related to health care needs, 
health care satisfaction or insurance problems, were also marked as failing the criteria. A 
statement was removed when two or more raters had marked it under one of the exclusion 
criteria. 
Step 2: Importance scoring
Th e next step was to ask experts to rate the remaining statements in terms of importance. 
Each chronic generic statement was scored by all centres on importance to the 
Statement pool generated from focus groups and interviews
Statement reduction: Redundancy, Importance, Item writing (step 1-3)
Assigning items to domains through card sorting (step 4)
Refi ning of item, scale and overall model prior to pilot testing (step 5)
chapter 5
Figure 1. Item reduction progress.
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DISABKIDS HRQoL instrument, relevance to the child’s age group (4-7, 8-12 and 13-16) 
and relevance for a parent questionnaire. Two to three experts from diff erent DISABKIDS 
centres also scored the condition-specifi c statements on importance according to the same 
procedure. An importance scoring of 0-5 was given, with 5 being extremely important. 
Step 3: Item writing
Each statement was rewritten into appropriate questionnaire items. Writing instructions 
were based on a general questionnaire format as presented in the World Health 
Organization Quality of Life (WHOQOL) study and the EUROHIS study protocol 
32,36. According to these guidelines, items should use simple language, avoid ambiguity 
in terms of either wording or phraseology, use short sentences, avoid double negatives, 
be convertible to a rating scale, ask about a single issue only, be applicable to individuals 
with a range of health status and should be stylistically comparable. At the same time the 
experts again checked statements for double, unclear or non-HRQoL statements. Each 
country wrote items for the condition-specifi c statements collected in their own centre. All 
chronic generic statements were rewritten and further reduced by the Dutch investigators. 
Step 4: Card sorting
Th e next step consisted of a card sorting process in a DISABKIDS workshop to categorize 
the items into domains and dimensions 6,37. Th is process was performed on the remaining 
item pool were each item was printed onto a card. Th e cards from each module (chronic 
generic and condition-specifi c) were sorted into three domains: the psychological, social 
and physical domain, each of which was perceived to be multidimensional. Th e process 
started with the chronic generic item pool, which needed to be reduced to roughly 100 
items. Th ree to four DISABKIDS members worked with each of the domains. Th e cards 
in each domain were checked for correct placement and grouped according to similarity 
into several dimensions within this domain. Th is procedure was continued until all the 
cards in a domain had been placed in a dimension. If necessary, cards were replaced into 
another more appropriate domain for sorting. Th e same process was then applied to the 
item pool of the seven condition-specifi c modules with as aim to minimise the item pool 
to approximately 30 items. Formed expert groups identifi ed the domains and dimensions. 
All sub-standard or double items were rejected and if the wording was unclear items were 
corrected.
 
Step 5: Refi nement 
In the fi nal step the remaining chronic generic and condition-specifi c items were read 
out loud in a DISABKIDS workshop. All attending DISABKIDS members had the 
opportunity to comment on each statement. Some items were removed or rewritten in 
instances that they were unethical, had double meaning, and were still redundant or not 
applicable to all countries. 
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Results
A total of 154 children and adolescents, 142 family members and 26 health care 
professionals participated in either focus groups or interviews. A total of 3515 statements 
were identifi ed from the DISABKIDS focus group and interview transcripts. Th e 488 
generic statements, which were not related to having a disease were sent to the parallel 
KIDSCREEN project 35. Of the remaining statements 1647 were applicable to any of the 
chronic medical conditions (chronic generic) while between 66 and 340 statements were 
specifi c to one of the seven chronic conditions (condition-specifi c). Th ese two groups were 
the start of the two modules in the development of the DISABKIDS HRQoL instrument.
One DISABKIDS member in Scotland, Germany and the Netherlands scored all of the 
items in the fi rst redundancy procedure (Step 1), each voted to remove 1404, 1614 and 
2239 statements respectively, with between 50 and 68% being scored as semantically 
equivalent or redundant. Eventually 1802 of the 3027 items were marked under one of the 
rules by 2 or more raters (Box 2). Th is left us with 1225 statements, a reduction of 60%.
Fails criteria:
You have got to be well informed, either search the internet or read books. 
She had had epilepsy for a long time but it was only noticed when she had a big seizure.
One feels so small at the hospital, you can't fi nd a parking place, it's impersonal, stressed. 
We didn't get any compensation for having a child with epilepsy and it costs money.
Semantically equivalent:
Do your teachers know that you have asthma?
Th e teachers didn't know that he had asthma.
We told them about asthma before the school started.
After the redundancy scoring (Step 1) the general domain distribution, as given by each 
investigator after selecting statements from the literal transcripts, remained the same 
(Table 2). Th e health care needs domain was minimised, which was consistent with our 
aim, as this topic did not meet the criteria for our HRQoL instrument. Th ese items were 
processed in a separate questionnaire development study 38.
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Box 2. Examples of removed statements in the fi rst reduction phase.
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428   (14,1 %)
396   (13,1 %)
336   (11,1 %)
262   (8,7 %)
253   (8,4 %)
180   (5,9 %)
126   (4,2 %)
123   (4,1 %)
95     (3,1 %)
70     (2,3 %)
214     (17,5 %)
138     (11,3 %)
46       (3,8 %)
143     (11,7 %)
112     (9,1 %)
91       (7,4 %)
35       (2,9 %)
52       (4,2 %)
39       (3,2 %)
17       (1,4 %)
An importance score (Step 2) was given to each of the remaining statements by members 
of the DISABKIDS group. Th e interrater agreement between the expert importance 
ratings varied strongly and the interrater correlations were relatively low (overall ICC = 
0.37, ranging from 0.05 to 0.69). Statements from the JIA and CF groups scored high on 
importance for a HRQoL questionnaire (3.44 (SD 0.59) and 3.48 (SD 0.48) resp.), while 
the asthma and epilepsy statements scored low on importance (2.77 (SD 0.74) and 2.76 
(SD 0.78) resp.). After analysing the results the decision was made to omit this step. It was 
decided to go directly to the next phase (Step 3): a standard methodology of writing items 
on the basis of statements. Statements in the database were sent around for item writing, 
which was based on existing criteria 32,36. Th e 1225 statements were divided into groups 
and rewritten by the DISABKIDS members into items appropriate for our instrument 
(Table 3). At the same time additional redundant or equivalent items and items not related 
to HRQoL were identifi ed and removed. Th is further reduced the data fi le to 796 items. 
Original statement Rewritten statement
Leading a normal life and being together with others is important. I can lead a normal life.
I'm glad that I've had arthritis for so long, so I don't know many 
things I can't do and therefore I didn't have to give anything up.
I accept that there are things I cannot 
do because of my condition.
It helps when others understand what you have, that they don't tease you. Others understand what I have.
Th ey want to do everything like the other children... but that is not 
possible…. afterwards she stays two days in bed, to recover. I get exhausted easily.
I took her to psychosomatic counselling because she was so depressed 
(because of the illness) it was really bad.
I was depressed because of 
my condition.
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Table 2. General distribution of the top 10 original domains (as provided by each investigator 
after selection from the literal transcripts) for the combined 3027 chronic generic and 
condition-specifi c statements before reduction and the remaining 1225 statements after step 1 
(%).
Table 3. Examples of rewritten statements.
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An iterative card sorting procedure (Step 4) was employed to assign items to (a) modules 
(chronic generic vs. condition-specifi c), (b) domains within modules and (c) dimensions 
within domains. At the same time remaining redundant or equivalent items were removed. 
Th is resulted in 148 items for the chronic generic module and between 25 to 54 items 
in each of the condition-specifi c modules. Th e rereading of the items in a DISABKIDS 
workshop again gave a slight reduction (Step 5). Th e fi nal chronic generic pilot module 
consisted of 100 items and the condition-specifi c pilot modules consisted of between 26 






































































Total 3515 1225 796 429 331
Discussion
Th e current opinion in HRQoL research is that patient-derived approaches are required 
for valid questionnaire development in which a common methodology is the focus group 
approach 10,16,39,40. Th e DISABKIDS project collected qualitative patient-derived data from 
seven chronic conditions. Unique is that the DISABKIDS project not only collected the 
items cross-nationally but that the selection steps were also carried out multi-centred, as 
experts from diff erent countries participated in each step.
We have discussed a combination of steps to reduce the vast amount of collected 
statements from focus groups and interviews to develop the DISABKIDS pilot instrument. 
Th is stepwise process was done in an eff ort to make the item selection transparent and 
replicable. It is important to have a database showing all the taken steps so that one can 
refer to where each statement came from. It is conceivable that such an extensive process 
has not been presented before, as it is a complex system to describe in detail, often 
combining objective and intuitive judgements. Th e bottleneck was that investigators 
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Table 4. Results of the stepwise statement reduction process. Listed are the amounts of 
remaining statements after each reduction step.
*Step 2 was omitted in the statement reduction procedure. 
†An item on independence was re-added.
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needed to make decisions about data that were supplied by children, adolescents and 
parents, causing the top-down procedure (investigators) to confl ict with the bottom-up 
procedure (patients). 
Before the pilot version items were selected, the DISABKIDS group had several moments 
of decision making. Th is started with which questions to ask in the focus groups, which 
HRQoL statements to select from the literal transcripts, how to translate these statements 
to one language, how to reduce the amount of statements, how to rewrite statements to 
items, which domains to utilize and whether all HRQoL aspects were selected. Th is process 
was complicated by the large amount of statements (3515 in total), the inclusion of seven 
chronic conditions and working in a multi-national group. 
Th ere are some issues in the DISABKIDS item selection methodology that need to be 
discussed. First, although the statements were generated from patient-derived methods 
the fi nal item selection was based on the investigators (top-down) judgement (Table 1). 
As there was such an extensive amount of statements the DISABKIDS group decided to 
have the experts (instead of the patients) do the statement redundancy scoring (Step 1) and 
the importance scoring (Step 2). Th e data pool was so large that even the experts found 
it diffi  cult to get an overview of all the statements. Th is is illustrated in the fi rst reduction 
step where there was a distinct diff erence in the amount of statements removed by each of 
the experts and several redundant or equivalent items were missed. In an eff ort to bring 
back the children and adolescent's opinion, we asked them to approve the selected items 
and judge them on comprehension and applicability in a cognitive interview during the 
pilot test 41. 
Other issues concern the construction of the statement pool. First, there was no 
opportunity to monitor how each country had selected the HRQoL statements from their 
national focus group and interview transcripts. Th e use of a computer was not applicable 
as the data were in several languages 42,43. Th us personal interpretations, interests and 
subjective factors may have infl uenced the statement selection process 44. In addition, 
there is a risk that when statements are taken out of their context they loose their original 
meaning 45. Secondly, the investigator was responsible for the translation of the selected 
statement into English. As there was no offi  cial forward-backward translation the quality 
of the supplied English translation may have altered the meaning of the original statement 
and infl uenced the chance of it being used as a fi nal item. Using expert or panel translators 
in this phase may have improved the quality of the statements and made the literal 
wording in the questionnaire more likely 46. 
Th e DISABKIDS members provided the expert importance scoring, which was aimed 
at selecting those items that were fundamental to the DISABKIDS HRQoL instrument. 
Such an expert importance scoring has been used in other cross-cultural studies, such as 
the WHOQOL group 32. Potential limitations resulted from this chosen method. Asking 
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only the experts for the importance of a statement may have linked the importance scoring 
to their experienced severity of the condition. Th e JIA and CF statements where generally 
scored higher than the asthma and epilepsy statements. Th is indicates that the severity 
of the condition was probably scored and not the importance of each statement for the 
HRQoL instrument. Furthermore the given results may not refl ect the highest frequency 
or importance as perceived by the patients with low and high disease severity. Th e expert 
scoring came with a risk that certain items (important to the patients) would be rejected 
in the selection process. Th erefore the expert importance scoring (Step 2) was discarded 
by the DISABKIDS group. In future we would reconsider an importance scoring but per 
chronic medical condition and for separate degrees of severity, to avoid an item bias in the 
retained statements. Due to time and organisational constraints it was not possible to redo 
the importance rating and the step was omitted. 
As most statements were literal phrases given by children and adolescents, the statements 
needed to be rewritten into items appropriate for the instrument. Th ere was a danger 
revealed in the rewriting of the statements, as some items were no longer related to the 
original statement. For example: "My teacher thinks that I can't do anything" was changed 
to "Do you fi nd schoolwork easy?" or "I can get colds much easier than others and have 
them longer" was rewritten into "Do you worry more than your friends about staying 
healthy?". Even though these changes lead to a confl ict with our bottom-up approach 
the opinion prevailed that these new items were of importance, and thus remained in the 
item pool. In future an international item-writing group would be preferred to guard for 
uniformity and quality. 
During the DISABKIDS item development process the card sorting was found to be a 
comprehensive and straightforward method to apply. As the item cards were grouped in 
piles, comparison was straightforward and it was easy to divide the items into domains 
and dimensions, identify redundant or equivalent statements or determine whether items 
had to be placed into another domain. Th eoretically all previous reduction steps could 
have been performed in the card sorting method. A preferred strategy would have been to 
apply the earlier reduction steps in a card sorting method and to identify themes instead of 
statements to avoid a large data pool (Box 3). 
• Statement selection Have two or more experts select the statements from the transcripts
• Card sorting Look for reoccurring themes per chronic condition and combine these in piles
• Redundancy Remove excessive and semantically equivalent statements from the card sorting piles
• Modules Compare the statements between the conditions and merge the overlapping statements 
to a chronic generic module
• Item writing Rewrite the remaining statements into items
chapter 5
Box 3. Suggested steps in reducing qualitative data based on expert decisions. 
84
Conclusion
We have described the DISABKIDS reduction process in detail and have shown that a few 
thousand HRQoL statements can make the item selection process of a new instrument 
quite complex. Th e current study shows that expert decisions were necessary to form a 
pilot instrument. By combining several reduction steps in this selection phase we tried 
to create the conditions for adequate face and content validity. Describing statement 
reduction methods has added value for future research as there is currently no basic guide 
of how to process qualitative patient-derived data. Th e DISABKIDS pilot and fi eld study 
will provide further data on internal consistency, stability, validity and reliability 41. 
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condition-specifi c modules to measure health related quality 
of life (HRQoL) in children and adolescents 
R.M.Baars, C. Atherton, H.M. Koopman, M. Bullinger, M. Power and the DISABKIDS 
group
Health and Quality of Life Outcomes 2005, 3:70.
Abstract
Th e European DISABKIDS project aims to enhance the health related quality of life 
(HRQoL) of children and adolescents with chronic medical conditions and their families. 
A description is given of the development of the seven cross-nationally tested condition-
specifi c modules of the European DISABKIDS HRQoL instrument in a population 
of children and adolescents. Th e condition-specifi c modules are intended for use in 
conjunction with the DISABKIDS chronic generic module. Focus groups were used 
to construct the pilot version of the DISABKIDS condition-specifi c HRQoL modules 
for asthma, juvenile idiopathic arthritis, atopic dermatitis, cerebral palsy, cystic fi brosis, 
diabetes and epilepsy. Analyses were conducted on pilot test data in order to construct 
fi eld test versions of the modules. A series of factor analyses were run, fi rst, to determine 
potential structures for each condition-specifi c module, and, secondly, to select a reduced 
number of items from the pilot test to be included in the fi eld test. Post-fi eld test analyses 
were conducted to retest the domain structure for the fi nal DISABKIDS condition-specifi c 
modules. Th e DISABKIDS condition-specifi c modules were tested in a pilot study of 
360 respondents, and subsequently in a fi eld test of 1152 respondents in 7 European 
countries. Th e fi nal condition-specifi c modules consist of an ‘Impact’ domain and an 
additional domain (e.g. Worry, Stigma, Treatment) with between 10 to 12 items in total. 
Th e Cronbach's alpha of the fi nal domains was found to vary from 0.71 to 0.90. Th e 
condition-specifi c modules of the DISABKIDS instrument were developed through a step-
by-step process including cognitive interview, clinical expertise, factor analysis, correlations 
and internal consistency. A cross-national pilot and fi eld test were necessary to collect these 
data. In general, the internal consistency of the domains was satisfactory to high. In future, 
the DISABKIDS instrument may serve as a useful tool with which to assess HRQoL in 
children and adolescents with a chronic condition. Th e condition-specifi c modules can be 
used in conjunction with the DISABKIDS chronic generic module. 
Introduction
Th e last few decades have seen an increase in the amount of constructed health related 
quality of life (HRQoL) questionnaires for use with children and adolescents 1,2. 
Although a number of questionnaires have been used for evaluative studies the 
questionnaires are only occasionally used in paediatric clinical trials or clinical practice 3-5. 
Th e expectation is that the implementation of HRQoL questionnaires will increase once a 
number of aspects of HRQoL research are improved.
One area of improvement concerns the need for valid cross-national questionnaires for use 
in international research 6-8. Most questionnaires have been developed in one country and 
A prime question … is whether the academic psychometric principles, although perhaps 
elegant statistically, are satisfactory for the clinical goal of indicating what clinicians and 
patients perceive as quality of life (T.M.Gill 1994).
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are then translated for use in other countries (sequential approach) 9. Th is is thought to 
have its limitations as true compatibility is not necessarily reached 8,10. A preferred design 
for the development of cross-national questionnaires is to construct a questionnaire in 
several countries through a simultaneous approach 8,9. A questionnaire that was developed 
in simultaneous collaboration with diff erent countries is the World Health Organization 
Quality of Life (WHOQOL) questionnaire, but it is only for use in adults 11. 
Investigators have also suggested further improvement of HRQoL questionnaires by 
combining generic and condition-specifi c modules to off er suffi  cient detail in the 
assessment of HRQoL 12. Generic questionnaires are generally used in HRQoL research 
and enable comparisons between groups of interest (i.e. diff erent chronic medical 
conditions). Supplementing a generic module with a condition-specifi c module is 
suggested to provide additional information concerning a specifi c condition and has 
the potential to identify smaller changes important to research or clinical practice 12-14. 
Examples of these are the 'How are you?' (HAY)-asthma 15,16 and the Paediatric Quality 
of Life Inventory (PedsQLTM) 17,18, which both consist of a generic core scale with an 
additional asthma module.
However, thus far there were no HRQoL questionnaires that were developed in several 
countries simultaneously and consisted of a chronic generic and condition-specifi c module 
for use in children and adolescents with a variety of chronic medical conditions. Th e 
European DISABKIDS project aimed to provide in this need. Th e project was conducted 
simultaneously in collaboration with seven European countries and developed a series 
of modules to assess the HRQoL of children and adolescents who suff er from chronic 
medical conditions 19. Th e unique combination consisted of the simultaneous cross-
national development, the patient-derived bottom-up procedure, a two modular design 
and the inclusion of seven chronic conditions. Th is paper will illustrate the psychometric 
procedures that have been employed in the development of the condition-specifi c modules 
for the European DISABKIDS instrument. Results will be presented and limitations 
will be discussed. A pilot study was performed to test the basic domain structure and 
reduce the number of items. A larger fi eld study was conducted to carry out the statistical 
analyses for the fi nal version of the seven condition-specifi c DISABKIDS modules. Th e 
asthma-specifi c module will be described in more detail to illustrate the developmental 
process.
Method
Th e DISABKIDS group has developed a European HRQoL instrument for children 
and adolescents with a chronic medical condition and their parents 19. Th e project is 
a collaboration of seven European countries (Austria, France, Germany, Greece, the 
Netherlands, Sweden and the United Kingdom) and included seven chronic medical 
conditions: asthma, juvenile idiopathic arthritis (JIA), atopic dermatitis, cerebral palsy 
(CP), cystic fi brosis (CF), diabetes and epilepsy. Th e work was closely linked to the 
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KIDSCREEN project, which is concerned with the development of a generic quality 
of life (QoL) questionnaire for children of the general population through a similar 
methodology 20,21. Th e instruments devised by these two projects form a three level 




Th e generic module is provided by the KIDSCREEN project and is a QoL questionnaire, 
suitable for all children, regardless of whether they enjoy complete health or suff er from 
a chronic medical condition. Th is generic module creates the possibility of comparing 
children with a chronic condition to healthy children. Th e DISABKIDS project has 
provided the other two modules. One is referred to as the chronic generic module, which 
is suitable for use with children and adolescents who suff er from any chronic medical 
condition. It can compare HRQoL across diff erent conditions while taking into account 
specifi c areas aff ected by a chronic condition 22. Th e third level consists of a condition-
specifi c module, one for every chronic condition studied in the DISABKIDS project. Each 
one concerns aspects related to a specifi c chronic condition and can only compare between 
data from patients with the same chronic condition. In practice children and adolescents 
with a chronic medical condition can complete all three modules as each provides diff erent 
information. 
Th e DISABKIDS project has followed a stepwise methodology of questionnaire 
construction. Prior to the development of the instrument, an extensive literature review 
was conducted, and existing HRQoL questionnaires were reviewed in order to obtain 
an understanding of items in use. Central to the DISABKIDS project was the ‘bottom-
up’ (patient-derived) nature of questionnaire construction, which was accomplished by 
involving children and adolescents with a chronic medical condition throughout the 
project. Focus groups and interviews were carried out in order to identify important 
HRQoL aspects from the perspective of children, adolescents and their parents. Th e 
participants were asked a series of semi-structured questions designed to facilitate 
discussion about their health and related quality of life issues. For example, “What kinds of 
things keep you healthy?” or “How does your condition aff ect you at school?”. Participants 
were also asked to make suggestions as to what questions could be included in a HRQoL 
questionnaire suitable for others who suff er from the same condition as them. In this way 
the perspective of the child has been incorporated in order to ensure that the content of 
the questionnaire is directly relevant to the targeted age group 23.
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Figure 1: Modular design of the DISABKIDS* and KIDSCREEN† instrument.
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HRQoL statements were selected from the collected qualitative data (focus group and 
interview transcripts) and merged into a data bank. Collected statements from each 
chronic condition group (asthma, epilepsy etc.) were then divided among the three 
modules of the instrument (fi gure 1). Statements that were considered relevant to all 
children and adolescents, either healthy or suff ering from a chronic condition were 
entered in the generic module and passed on to the KIDSCREEN project. General 
statements concerning chronic medical conditions were entered into the chronic generic 
module. Every disease specifi c statement was placed in the appropriate condition-specifi c 
module. To minimise the number of items, a redundancy scoring, item writing and 
card sorting procedure was constructed 22. Th e card sorting procedure was performed 
by the DISABKIDS investigators and assisted in the fi nal item selection and provided a 
preliminary domain structure for each module for use in the pilot study. Th e selected items 
were translated to the appropriate languages following general guidelines 24. 
Th e aim of the pilot test was to select a reduced number of items to be included in the fi eld 
test and to determine a preliminary scale structure within each condition-specifi c module. 
At this stage it was considered important to integrate both statistical and subjective 
data during the item selection process. Th is included the percentage of ‘not applicable’ 
and ‘never’ responses, a cognitive interview and the clinical judgment of clinicians and 
investigators. Th e cognitive interview provided detailed feedback on the relevance, age 
appropriateness and comprehensibility of the condition-specifi c items 25-27. Children and 
adolescents were asked to rate the diffi  culty of each item and to rephrase each item in 
their own words. Th is feedback was used in conjunction with statistical analyses in order 
to make informed decisions about the item reduction 22. Th e aim of the fi eld test was to 
re-analyse the fi nal domain structure of each condition-specifi c module and to calculate 
the internal consistency of each domain with data from a larger cross-national sample. 
Items were also examined for distribution of responses, frequency of non-response, ceiling 
and fl oor eff ects. 
Children and adolescents between 8 and 16 years of age and their parents were asked to 
participate in the DISABKIDS pilot and fi eld study, completing the instrument either 
at the hospital or at home. Data from the children and adolescents were used for the 
statistical analyses. Condition-specifi c modules were generally tested in two or more 
countries; only asthma was tested in all seven countries. Analysis of the condition-specifi c 
modules was carried out centrally (in the UK) to ensure that the item selection was done 
in a consistent way across all seven conditions. Th e analyses were performed separately for 
each condition-specifi c module and were carried out using SPSS Version 11. 




Th e pilot study instrument included the pilot version of the chronic generic module (100 
items) and the pilot version of the condition-specifi c modules (between 26 and 44 items) 
(Table 1). Th e applied answer categories were never, seldom, quite often, very often and 
always, which were scored on a scale from 1 to 5 and an additional ‘not applicable’ option. 
Th e pilot study was conducted between May and August 2002. 































Th e sample for the pilot study consisted of 360 participating families. An equal number 
of boys and girls (48% and 52%) were included, mean age 12.5 (SD 2.55). Th e asthma 
group was the largest group of the sample (n = 132). Questionnaire data were only 
included when more than 60% of the items were completed, resulting in a total of 342 
cases for the analyses. Th is left a few missing values, which were replaced with their series 
mean to evade losing additional data.
Various sources of data were systematically considered in the selection of items for 
domains. Some of the data were qualitative in nature, for example the clinical opinion 
gained from the relevant consultants participating in the project, cognitive interview 
feedback from the children and adolescents, and the investigator's judgement of the quality 
of the item. Th ese qualitative aspects were used in conjunction with quantitative results 
from statistical analyses of the pilot test data (missing values, fl oor and ceiling eff ects). 
Some items were removed solely on the basis of qualitative data when 3 or more qualitative 
factors were identifi ed as problematic (for example: not understood in the cognitive 
interview, too many missing values and not suffi  ciently related to HRQoL). 
Th e structure of the condition-specifi c modules, as derived from the card sort procedure, 
was used as a starting point for the identifi cation of domains within the pilot test modules. 
Item-domain correlations and reliability (Cronbach's alpha) were calculated for these 
scales. Th e domain structures resulting from the card sorting method were not generally 
robust in the statistical analyses. Th erefore, principal components analysis with varimax 
rotation was conducted in order to identify possible new domains. Th e sample size was 
quite low for some conditions, and therefore factor analyses were viewed with caution. 
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Table 1. Number of items and participants (n=360) in the pilot study for each condition-
specifi c module.
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An iterative procedure was followed in order to examine possible domain structures. Item 
groupings, found in the principal components analysis as being similar to those of the 
original domain structures (from the card sort procedure), were identifi ed. On the basis 
of a similarity between these two methods, 3-6 items were selected per domain. A scale 
was then computed and the reliability calculated. If the Cronbach's alpha (α) value was 
acceptable (above 0.6 to 0.7) and could not be improved by the removal of items, this 
was acknowledged as a domain 28. Th e process was carried out for all feasible domains 
(typically two or three per condition). Th e resulting domains were then correlated with 
all the remaining condition-specifi c items. An item was added to a domain if it correlated 
with a domain, it loaded only on one domain, and it generally made sense to include the 
item in the domain 29. Th e reliability of the domain, including the added items, was then 
re-calculated to ensure a good fi t. In some instances items were removed on the basis of 
low corrected item-total correlations, which ideally should be above 0.4 28. 
If the constructed domains displayed an unsatisfactory (depending on group size and 
number of items) Cronbach's alpha value (i.e. α below a value of 0.7 to 0.6), the factor 
analysis was repeated, restricting it to two or three domains. Th is typically resulted in the 
grouping of similar items that could be formed into possible new domains (not necessarily 
those identifi ed in the card sorting procedure). If a domain contained too many items 
and had a very high alpha value (α over 0.9), item-item correlations were carried out to 
identify and consequently exclude duplicate items. 
When two or three domains had been identifi ed with a total of around 15 items, a fi nal 
check was run that consisted of the reliability of the domain, the item-domain correlation, 
and conceptual analysis that included whether or not the scale made sense. Th e internal 
consistency of the domains in each condition-specifi c module was between 0.75 and 
0.89 (Table 2 ). Each domain was given a label that represented the semantic content. 
Consultants (with knowledge of a specifi c chronic condition) within the DISABKIDS 
project were given the opportunity of adding 1 or 2 items to a module on the basis of 
clinical importance; these items were not added to the domains, but were maintained as 
single items for separate analyses after the fi eld study.



























































Development of seven condition-specific modules
Table 2. Domains, number of items (n) and the Cronbach's alpha (α) after the pilot analysis.
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Example: the asthma pilot study analysis
After the card sorting methodology the asthma module originally consisted of 8 domains 
(Limitations, Symptoms, Worry, Allergy, Sleep, Medical, Interpersonal and Lack of energy) 
with a total of 32 items (Table 3). Analysis of the module as described above (including 
information from the cognitive interviews and clinical judgements) resulted in a 2 domain 
structure (13 items). Th e domains were labelled ‘Impact’ and ‘Worry’ due to their semantic 
content. Th e mean score on the 'Impact' domain was 3.63 (SD 0.82) and 4.15 (SD 0.89) 
on the 'Worry' domain. Th e DISABKIDS asthma consultants added two extra items, not 
selected through statistical analysis but based on clinical relevance.
Field study 
Th e next step in the DISABKIDS project was the fi eld study, which took place between 
April and July 2003. Th e sample for the fi eld study consisted of 1152 participating 
families. Th e fi eld study instrument included the chronic generic module (56 items)22 
and the seven condition-specifi c modules (between 14 and 19 items) (Table 4). An equal 
number of boys and girls (52% vs. 48%) were included, mean age 12.2 (SD 2.8). Th e 
asthma group was the largest in the sample (n = 405). Data from 1094 children and 
adolescents were used in the analysis, selected on the basis of more than 60% of the items 
in the module being completed.
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Asthma condition-specifi c items Pilot study domains
Field study 
domains Final domains
Do you have problems sleeping at night because of your cough? Sleep Extra item
Are you bothered by coughing during your sleep? Sleep
Are you scared at night because of your asthma? Sleep Worry Worry
Does coughing give you attention from people? Interpersonal
Do other children understand that you are sometimes out of 
breath? Interpersonal
Do other kids make fun of your inhaler? Medication
Do you hate blowing into a peak fl ow meter? Medication
Do you need medicine to relieve your symptoms before going 
to bed? Medication
Do you worry that others do not know what to do if you have 
an asthma attack? Worry Worry Worry
Are you worried that you might have an asthma attack? Worry Worry Worry
Do you feel scared that you might have diffi  culty breathing? Worry Worry Worry
Are you scared that you might have to go to the emergency 
ward? Worry Worry Worry
Are you bothered that you have to stay indoors because of your 
allergies? Worry
Do you have to ask people not to smoke or to wear perfume? Allergy
Do you have to wear special clothes because of your asthma? Allergy
Are you bothered by hay fever? Allergy
Do you have to be careful about washing yourself due to the 
eczema? Allergy
Are you bothered by feeling sleepy? Lack of energy
Do you feel that you get easily exhausted? Lack of energy Impact Impact
Do your parents prevent you from going out as much as your 
friends because of your asthma? Limitations
Does asthma bother you if you want to go out? Limitations Impact Impact
Do you avoid going to people’s houses in case they are not clean 
enough? Limitations
Are you not able to take part in certain sports? Limitations Impact Impact
Do you miss having a pet? Limitations
Do you miss cuddly toys? Limitations
Does your allergy stop you from doing what you want to do? Limitations Extra item
Do you feel terrible when you are out of breath? Symptoms Impact Impact
Do you feel short of breath when you do sports? Symptoms Impact Impact
Are you bothered by the amount of time you spend wheezing? Symptoms Impact Impact
Are you bothered by the amount of time you spend coughing? Symptoms Impact
Have you been embarrassed about coughing in front of others? Symptoms
Do you cough when you do sports? Symptoms Impact
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Table 3. Item selection and domain appointment after the asthma pilot and fi eld study.
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Condition-specifi c modules Number of items Number of participants






























At this stage the purpose of the analysis was to replicate the domains found in the pilot 
test analysis. Principal components analysis was carried out. Components that were found 
to be similar to the pilot test domains (like the asthma and CF module) were directly 
checked for reliability. A domain was kept if the alpha value was above 0.7 and could not 
be improved by the removal or inclusion of items.
All domains were correlated with each of the condition-specifi c items. An item was added 
to a domain if it correlated with the domain, it loaded clearly on one domain and it 
generally made sense to include the item in the domain. Items were removed if they loaded 
on more than one domain (above 0.4 for each domain) or on the basis of high item-item 
correlations (above 0.9) 29. If necessary, items were also removed from a domain on the 
basis of low corrected item-total correlations and/or a substantial increase in alpha value 
if removed. Th e internal consistency of the domains was checked after each step. Each 
procedure was repeated until the optimal solution was found. In some cases domains 
were renamed or two domains were merged (for example for the diabetes, JIA, and atopic 
dermatitis modules). Th e internal consistency of the domains for each condition-specifi c 
module was between 0.71 and 0.90 (Table 5). It became clear that one domain of each 
condition related to the actual impact of the condition on a child or adolescent’s life. Th ese 
domains were relabelled 'Impact'. Over half of the extra items that were included on the 
basis of clinical relevance after the pilot study analysis were integrated in the fi nal domains. 



















































Table 4. Number of items and participants (n=1152) in the fi eld study for each condition-
specifi c module.
Table 5. Domains, number of items (n) and Cronbach's alpha (α) after the fi eld study 
analysis.
*With only two items this is the inter-item correlation.
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Example: the asthma fi eld study analysis
Th e domain structure of the asthma pilot test analysis was successfully replicated 
resulting in a 2 domain structure of 'Impact' and 'Worry', which consist of 6 and 5 items 
respectively. Four items were removed on the basis of duplication and low item-domain 
correlations, including the two extra clinical items (Table 3). Th e cumulative proportion 
of the variance explained by the fi rst two domains was 53% and the internal consistency 
(α) was 0.83 and 0.84 (Table 5). Th e mean score on the 'Impact' domain was 3.61 (SD 
0.91) and 4.17 (SD 0.84) on the 'Worry' domain. Th e asthma-specifi c module was tested 
separately for all participating DISABKIDS countries. Th e reliability in each country was 
mostly above 0.8 (Table 6). 





































Th is study describes part of the developmental process of the seven DISABKIDS cross-
national condition-specifi c modules (Box 1). Th e DISABKIDS instrument for children 
and adolescents is the fi rst to be developed cross-nationally in collaboration with several 
European countries and to include a chronic generic and condition-specifi c module. 
Th e DISABKIDS instrument has several advantages. First the construction of the chronic 
generic and condition-specifi c modules allows for a comprehensive assessment of HRQoL. 
Th e chronic generic module can be used in conjunction with any of the condition-specifi c 
modules. Combining these modules gives the clinician and investigator the unique 
opportunity to compare between countries and between diff erent conditions. 
Th e second advantage is the simultaneous cross-national patient-derived development of 
the DISABKIDS instrument. Children and adolescents from each DISABKIDS country 
were included in the developmental process of the instrument. HRQoL statements were 
collected from the cross-national focus groups and interviews. Investigators from the 
DISABKIDS centres were involved in the item selection process, assuring that all items 
where relevant in each country. Th is was again tested in the cognitive interview in the pilot 
study. Th is simultaneous setup in diff erent countries supported the developmental process 
by taking into account cross-national consensus on important HRQoL issues.  
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Table 6. Th e Cronbach's alpha (α) and number of participants (p) for the fi nal two asthma-
specifi c domains calculated for each country.
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In addition, the construction of the DISABKIDS instrument has been a refl ective one, 
combining subjective and statistical procedures. Item selection and reduction was not 
carried out solely through the use of statistical methods, but also through the inclusion of 
qualitative factors, such as the views of children and adolescents (gained from cognitive 
interview) and clinical judgement. Th e domain structure that resulted from the pilot 
test was to a great extent successfully replicated after the fi eld test. Th e reliability of each 
domain was satisfactory in each condition-specifi c module.
However, some limitations should be given consideration. Th e number of respondents 
in some condition groups in both the pilot and the fi eld test was relatively small, CP 
(n=21 and 43) and atopic dermatitis groups (n=29 and 65) in particular (Table 1 and 4). 
It was therefore not possible to solely use statistical methods to develop these modules. 
It is important to carry out further data collection and to test the reliability and validity 
in larger patient groups for these conditions. It will also be necessary to carry out large 
cross-national studies in the future in order to use modern psychometric methods based on 
Item Response Th eory (IRT), which will permit the testing of diff erential item functioning 
across cultures and inform the degree to which cross-national comparisons can be validly 
made. Th e use of such IRT-based tests was not possible at this stage of the development of 
the measure because IRT methods require very large sample sizes.
A second limitation is that the condition-specifi c modules were not tested in every country. 
Only asthma was tested in all the participating DISABKIDS countries. Th e Cronbach's 
alphas were adequate for each asthma domain in each country. Th e lower alphas in Greece 
might not only be due to lower numbers of tested participants but also to the fact that the 
researched population included mostly exercise-induced asthma, which might result in 
a diff erent impact on their HRQoL. As the number of participants in the other chronic 





• Select data for each condition separately
• Remove children with more than 40% missing on condition-specifi c module
• Descriptives including mean, SD, missings, skewness, and kurtosis
• Check total domain alpha and each item’s corrected item-total correlation
• Check item-item correlations for high or not correlating items
Checking existing domains:
• Compute original scales from card sorting
• Reliability of existing scales
Replicating domain structure:
• Factor analysis, if necessary restricted to four, three or two factors
• Comparing meaningfulness of solutions
• Computing domains, calculating reliability and the item-domain correlation
• Adding any correlated items to domains 
• Item-domain correlations
Testing domains:
• Total reliability of the domains
• Checking item-domain correlations (ensure corrected item-total correlation is above 0.4)
• Domain-domain correlation
• Check deleted items against content of chronic generic items
Future studies will be necessary to provide more details on the reliability and validity of 
the DISABKIDS modules, especially in larger groups and in diff erent countries. Evidence 
also needs to be supplied on the value of the instrument in clinical practice. Further 
possibilities include testing the chronic generic module for applicability in other chronic 
medical conditions (e.g. haemophilia, heart disease or obesity). 
Th e developmental steps within the DISABKIDS project have included a combination of 
qualitative and quantitative methods. Th e two methods were used in succession in order 
to complement each other, as has been the case throughout the DISABKIDS project. 
Th e qualitative data (cognitive interview and clinical judgement) collected in the pilot 
study was fi rst used to disregard irrelevant items. Th is was followed by the psychometric 
calculations. In some cases the project members found removed items to be clinically 
relevant. Th ese were therefore added as the two extra items in the fi eld study. 
Although the process of item reduction for each of the condition-specifi c modules 
was similar and included well know procedures 28,29, it remains diffi  cult to describe the 
developmental process. As the value of each test depended on the size of the group and 
the number of items in the domain, and common sense judgements were also included, 
the taken steps may not always seem transparent. Th e number of countries included in 
the study meant that there were more national factors and individual opinions to include. 
Several processes within the DISABKIDS project (team meetings, group discussions) have 
infl uenced decisions. An example was the post-hoc decision to add extra items based on 
clinical relevance.
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Conclusion
Th e condition-specifi c modules for the DISABKIDS instrument were developed through 
a step-by-step process including cognitive interview, clinical expertise, factor analysis, 
correlations and reliabilities. Th e seven condition-specifi c modules consist of an 'Impact' 
domain and an additional domain with a total of 10 to 12 items (See appendix). Th e 
DISABKIDS project has constructed a unique instrument, which was developed cross-
nationally, included the patient's perspective and has a chronic generic module, which can 
be combined with one of the seven condition-specifi c modules. Th e expectation is that 
the instrument will be used in a wide variety of (international) studies of children and 
adolescents with common disorders of childhood.
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Do you feel that you get easily exhausted? 
Does asthma bother you if you want to go out?
Are you unable to take part in certain sports?
Do you feel short of breath when you do sports?
Are you bothered by the amount of time you spend wheezing?
Do you feel terrible when you are out of breath?
Are you worried that you might have an asthma attack?
Do you worry that others do not know what to do if you have an attack?
Do you feel scared that you might have diffi  culty breathing?
Are you scared that you might have to go to the emergency ward?




Do you feel stiff  in the mornings (like an old grandma/granddad)?
Do you get exhausted easily? 
Does arthritis make you feel too exhausted to be with friends?
Do you hate being in pain?
Does it annoy you that the pain sometimes comes on so suddenly?
Does pain stop you from doing what you want?
Does it bother you that you can’t do all sports/hobbies because of your arthritis?
Do you hate being restricted in movement?
Does it bother you that you have trouble writing/ drawing? 
Do others understand that your symptoms may change suddenly?
Do your friends understand that you may feel poorly quite suddenly?




Does the itching bother you?
Does the appearance of your skin bother you?
Does itching bother you during the night?
Does your skin condition aff ect your concentration at school?
Does looking at your skin scare you?
Does your skin get worse when you are under stress?
Does your skin condition aff ect your free-time (sports, playing)?
Do you feel comfortable with the way your skin is?
Do you try to hide your skin condition?
Are you annoyed by others giving you strange looks?
Do you dislike it when your friends see the cream being applied?
Do you feel uncomfortable when others look at you?
Cerebral palsy





Is it frustrating to be unable to keep up with other children?
Do you wish that you could run around like everyone else?
Do you wish that you could swim as well as other children?
Does it bother you that getting dressed takes a long time?
Do people think that you are not as clever as you are?
Do you have trouble getting in and out of buildings?
Are you able to do most things even though your legs don’t move well?
Does it upset you that you are unable to walk without help?
Do you dislike being washed and dressed by other people? 
Does it upset you that you need help to use the toilet?
Can you communicate as well as you’d like?




Do you get exhausted when you do sports?
Do you feel tired during the day?
Do you get out of breath?
Do you need to rest more than others?
Does it bother you that you must take your enzymes before every meal?
Does it bother you that you have to eat a special diet to keep you healthy?
Does it bother you that you have to spend a lot of time having treatment?
Are you bothered because you have to do physiotherapy everyday?
Have you felt that your treatment takes up too much of your free time?




Does diabetes stop you from doing the things you want to do?
Does diabetes rule your day? 
Does it bother you that you have to be careful about what you eat?
Is it diffi  cult for you to stick to your diet? 
Do you worry about your blood sugar level? 
Does it bother you that others can always eat and drink as much as they like? 
Are you annoyed that you have to carry the testing equipment with you?
Are you bothered that you have to plan everything?
Do you mind taking insulin? 




Are you afraid that you might hurt yourself during a seizure?
Are you worried that you might have a seizure in public?
Are you afraid of having a seizure? 
Do your seizures make you feel helpless? 
Are you scared that you could have a seizure at any time?
Does it embarrass you when people take care of you when you have a seizure?
Are you worried that people make fun of you when you have a seizure?
Are you afraid that you can’t remember what happens during a seizure?
Are you ashamed of having seizures?




1.  Andelman RB, Zima BT, Rosenblatt AB. Quality of life of children: toward 
 conceptual clarity. In: Maruish ME, editor. Th e use of psychological testing for 
 treatment planning and outcomes assessment. Mahwah, NJ: Lawrence Erlbaum; 1999. 
 p. 1383-413.
2.  Eiser C, Morse R. Quality-of-life measures in chronic diseases of childhood. Health 
 Technol Assess 2001;5(4):1-157.
3.  Clarke SA, Eiser C. Th e measurement of health-related quality of life (QOL) in 
 paediatric clinical trials: a systematic review. Health Qual.Life Outcomes. 2004;2 
 (1):66.
4.  Baars RM, van der Pal SM, Koopman HM, Wit JM. Clinicians' perspective on quality 
 of life assessment in paediatric clinical practice. Acta Paediatr. 2004;93(10):1356-62.
5.  Bender BG. Measurement of quality of life in pediatric asthma clinical trials. Ann. 
 Allergy Asthma Immunol. 1996;77(6):438-45.
6.  Quality of life and clinical trials. Lancet 1995;346(8966):1-2.
7.  Acquadro C, Jambon B, Ellis D, Marquis P. Language and translation issues. In: 
 Spilker B, editor. Quality of life and pharmacoeconomics in clinical trials. Second 
 Edition ed. Philadelphia: Lippincott-Raven; 1996. p. 575-85.
8.  Skevington SM. Advancing cross-cultural research on quality of life: observations 
 drawn from the WHOQOL development. Qual.Life Res. 2002;11(2):135-44.
9.  Schmidt S, Bullinger M. Current issues in cross-cultural quality of life instrument 
 development. Arch.Phys.Med.Rehabil. 2003;84(4 Suppl 2):S29-S34.
10.  Swaine-Verdier A, Doward LC, Hagell P, Th orsen H, McKenna SP. Adapting quality 
 of life instruments. Value.Health 2004;7 Suppl 1:S27-S30.
11.  Th e WHOQOL group. Th e World Health Organization Quality of Life assessment 
 (WHOQOL): position paper from the World Health Organization. Soc.Sci.
 Med. 1995;41(10):1403-9.
12.  Fitzpatrick R, Davey C, Buxton MJ, Jones DR. Evaluating patient-based outcome 
 measures for use in clinical trials. Health Technol.Assess. 1998;2(14):i-74.
13.  Ware JE, Jr., Kemp JP, Buchner DA, Singer AE, Nolop KB, Goss TF. Th e 
 responsiveness of disease-specifi c and generic health measures to changes in the severity 
 of asthma among adults. Qual.Life Res. 1998;7(3):235-44.
14.  Guyatt GH, King DR, Feeny DH, Stubbing D, Goldstein RS. Generic and specifi c 
 measurement of health-related quality of life in a clinical trial of respiratory rehabilita-
 tion. J.Clin.Epidemiol. 1999;52(3):187-92.
15.  Bruil J. Development of a quality of life instrument for children with a chronic illness 
 [dissertation]. University of Leiden; 1999.
16.  le Coq EM, Colland VT, Boeke AJ, Boeke P, Bezemer DP, van Eijk JT. 
 Reproducibility, construct validity, and responsiveness of the "How Are You?" 
 (HAY), a self-report quality of life questionnaire for children with asthma. J.Asthma 
 2000;37(1):43-58.
Development of seven condition-specific modules
105
17.  Varni JW, Seid M, Kurtin PS. PedsQL 4.0: reliability and validity of the Pediatric 
 Quality of Life Inventory version 4.0 generic core scales in healthy and patient 
 populations. Med.Care 2001;39(8):800-12.
18.  Varni JW, Burwinkle TM, Rapoff  MA, Kamps JL, Olson N. Th e PedsQL in pediatric 
 asthma: reliability and validity of the Pediatric Quality of Life Inventory generic core 
 scales and asthma module. J.Behav.Med. 2004;27(3):297-318.
19.  Bullinger M, Schmidt S, Petersen C. Assessing quality of life of children with 
 chronic health conditions and disabilities: a European approach. Int.J.Rehabil.Res. 
 2002;25(3):197-206.
20.  Herdman M, Rajmil L, Ravens-Sieberer U, Bullinger M, Power M, Alonso J. Expert 
 consensus in the development of a European health-related quality of life measure for 
 children and adolescents: a Delphi study. Acta Paediatr. 2002;91(12):1385-90.
21.  Ravens-Sieberer U, Gosch A, Abel T, Auquier P, Bellach BM, Bruil J et al. Quality of 
 life in children and adolescents: a European public health perspective. Soz.Praventiv
 med. 2001;46(5):294-302.
22.  Petersen C, Schmidt S, Power M, Bullinger M, and the DISABKIDS group. 
 Development and pilot-testing of a health-related quality of life chronic generic 
 module for children and adolescents with chronic health conditions: A European 
 perspective. Qual Life Res. 2005;14(4):1065-77.
23.  Gill TM, Feinstein AR. A critical appraisal of the quality of quality-of-life 
 measurements. JAMA 1994;272(8):619-26.
24.  Guillemin F, Bombardier C, Beaton D. Cross-cultural adaptation of health-related 
 quality of life measures: literature review and proposed guidelines. J.Clin.Epidemiol. 
 1993;46(12):1417-32.
25.  Grant EN, Turner-Roan K, Daugherty SR, Li T, Eckenfels E, Baier C et al. 
 Development of a survey of asthma knowledge, attitudes, and perceptions: the 
 Chicago Community Asthma Survey. Chicago Asthma Surveillance Initiative Project 
 Team. Chest 1999;116(4 Suppl 1):178S-83S.
26.  Bullinger M, Von Mackensen S, Fischer K, Khair K, Petersen C, Ravens-Sieberer U et 
 al. Pilot testing of the 'Haemo-QoL' quality of life questionnaire for haemophiliac 
 children in six European countries. Haemophilia. 2002;8 Suppl 2:47-54.
27.  Barofsky I. Cognitive aspects of quality of life assessment. In: Spilker B, editor. Quality 
 of life and pharmacoeconomics in clinical trials. Second Edition ed. Philadelphia: 
 Lippincott-Raven; 1996. p. 107-15.
28.  Bullinger M, Power MJ, Aaronson NK, Cella DF, Anderson RT. Creating and 
 evaluating cross-cultural instruments. In: Spilker B, editor. Quality of life and 
 pharmacoeconomics in clinical trials. Second Edition ed. Philadelphia: Lippincott-
 Raven; 1996. p. 659-68.
29.  Hawthorne G, Richardson J, Osborne R. Th e Assessment of Quality of Life (AQoL) 





Th e European DISABKIDS health related quality of life 
(HRQoL) instrument for childeren and adolescents with a 
chronic medical condition: psychometric properties of the 
cross-national asthma sample




Th is study was conducted to cross-nationally test the European DISABKIDS health 
related quality of life (HRQoL) instrument in a population of children and adolescents 
with asthma. Th e European DISABKIDS HRQoL instrument was developed through 
a step-by-step cross-national process. Th ere is a core chronic generic module, with 37 
items, covering 6 domains (Independence, Limitation, Emotion, Social inclusion, Social 
exclusion and Medication). In addition there are seven condition-specifi c modules, of 
which one is an asthma module that consists of 11 items and has 2 domains (Impact and 
Worry). Both DISABKIDS modules were tested in 7 countries within Europe on a total 
sample of 405 children and adolescents with asthma. Th e internal consistency for all the 
domains was between 0.66 and 0.85. Domain test-retest correlations were between 0.71 
and 0.82, indicating good retest reproducibility. Th e correlation of the domains with 
the validation questionnaires was variable. Th e domain scores diff erentiated between 
asthma severity scores. Th e domain results diff er systematically between countries but 
this has no signifi cant eff ect on the validity of the instrument. Th e DISABKIDS HRQoL 
instrument is unique in being developed cross-nationally and in a modular structure. Th e 
psychometric properties of the DISABKIDS chronic generic and asthma-specifi c modules 
are suffi  cient for HRQoL assessment in children and adolescents with asthma.
Introduction
Asthma is the most common chronic medical condition among children, but the 
prevalence of asthma varies greatly, with up to a 20-fold diff erence between some 
countries. An average of 17 % of the children in Western Europe report wheezing and 
13% have had asthma 1. 
Children with asthma can experience limitations or impairments in various aspects of 
their life. Having asthma can lead to restrictions in activities 2-4, emotional problems 5,6, 
behavioural problems 6,7, adjustment diffi  culties 7, feelings of depression 5, a fear of being 
rejected by peers due to being "diff erent" 8, lower perceived well-being 2, anxiety 3,9 and 
family stress 10,11. In general asthma can be kept under control through pharmacological 
therapy and the avoidance of triggers that infl uence the asthma symptoms 12,13. However, 
there are still indications that the health related quality of life (HRQoL) of children with 
asthma is decreased compared to their healthy peers 2,14. It is therefore found crucial that, 
next to the medical treatment of a child with asthma, attention is paid to the child's 
HRQoL.
HRQoL information can help to assess the impact of a chronic medical condition on the 
daily life of a child and his or her family 15-17. It can make clinicians aware of how the child 
perceives his or her illness. Consequently the increasing importance of HRQoL assessment 
A good quality of life can be said to be present when the hopes of an individual are 
matched and fulfi lled by experience (K.C. Calman, 1984).
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in paediatric health care and research also makes it a new parameter in evaluating children 
with asthma.
In the last few decades there has been an increase in the development and testing of various 
paediatric HRQoL questionnaires 18,19. Examples of some asthma-specifi c questionnaires 
are the Pediatric Asthma Quality of Life Questionnaire (PAQLQ) 20, the Childhood 
Asthma Questionnaire (CAQ) 21,22, the Life Activities Questionnaire for Childhood 
Asthma 23 and the Pediatric Quality of Life – Asthma module (PedsQLTM asthma module) 
24. Most of these questionnaires have been developed through a sequential approach, where 
the questionnaire was developed in one country and it has been translated into other 
languages 25. Consequently, these translated questionnaires may need to be adapted due to 
diff erent cultural or lifestyle aspects in certain countries, e.g. problems riding a bike may 
not be as relevant in Greece as they are in the Netherlands 26,27. Developing a questionnaire 
in several countries through a simultaneous approach would diminish this problem and 
create the advantage of a cross-national questionnaire 28. However, there have been only 
a few attempts to develop a HRQoL questionnaire in several countries simultaneously 25. 
Th e WHOQOL questionnaire is a well-known example but this is a generic questionnaire 
and is only for use in adults 29. 
With the exception of the PedsQLTM, multi-language HRQoL paediatric questionnaires are 
either generic or condition-specifi c. Having both generic and condition-specifi c modules 
has the advantage of collecting information that can be compared with other illness groups 
and at the same time collecting specifi c data for a certain condition. Yet, until now, there 
was no questionnaire that combined a generic module, applicable to living with a chronic 
medical condition, with a condition-specifi c module. Th e DISABKIDS project's aim 
was to develop a cross-national paediatric HRQoL instrument simultaneously in several 
countries and at the same time developing a chronic generic and several condition-specifi c 
modules.
Th e aim of this paper is to evaluate the psychometric properties of the cross-nationally 
developed DISABKIDS HRQoL instrument in a population of children and adolescents 
with asthma in Europe. Th e results are a part of the DISABKIDS project conducted to 
develop and psychometrically test the DISABKIDS HRQoL instrument for several chronic 
medical conditions. 
Material and Methods
Th e DISABKIDS project 
Th e European DISABKIDS project is a collaboration of eight research institutions in seven 
European countries (Austria, France, Germany, Greece, the Netherlands, Sweden and the 
United Kingdom) and aims at cross-nationally developing a European HRQoL instrument 
for children (aged 8-12) and adolescents (aged 13-16) with a chronic medical condition 30. 
Chronic conditions included in the project were asthma, juvenile idiopathic arthritis (JIA), 
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atopic dermatitis, cerebral palsy (CP), cystic fi brosis (CF), diabetes and epilepsy. Th e fi nal 
instrument should represent the child and adolescent's view by including aspects that are 
important to them, be multidimensional, cross-nationally applicable, valid and reliable. 
Central to the development is the bottom-up construction. Th is means that the children 
and adolescents with a chronic medical condition were involved in the development of the 
instrument by identifying the HRQoL aspects that they found important in their lives. 
However, what is new about the development of this paediatric HRQoL instrument is not 
so much the bottom-up construction, as the cross-national step-by-step process and the 
modular structure.
Instrument development
Focus groups and interviews were conducted with children, adolescents, their parents and 
health care professionals in all participating DISABKIDS countries to identify relevant 
HRQoL aspects from their perspective. Collected statements generated through these focus 
groups formed the basic item pool in which the common working language was English. 
Item selection was performed through redundancy scoring, item writing and card sorting 
31,32. Applied methods and results have been described elsewhere 33. Th ese items were 
then translated to the appropriate languages following established guidelines (forward-
backwards translations) 26. Th e DISABKIDS modules were tested in a pilot study (n=360). 
Th is included a cognitive interview in which the meaning of each national item was 
described by children and adolescents with the diff erent chronic medical conditions and 
were internationally compared to assure similar meaning. Th e fi nal DISABKIDS modules 
and domains were constructed through psychometric analyses and Rasch modelling using 
the fi eld study data (n=1152) 33. 
Th e fi nal DISABKIDS instrument
Th e fi nal European DISABKIDS instrument is a multi-module HRQoL questionnaire 
for children and adolescents with a chronic medical condition. Th e instrument, when 
used for one of the seven medical conditions, consists of two modules (Box 1). Th e fi rst 
is a chronic generic module, which is applicable to all children and adolescents with a 
chronic condition regardless of the specifi c nature of their disease. Th is module consists of 
37 items, which covers 6 domains (Independence, Limitation, Emotion, Social exclusion, 
Social inclusion and Medication). Th e second part consists of a series of condition-specifi c 
modules (e.g. asthma, JIA, atopic dermatitis, CP, CF, diabetes and epilepsy). All condition-
specifi c modules consist of an 'Impact' domain and a complementary domain. Th e 
asthma-specifi c module consists of 11 items that form two domains (Impact and Worry). 
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Children and adolescents are asked to think about a 4-week time frame and score each 
item on a 5-point Likert scale (1= never to 5 = always). Th e mean score of each domain 
forms a domain score. Th ere is also a parent proxy version that consists of similar 
questions, but in the third-person tense. While the chronic generic module creates the 
opportunity to compare between diff erent conditions, the condition-specifi c module 
should supply the clinician with more specifi c disease information 34-36. Both modules can 
be used in conjunction with each other. 
Validation measures
Integrated in the study were standard HRQoL instruments with a known relationship to 
HRQoL, including the Dutch DUX-25 (in the Netherlands and Sweden) and the German 
KINDL (in Austria, Germany and Greece). Th e DUX is a 25-item HRQoL questionnaire 
with four domains (Emotional, Home, Social and Physical) 37. Th e KINDL is a HRQoL 
questionnaire with 24 items in 6 domains (Physical well-being, Emotional well-being, 
Self esteem, Family, Friends and Everyday function) and a 6-item disease module 38,39. 
Sociodemographic and clinical items were also included, assessing age, gender, ethnicity, 
education, missed schooldays and asthma severity. 
Asthma severity
Several classifi cations have been developed for asthma severity in recent years 12,40-43. In 
daily practice asthma severity is frequently based on a combination of several parameters, 
including symptom frequency and severity, use of medication, physical limitations and 
pulmonary function tests 12,44. Sometimes these parameters are combined with school 
or work absences, daily activities and use of health care facilities 5,45,46. Severity was 
evaluated in several ways in the DISABKIDS project. Information was collected from the 
parents, the child and adolescent, and the clinician. Th ere were single items, for children, 
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Box 1. Th e DISABKIDS instrument: the chronic generic module with 6 domains and in this 
example the asthma-specifi c module with its two domains.
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health is?') and disease severity ('How severe was your asthma during the last year?'). 
Parents were also asked to complete a symptom checklist for asthma severity based on a 
scale by Rosier (1994) 40. Clinicians rated asthma severity through a single item ('How 
would you rate this child’s asthma severity?') and a short questionnaire, in which the 
calculated score was based on questions concerning symptoms, medication and lung 
function 47.
Asthma fi eld study population
Th e studied population consisted of children and adolescents with asthma and their 
parents. Participants were recruited through clinicians from paediatric clinics in all 
seven participating European countries. Children and adolescents were selected on the 
basis of: (a) their age being between 8-12 and 13-16 years, (b) diagnosed with asthma 
by a paediatrician, (c) ability to understand and read the questionnaire in the countries' 
national language, (d) absence of co-morbidity. 
Field Procedure
Between April and July 2003, families were sent an information letter asking them to 
participate in the DISABKIDS study. Th e DISABKIDS instrument and additional 
questionnaires were administered to children and adolescents with asthma by an 
interviewer on the day of a doctor's appointment. If necessary the questionnaire was taken 
home to be completed. Th e parents completed the proxy version of the questionnaires at 
the same time, which also included the asthma severity rating. In addition questionnaires 
were posted to families who were not seen at the medical centres. Clinicians were also 
asked to complete a questionnaire, which included diagnosis, co-morbidity, development 
and disease severity. In each country the questionnaires were administered in the native 
language. All participants were asked to complete retest questionnaires at home 2 weeks 
later and to report if any major events had happened in the meantime and whether this 
was positive or negative. Where necessary a reminder phone call was made to stimulate the 
return of the retest. Th e European commission and each of the Medical Ethics Committees 
in the participating study centres approved the study. Informed consent was obtained from 
all participating families.
Statistical analysis
Th e Statistical Package for Social Sciences (SPSS 10.0; SPSS Inc., Chicago, IL) was 
used for the data analyses. Each country entered the anonymised data into a database 
to protect confi dentiality and meet data protection requirements. Descriptive statistics 
were used to describe the range of responses to each question (variability) and the 
distribution of the domain scores (mean, SD). Further analyses focused on domain scores 
rather than individual item scores. Domain scores were obtained by adding item scores 
within domains and were only calculated if at least 70% of the items in the domain 
were completed. Th e scores were transformed to a linear scale from 0-100 to make 
comparisons between the domains possible in which higher scores indicate a better quality 
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of life. Th e statistical level of signifi cance was set at 0.01 in each analysis. Th e reliability, 
reproducibility, convergent validity and discriminant validity of the chronic generic and 
condition-specifi c domains were calculated.
Th e Cronbach's alpha (α) coeffi  cient was used to measure the extent in which items within 
each domain correlate with each other to form a multi-item domain and how well the 
items within a domain fi tted together as a single construct. An α coeffi  cient of 0.70 or 
higher is considered acceptable for questionnaire validation, whereas an α of 0.90 or above 
is considered necessary for individual or clinical decision making 48,49. Th e reproducibility 
was measured through a test-retest procedure. Th e DISABKIDS domains were correlated 
to existing HRQoL questionnaires (convergent validity) and parameters of asthma severity 
(discriminant validity) to assess the validity. Th e convergent validity was evaluated by 
calculating the Spearman's correlation coeffi  cient between the DISABKIDS domains and 
the domains of the KINDL and the DUX-25 questionnaires. Th e discriminant validity 
was assessed with the spearman's correlation coeffi  cient to explore the instrument's 
ability to distinguish levels of disease severity. Th e factors that were expected to infl uence 
the HRQoL were child and parent reported disease severity, last asthma attack, missed 
schooldays and clinician reported severity. Th e expectation was that children and 
adolescents with more severe asthma or missed school days would score lower on the 
domain scores and have a poorer HRQoL score. 
Results
Respondents
Data were obtained from eight medical centres in the seven participating countries; Austria 
(AU), Germany (DE), Greece (GR), France (FR), the Netherlands (NL), Sweden (SW) 
and the United Kingdom (UK). Th e sample consisted of 405 children and adolescents 
who completed the questionnaires. Th eir age ranged between 8 and 17 years (mean age 
11.4 years, SD=2.47): 66% were children (aged 8-12) and 34% adolescents (aged 13-17). 
Th e percentage of boys in the sample was 59%. Th ree hundred eighty two parents (85% 
mothers) participated in the study. Just over half of the questionnaires were completed 
in the clinic (51%), and the remainder were completed at home. Table 1 displays the 
demographic characteristics of the study sample. 
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When asked how severe their asthma had been in the last year (single question), 27% 
of the children and adolescents rated not severe, 34% a little, 23% average, 12% said 
quite severe and 4% rated their asthma as bad (not shown in a table). Eleven percent 
of the children and adolescents reported having an asthma attack in the last week and 
62% had missed one of more school days due to asthma in the last year. Th e parent and 
clinician asthma severity scores are presented in table 2. Th e parents' severity score, based 
on Rosier's (1994) 40 asthma symptom checklist, correlated 0.55 with the child's severity 
rating (single question) and 0.37 with the clinicians' questionnaire 47. Th e correlation 
between both the clinicians' ratings (single item and short questionnaire) was 0.75, the 
correlations between the clinician and the child/adolescent or parent severity scores varied 
between 0.29 and 0.46. 
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Table 1. Demographic characteristics of the children and adolescents in the DISABKIDS 
asthma sample in percentages (n= 405).
* Sp. = special 
† Assessed by the child and adolescent
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Severity Parent asthma symptom checklist 40 (n=382)





















Th e percentage of missing items was low, <2.5% in the chronic generic module and <3.2% 
in the asthma-specifi c module. Th e mean domain scores, which were computed on a 
linear scale from 0-100, ranged from 65 to 89, in which a higher score represents a higher 
HRQoL. Th e percentile distributions show that the domains were slightly skewed, that 
the fl oor eff ects were minimal (% with a domain score of 0) but that there were substantial 
ceiling eff ects (% with a domain score of 100), especially for the chronic generic 'Social 
exclusion' domain. Th ere were no signifi cant diff erences between the domain scores for 
questionnaires that were completed in the clinic or at home. Th e Cronbach's alpha (α) 
coeffi  cient was determined to assess the internal consistency reliability of the DISABKIDS 
domains. Th e α coeffi  cient for the chronic generic domains ranged from 0.66 to 0.85. For 
the two asthma-specifi c domains the α was 0.83 and 0.84. Th e general descriptives of the 
DISABKIDS domains are shown in table 3. 
Test-retest reliability
One hundred and forty-six children and adolescents completed both the test and retest 
questionnaires. Th e α coeffi  cient for the retest ranged from 0.70 to 0.89 (n=146). Th e test-
retest reliability was only calculated in the sub-sample that had completed the retest within 
30 days (mean 16 days, SD 7) and included only those children and adolescents that had 
stated that no changes had taken place. A total of 59 children and adolescents fi tted these 
conditions. Th e Pearson test-retest correlation of the DISABKIDS chronic generic and 
asthma-specifi c domains was between 0.71 and 0.83 (all p <0.01). Most domain scores 
were slightly higher in the retest, but the diff erences were not signifi cant (p >0.01). 
Psychometric properties of the DISABKIDS instrument























































































































































































































































































































































































































































































































Th e relationship between the domains of the chronic generic and condition-specifi c 
module was computed by calculating the Spearman’s correlation coeffi  cients. Th e domain-
domain correlations varied between 0.29 and 0.71 (Table 4). Th e highest correlation 
between the domains was seen between the asthma 'Impact' domain and the chronic 
generic 'Limitation' domain.














































Th e cross-sectional correlations between the chronic generic DISABKIDS domains and 
the domains of the Dutch DUX-25 ranged from 0.24 to 0.52. Th e correlations with the 
asthma-specifi c domains were between 0.15 and 0.46. Similar correlations were found with 
the German KINDL (Table 5). 
Discriminant validity
Scores on the DISABKIDS domains were examined within the asthma severity subgroups 
based on parent, child/adolescent and clinician scores, missed school days and last asthma 
attack (Table 6). Th e Spearman's correlations for the parent and child/adolescent severity 
scores were between 0.23 and 0.50. Th e correlations with the clinician severity measures 
were between 0.09 and 0.18. Th e correlations were generally the highest for both the 
'Limitation' and asthma 'Impact' domains.
Psychometric properties of the DISABKIDS instrument
Table 4. Spearman's correlation coeffi  cients of domains in the DISABKIDS modules for the 
asthma sample (n=405).





































































































































































































































































































































































































































































































































































Th e relationship between the domain scores and the asthma severity score (based on the 
parents rating) is illustrated in fi gure 1. Th e DISABKIDS domain scores were signifi cantly 
higher (better quality of life) in children and adolescents with low asthma severity than 
in those with severe asthma. Similar diff erences were observed for the child- and clinician 
severity scores (data not shown). Th ere was also a relation between the HRQoL score and 
missed school days and last asthma attack (Table 6). Children and adolescents with more 
missed school days or with a recent asthma attack had signifi cantly lower HRQoL scores.
Cross-national comparison
Univariate analysis of variance showed that the domain scores were not only dependent on 
the asthma severity but were also infl uenced by country. Relatively more severe asthmatic 
patients were included in the UK sample, whereas relatively fewer severe patients were 
included in the Swedish sample. Corrected for diff erences in asthma severity, the average 
domain scores remained signifi cantly diff erent between the countries (p<0.001). Th e linear 
association between asthma severity and the DISABKIDS domain scores however, did not 
diff er signifi cantly between participating countries (p>0.11). Th us, the relation between 
the domain scores and the asthma severity remains similar in all the countries.
Psychometric properties of the DISABKIDS instrument
Table 6. Spearman's correlation coeffi  cients were used to compare the DISABKIDS domains to 
the parent asthma symptom checklist 40, the child severity score (single question), the clinician 
severity questionnaire 47, the number of missed school days and the last asthma attack.
NB: all signifi cant, p <0.01 with the exception of * 
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Age and gender groups
To establish age and gender diff erences in the DISABKIDS instrument, independent 
sample t-tests were performed. In each analysis, a DISABKIDS domain was the dependent 
variable, while age group or gender were the independent variables. In general the HRQoL 
domain scores were similar in both gender and age groups. However, some diff erences 
were identifi ed: girls scored signifi cantly lower on the 'Limitation' and the asthma 'Impact' 
domain, adolescents (aged 13-16) had signifi cantly lower scores on the asthma 'Impact' 
domain and children (aged 8-12) scored signifi cantly lower on the 'Social inclusion' 
domain (data not shown).
Discussion
Th e DISABKIDS instrument was developed simultaneously in seven European countries 
and consists of a chronic generic and condition-specifi c module, which include HRQoL 
aspects that were identifi ed through a patient-derived method. We have described the 
psychometric performance of the DISABKIDS chronic generic and asthma-specifi c 
module in a cross-national population of children and adolescents with asthma. Th e 
chronic generic module can provide information on the overall impact of a chronic 
medical condition on a child or adolescent's life and allows comparison across chronic 
conditions. Th e asthma-specifi c module can supplement this with information on specifi c 
asthma symptoms, which may be more closely related to the treatment regime 18,35. 
Th e internal consistency of the domains was suffi  cient for the total asthma population, 





















































Figure 1. Th e DISABKIDS domains scores (0-100) of children and adolescents with asthma. 
Severity is based on the Rosier's (1994) 40 asthma symptom checklist completed by the parents.
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0.70 and 0.89 in the retest. However, higher levels of reliability (Cronbach's alpha ≥ 
0.9) are necessary for the DISABKIDS instrument to be psychometrically acceptable as 
an individual screening tool 48,49. Further studies are being prepared to investigate the 
instrument's potential as an individual screening tool. 
Within the population of children and adolescents that had completed the questionnaires 
within a month and had unchanged circumstances the measure generally reproduced 
similar results. Th e test-retest correlation was above 0.70 for all domains. Th is analysis 
supports the basic reliability of the instrument but needs to be taken cautiously. A selection 
bias might have taken place in the retest and only 59 questionnaires were completed 
within 30 days. 
Th e inter-domain correlations suggest an overlap between the domain constructs. 
Correlations between some domains are to be anticipated (Limitation and Impact) while 
for some domains we expected a lower correlation (Social and Medication). Th is overlap 
can be explained when HRQoL aspects are closely intertwined in the lives of children and 
adolescents.  
In the DISABKIDS project the face and content validity was achieved by the use of a 
bottom-up patient-derived construction. Th e children and adolescents further added to 
the item generation through their judgement of clarity and comprehension of items in 
the cognitive interviews 33,50-52. Th e DISABKIDS instrument covers aspects of HRQoL as 
indicated by the patients as being important. However, coping and health care needs have 
not been included. New questionnaires including these aspects have been developed as 
separate entities 53.
Concurrent validity was evaluated by correlating the DISABKIDS domains with validated 
HRQoL questionnaires. Th e domains in the DISABKIDS chronic generic and asthma-
specifi c modules displayed variable correlations with the DUX-25 and the KINDL 
domains. Th e scores indicate that the DISABKIDS domains correlate with some domains 
from the DUX-25 and the KINDL but that they also off er a diff erent perspective through 
other domains (Medication, Worry). Due to the simultaneous testing of several chronic 
conditions the choice was made to include only generic questionnaires (KINDL and 
DUX-25) for the concurrent validity, thus missing the possibility to compare the asthma-
specifi c module to existing asthma measures.
 
Th e construct validity was tested by examining the relationship between the domain scores 
to other measures at a single point in time. Th e DISABKIDS domains were sensitive to 
diff erent ratings of asthma severity (parent and child/adolescent judgements of severity, 
missed schooldays and last asthma attack). Th e correlations between the severity scores and 
the DISABKIDS domains relating to physical aspects (Limitation and Impact) were the 
most apparent (Table 6). Th e correlations between severity and HRQoL were the highest 
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for the parent and child ratings. Th e instrument is therefore sensitive to severity as judged 
by the parent and child or adolescent, which may be useful in clinical practice. In contrast, 
the correlations with the clinician's severity scores were distinctly lower. Th is again 
demonstrates that the child or adolescent's HRQoL is not directly related to clinician's 
disease severity rating or HRQoL judgement 54-57.
Th e cross-national focus and modular structure has been the specifi c approach of the 
DISABKIDS project. Cross-nationally developing a HRQoL questionnaire can limit 
the inclusion of national and socio-economic diff erences between countries in the 
measurement of health eff ects. A questionnaire applicable to countries across Europe can 
be of importance to cross-national research trials or individual HRQoL assessment 28. 
We should however be aware of some disadvantages of this approach. Th e focus group 
and cognitive interview phase in the pilot test were used to collect information on face 
validity by asking children and adolescents what was important to them. However, the 
cross-national developmental process has caused some items (concerning pets, riding a 
bike to school, going to the beach or mountains) to be disregarded due to cross-national 
diff erences, as they were not found to be applicable in all countries. 
We also need to consider some specifi c restrictions in this study. Firstly, there is a possible 
selection bias within the group that participated. Participants with a higher HRQoL and 
acceptance of their condition might be the ones to participate. Th e demonstrated ceiling 
aff ect may be related to this bias (Table 3). However, it is reassuring that the severity 
distribution was similar to the results reported by Rosier (1994) 40, who developed 
the symptom checklist, which suggests that we assessed a commonly found range of 
asthma patients. Secondly, the severity and domain scores diff ered between the countries 
(p<0.001). Fortunately, we could conclude that after correcting for the asthma severity, 
the linear association between asthma severity and the DISABKIDS domains remained 
the same and thus had no eff ect on the validity of the instrument. In follow-up research 
the psychometric properties should be assessed in suffi  ciently large groups for each 
country separately. Finally, there is no gold standard for HRQoL. We used several criterion 
variables as self scored severity of asthma and existing generic HRQoL questionnaires 
(Table 5 and 6). Future studies should provide more data on other criterion variables such 
as medication, lung function or asthma specifi c HRQoL and on responsiveness to clinical 
changes. Th e aim is to collect longitudinal data, setup intervention studies and test the 




Overall the DISABKIDS instrument displays a suffi  cient degree of reliability and validity. 
Th e domain scores correlate with measures of severity and existing HRQoL questionnaires. 
Th e DISABKIDS instrument is available as paper-pencil and computer version, is simple 
to administer and takes around 15 minutes to complete. Th e instrument has the advantage 
of a chronic generic and condition-specifi c module, is multilingual and has been tested 
cross-nationally. On the whole there is ample support for the use of the DISABKIDS 
instrument as a measure of HRQoL in a child or adolescent with asthma. In the future the 
instrument may prove to be relevant for clinical trials and individual assessment in clinical 
practice. 
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1. Are you confi dent about your future? 
2. Do you enjoy your life? 
3. Are you able to do everything you want to do even though you have your condition? 
4. Do you feel like everyone else even though you have your condition? 
5. Are you free to lead the life you want even though you have your condition? 
6. Are you able to do things without your parents?
7. Are you able to run and move as you like?
8. Do you feel tired because of your condition?
9. Is your life ruled by your condition? 
10. Does it bother you that you have to explain to others what you can and can’t do?
11. Is it diffi  cult to sleep because of your condition?
12. Does your condition bother you when you play or do things?
13. Does your condition make you feel bad about yourself?
14. Are you unhappy because of your condition?
15. Do you worry about your condition?
16. Does your condition make you angry?
17. Do you have fears about the future because of your condition?
18. Does your condition get you down?
19. Does it bother you that your life has to be planned?
20. Do you feel lonely because of your condition?
21. Do your teachers behave diff erently towards you than towards others?
22. Do you have problems concentrating at school because of your condition?
23. Do you feel that others have something against you?
24. Do you think that others stare at you?
25. Do you feel diff erent from other children/adolescents?
26. Do other kids/adolescents understand your condition?
27. Do you go out with your friends?
28. Are you able to play or do things with other children/adolescents (like sports)?
29. Do you think that you can do most things as well as other children/adolescents?
30. Do your friends enjoy being with you?
31. Do you fi nd it easy to talk about your condition to other people?
32. Does having to get help with medication from others bother you?
33. Is it annoying for you to have to remember your medication?
34. Are you worried about your medication? 
35. Does taking medication bother you?
36. Do you hate taking your medicine?
37. Does taking medication disrupt everyday life?




Independence: 1, 2, 3, 4, 5, 6
Limitation: 7, 8, 9, 10, 11, 12
Emotion: 13, 14, 15, 16, 17, 18, 19
Social exclusion: 20, 21, 22, 23, 24, 25 
Social inclusion: 26, 27, 28, 29, 30, 31
Medication: 32, 33, 34, 35, 36, 37.
Asthma-specifi c module
1. Do you feel that you get easily exhausted?
2. Does asthma bother you if you want to go out?
3. Are you unable to take part in certain sports?
4. Do you feel short of breath when you do sports?
5. Are you bothered by the amount of time you spend wheezing?
6. Do you feel terrible when you are out of breath?
7. Are you worried that you might have an asthma attack?
8. Do you worry that others do not know what to do if you have an attack?
9. Do you feel scared that you might have diffi  culty breathing?
10. Are you scared that you might have to go to the emergency ward?
11. Are you scared at night because of your asthma?
Answer category: Never – Seldom - Quite often - Very often – Always
Asthma-specifi c domains
Impact: 1, 2, 3, 4, 5, 6 
Worry: 7, 8, 9, 10, 11
Psychometric properties of the DISABKIDS instrument
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Implementation of the DISABKIDS instrument: 
general discussion
DISABKIDS's past 
Th e aim of the DISABKIDS project was to develop, test and implement a new European 
health related quality of life (HRQoL) instrument for children and adolescents between 
the age of 4-16 with a chronic medical condition, and their parents 1. Th e DISABKIDS 
instrument is the fi rst paediatric measure that was developed cross-nationally in Europe, 
applied a patient-derived method and includes a chronic generic module and seven 
condition-specifi c modules. 
Th e DISABKIDS project consisted of predefi ned work packages (WP) (Chapter 1). Th e 
literature review (WP 1) in Medline (1985-2000) identifi ed 8233 abstracts concerning 
HRQoL assessment in children and adolescents with a chronic medical condition. 
Several HRQoL questionnaires were reviewed, and published HRQoL domains were 
considered for the DISABKIDS domain structure. A total of 154 children and adolescents 
participated in the focus groups or interviews, 142 family members and 26 health care 
professionals participated in either focus groups or interviews (WP 2). A total of 3515 
statements were collected from the focus group transcripts. Th e item development steps 
led to a chronic generic module with 100 items and seven condition-specifi c modules 
with 26 to 44 items which made up the pilot study instrument (WP 3). Th e items were 
translated through a forward –backward –forward translation in each country (WP 4). A 
total of 360 children and adolescents with a chronic medical condition and 345 parents in 
seven European countries participated in the pilot study (WP 5). Th e analysis of the pilot 
study resulted in a fi eld study instrument with 57 items in the chronic generic module and 
between 14 and 19 in each condition-specifi c module (WP 6). A total of 1152 families 
(including 405 children and adolescents with asthma), spread over 7 European countries, 
participated in the fi eld study (WP 7). After the analysis of the fi eld study data the fi nal 
DISABKIDS instrument consisted of a 37-item chronic generic module with 6 domains 
and seven 10 to 12-item condition-specifi c modules consisting of 2 domains (WP 8). Th e 
implementation of the DISABKIDS instrument is still ongoing in several countries for the 
paper-pencil and computer versions (WP 9). 
Th is thesis aimed to describe and discuss some of the steps taken within the European 
DISABKIDS project with a specifi c emphasis on the results obtained for asthma. 
DISABKIDS at present 
Th e two level modular DISABKIDS instrument is now available for children and 
adolescents between the age of 8 and 16 years with asthma, juvenile idiopathic arthritis 
(JIA), atopic dermatitis, cerebral palsy (CP), cystic fi brosis (CF), diabetes and epilepsy 
Th us, QoL, and its measurement, can seem nebulous or unscientifi c compared with 
traditional endpoints. However, the more elusive and subjective outcomes may, in the 
end, be more important (C. Eiser and R. Morse, 2001).
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(Chapter 6). A short 6-item smiley module is available for the 4-7 year old children 
with any chronic medical condition. Th e instrument has been psychometrically tested in 
Austria, France, Germany, Greece, the Netherlands, Sweden and the United Kingdom, 
and is available in each of these languages in a paper-pencil and computer version. Th e 
instrument is simple to administer, the modules are relatively short and it takes about 15 
minutes to complete. 
Advantages
Th e DISABKIDS instrument has several advantages above other instruments (Box 1). Th e 




• Applicable cross-nationally 
• Several chronic conditions
• Short and easy to use
• Paper and computer version
• Wide age range
• Proxy version
A unique combination is created when combining the generic module from the 
KIDSCREEN project with the DISABKIDS chronic generic and condition-specifi c 
modules (Chapter 1). Th e combination of the generic, chronic generic and condition-
specifi c modules allows for a comprehensive assessment of HRQoL. Th e generic mo-
dule assesses the HRQoL of any child or adolescent, with or without a chronic medical 
condition while the chronic generic module focuses on issues related to living with a 
chronic medical condition. Th e chronic generic module off ers the possibility of comparing 
the HRQoL score between diff erent chronic medical conditions. By supplementing the 
chronic generic module with a condition-specifi c module the clinician or investigator are 
given additional information concerning a specifi c condition. It is suggested that collected 
information from a condition-specifi c module relates more closely to the treatment regime 
and is more responsive to clinically signifi cant changes 2-5. 
Before actual HRQoL assessment can take place a questionnaire has to meet certain 
standards (Box 2). Th ese criteria have been established to achieve a certain level of 
international conformity and facilitate the chance of incorporation in future studies or 
clinical use 6. Th e DISABKIDS project aimed to meet the necessary requirements, yet 
some aspects such as responsiveness and interpretation still need to be further assessed. 
General discussion
Box 1. Advantages of the DISABKIDS instrument.
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• Sound theoretical basis and defi nition of HRQoL
• Multidimensional measurement
• Suitable for study question
• Domains are described and scored separately
• Adequate psychometrics (reliability and validity) 
• Sensitive to changes over time (responsiveness)
• Norm group data available (for disease and age)
• Practical in use (administration and interpretability)
• Accepted by patients
• Appropriate to culture and lifestyle
Limitations 
Although the design and aim of the DISABKIDS instrument sounds promising there are 
still several limitations and methodological issues that need to be addressed. A recurring 
problem is the recruitment and inclusion of participants. Selection bias is a possibility 
as the participants who were willing to contribute may not be representative for the 
population. Recruitment may have been infl uenced by the attitude or interest towards 
HRQoL, individual confi dence, the willingness to do something for the paediatrician, 
better coping mechanism or a higher experienced HRQoL 12. Non-responders might 
have more severe asthma, may lack the energy to participate or have a diff erent view on 
illness and the eff ect it has on their lives. However, there are also several aspects that help 
to strengthen the validity of the fi ndings. Central is the fact that the respondents were 
recruited from several European locations and the severity distribution of the asthma group 
was similar to other reports 13. If a selection bias has occurred in the DISABKIDS project 
the observed HRQoL would probably be higher with a narrower severity distribution, 
compared to the population of interest. Th us, our results may underestimate the real 
variation in HRQoL among the diff erent severity states and underrate the discriminative 
properties of the DISABKIDS instrument. 
A further limitation was that the number of respondents in some chronic condition 
groups, cerebral palsy and atopic dermatitis in particular, was relatively small in both 
the pilot and the fi eld studies. So even though the total number of participants over all 
conditions and countries was acceptable, the results of the separate analyses of some 
chronic conditions should be interpreted with caution. Although the cross-national focus 
has been an explicit approach of the DISABKIDS project, lack of time and resources 
stood in the way of testing each chronic condition in each DISABKIDS country. Only 
the asthma specifi c module was tested adequately in all seven countries (Chapter 6 and 7). 
However, a comparison of the asthma outcome between countries is still problematic, as 
some countries have only tested around 30 or 40 children and adolescents. All modules 
will need to be tested further in larger groups and across countries in future studies. 
chapter 8
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Another critical note relates to the DISABKIDS project as a European consortium. 
Within the European project, all countries worked individually on each work package. 
Although care was taken to stress uniformity in the group (such as supplying a manual 
for the focus groups, planning regular DISABKIDS meetings and describing every work 
package in detail) each DISABKIDS member had a considerable amount of autonomy. 
Th ere was no opportunity to monitor how investigators in each country completed the 
work packages and no way of checking aspects such as the method of recruitment or data 
collection. Several factors could have played a role, including personal interpretations 
and interests, hospital facilities, time constraints and earlier research experience. For 
example, focus groups were used in the DISABKIDS project to take into account the child 
and adolescent's own ideas and language (Chapter 3 and 4). Th e literal transcripts were 
available in each national language and the investigator was responsible for the selection of 
statements and the translation into English. As there was no offi  cial translation the quality 
of the supplied English statement could not be guaranteed. Th e meaning of the original 
statement may have been altered, which could infl uence the chance of being selected 
as fi nal instrument item. A possible solution would have been to use expert or panel 
translators, supply training sessions or perform these tasks with an international group 
to facilitate European conformity 14,15. We emphasise the importance of training, as the 
quality of the collected data is very much tied to the skills of the investigator (Box 3). 
Th e bottom-up (patient-derived) methodology that was applied in the DISABKIDS 
project was another reason for debate. Th e collection of the HRQoL statements from 
the focus groups and interviews were the basis of the DISABKIDS instrument and were 
applied to secure that the child and adolescent's opinion was incorporated (Chapter 3 and 
4). Th is patient-derived method was followed by the (top-down) investigator's judgement 
for the selection of the fi nal items (Chapter 5). Th is top-down procedure confl icted with 
the aim of developing the DISABKIDS instrument through a bottom-up procedure 
(child and adolescent input). With a patient-derived method one would prefer to have the 
children and adolescents select the important items but the extensive statement pool (3515 
statements) was thought to be too large for them 16-19. To compensate for the top-down 
procedure the child and adolescent's opinion was again included into the pilot test when 
they were asked to approve the selected items and judge them on comprehension and 
applicability in the cognitive interview 20-22. 
• Recruitment of the participants
• Moderating the focus groups
• Identifying the appropriate statements from the focus group transcripts
• Translation of the HRQoL statements and items 




Box 3. Situations in which specifi c guidelines, expert translators, training sessions or 
international working groups would be advised.
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On the other hand, because most aspects identifi ed in the DISABKIDS asthma focus 
groups had been discussed in earlier publications (Chapter 4), one might question whether 
it is still necessary to include the patient's opinion when developing a questionnaire. 
Despite the extensive research of certain conditions (i.e. asthma) we still advocate to 
include the patients' opinions. Information on some chronic conditions (i.e. cerebral 
palsy or atopic dermatitis) is still limited and new results and diff erent viewpoints may be 
yielded through patient-derived methods. Furthermore, the main advantage of the focus 
groups in the DISABKIDS project was the cross-national recurrence of issues and the 
combination of patient, parent and clinician's data.
A further drawback in our method is that we cannot assume that all important issues 
were included in the DISABKIDS instrument. Not all relevant topics may have been 
discussed in the focus groups or some children may have found it diffi  cult to talk about 
certain topics. It is also possible that some topics were removed in the item selection phase 
(Chapter 5). Th e cross-national developmental process disregarded some items that may 
have been important in certain countries (for instance items concerning pets or riding a 
bike to school). A possibility would have been to run focus groups till no new issues were 
presented 12,23,24. Th is was not possible in the DISABKIDS project as each work package 
was set in a certain time frame.
In short, there where a number of methodological issues and limitations during the 
development of the DISABKIDS instrument. Even so, the initial psychometric results and 
the fi rst implementation experiences by clinicians and investigators are promising. Future 
research will help to explore the implementation possibilities. 
DISABKIDS's future
Th e DISABKIDS instrument can play an important part in the future of paediatric 
HRQoL assessment. Th e two level modular build-up and the multiple language versions 
of the DISABKIDS instrument makes it utilizable in several circumstances, including 
population studies, clinical trials and individual assessment. 
 • HRQoL evaluation: includes mainly the description of a population group or a 
  comparison between patient groups 25-31,31,32. It can give the clinician a fair 
  description of a group but is of little use for the care of the individual patient. Th e 
  availability of the diff erent DISABKIDS language versions makes the instrument 
  suitable for group and cross-national comparisons. 
 • HRQoL in clinical trials: is mainly used to compare the outcome of diff erent 
  treatments within a group or to evaluate therapeutic eff ectiveness between groups 
  2,33,34. While the use of HRQoL is increasingly being implemented in adult clinical 
  trials the inclusion of HRQoL in paediatric clinical trials is still limited 35-38. In the 
  future the DISABKIDS instrument can be of use in (cross-)national clinical trials. 
  Results are of use to the clinician and the general patient group but have no role in 
  the individual evaluation and treatment of the patient. 
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 • HRQoL in clinical practice: is aimed at the care of the individual. Objective 
  measures of disease or clinical judgement in for instance asthma only weakly 
  correlate with how a patient feels and functions (Chapter 7) 39-42. HRQoL assessment 
  can therefore provide a broader picture of health and provide insight into the 
  impact of a chronic medical condition on the daily life of an individual child or 
  adolescent. Knowledge of the HRQoL status can improve medical guidance to the 
  children and their parents, identify those that need particular attention, screen for 
  psychosocial problems or monitor the patient's progress 43. Th e children and 
  adolescent's HRQoL can be assessed with the help of a paper-pencil or computer-
  assisted instrument. Th e use of the DISABKIDS instrument in clinical practice will 
  still need to be tested.
While the fi rst psychometric results of the DISABKIDS instrument sound promising 
and the design comes with several advantages it is still essential to further test the current 
instrument in several situations to judge where improvements are necessary (Box 4). 
For instance additional testing of the modules is necessary in each country and for each 
module in suffi  ciently large groups. Th e chronic generic module can also be tested for 
applicability in other chronic medical conditions, for example haemophilia, heart disease 
or obesity. Th ere is also need for more evidence that the instrument can function as an 
individual screening tool, which includes higher levels of reliability (Cronbach's alpha ≥ 
0.9)6,44. 
• Psychometric properties in each country with suffi  ciently large groups 
• Psychometric properties for each chronic condition in larger groups
• Comparisons to existing condition-specifi c HRQoL questionnaires
• Comparisons to clinical outcome and physiologic assessment of disease severity
• Sensitivity and the responsiveness to change in individual patients 
• Longitudinal data to assess long-term changes in measured HRQoL 
• Use in comparing interventions, treatment changes or diff erent medications
• Relevance to clinical practice 
• Appropriateness for cultural background of the patient 
However, continuation of the DISABKIDS project is not uncomplicated and depends on 
external factors as time and resources. Since the European funding of the DISABKIDS 
project has ended there is a danger of discontinuation. Nevertheless, we still aim to 
interest investigators and clinicians in the continuation of testing and implementing 
the DISABKIDS instrument. Th e current advantages of the DISABKIDS instrument, 
especially the possibility of working with an international consortium, should give the 
instrument a fair chance. Th e available DISABKIDS manual should also assist in the 
proceedings to look for cross-national collaborations in the future to further validate and 
implement the DISABKIDS instrument. 
General discussion
Box 4. Aspects that need to be studied further.
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HRQoL assessment in clinical practice; implementation philosophy
Since the management of chronic medical conditions revolves more around care than cure 
and HRQoL has been recognised as important to the care of children and adolescents, 
the number of paediatric HRQoL questionnaires has grown over the last decades 45,46. 
Th ere is however, still little evidence of their relevance in and infl uence on adult and 
paediatric clinical practice and the current need is to discuss why HRQoL assessment is 
not systematically implemented (Chapter 2)37,47-51. 
Experienced barriers
One problem is that there are several defi nitions of quality of life (QoL). Th ere is no gold 
standard as to what it represents or how it can be measured as it includes subjective issues 
and the concept depends on the applied perspective (social, economical, psychological) 
2,7,45,52,53. A similar problem concerns HRQoL 54. One can question whether we are able 
to reliably assess a subjective concept as HRQoL. A person's perception of health and 
expectations are related to the individual and can vary over time 55. Further complicating 
is that when HRQoL is assessed in children and adolescents there are even more practical 
aspects to consider as cognitive development, changing perspectives, disease knowledge 
and age related activities, all of which can infl uence HRQoL outcome 56. Th ere is no 
straightforward way of solving these aspects.
Another issue that needs to be considered is that clinicians may feel that identifi ed 
problems lay outside the traditional area of medical care and may not see it as their task 
to discuss HRQoL issues with their patients 33,47,49,50. Clinicians were found to focus on 
symptoms and physical functioning but rarely on emotional or social problems (Chapter 
4)47,57-60. A dilemma is that if psychosocial problems are revealed and the clinician feels 
incapable of interfering with these problems, they may be reluctant to adopt HRQoL 
measures. Th is is one of the reasons why the clinicians' perspective also needs to be taken 
into account during the development of a HRQoL questionnaire for clinical use (Chapter 
2). Th e clinician may contribute by suggesting which aspects to measure so that the 
questionnaire relates to issues he feels he can intervene in. Strategies can also be discus-
sed on how a questionnaire is best implemented and experienced barriers can be avoided. 
Th e possibility of giving HRQoL feedback to other health care professionals such as 
(specialised) nurses or psychologists also need to be considered 48,49.
Although some patients do not feel comfortable about discussing certain issues with their 
clinicians, the majority of patients want their clinicians to assess HRQoL aspects and feel 
this is useful to clinical practice 47,48,57-59,61,62. Communication is seen as a crucial element in 
the quality of health care and can positively infl uence patient health outcome 63-66. 
In summary, there are still ample problems that need to be solved before HRQoL is 
regularly assessed in clinical practice. Fortunately, there is evidence that clinicians are 
interested in HRQoL outcome, especially when it concerns a chronic medical condition 
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(Chapter 2 and 4)48-50,67. It is now essential to identify and reduce experienced barriers 
(Chapter 2) to encourage the implementation of HRQoL assessment in clinical practice on 
a regular basis (Box 5). 
• HRQoL not seen as a priority in clinical practice
• Unfamiliar with HRQoL questionnaires
• Insuffi  cient training in and knowledge of HRQoL
• Unavailability of appropriate questionnaires
• Unsatisfactory psychometric properties
• No proof of clinical relevance 
• Insuffi  cient feasibility (ease of collection and use)
• Costs of implementation
• Limited time and resources
• No intervention guidelines
Requirements necessary before clinical implementation
A fundamental concern is whether a questionnaire, like the DISABKIDS instrument, can 
and will be used for individual patient assessment. Current studies inform us more about 
experienced barriers and lack of clinical impact than about required essentials for successful 
and meaningful use of HRQoL assessment in daily clinical practice 69. Th us, if HRQoL 
questionnaires are to be used routinely and become an important part of clinical practice 
(especially paediatric health care) the given obstacles (Box 5) need to be dealt with and 
HRQoL assessment needs to be promoted. Requirements to achieve acceptance of HRQoL 
assessment include: informing clinicians about available questionnaires, proving clinical 
relevance and providing guidelines for interpretation of HRQoL outcome scores (Box 6). 
If the necessary requirements are achieved the HRQoL questionnaire is more likely to be 
accepted by clinicians and to be included as outcome in the care for the patient. 
Promotional needs:
• Information: increase familiarity with HRQoL and publish data in clinical journals
• Training: in implementation possibilities and interpretation of HRQoL outcome 
• Health care professionals: stimulate a multidisciplinary approach in HRQoL assessment
Questionnaire factors:
• Content: includes items regarding important aspects for the patient 
• Design: short, practical, computerised 
• Psychometrics: reliable, valid, sensitive to change and availability of norm data 
• Outcome: clinical relevance 
Practical requirements:
• Implementation: easily available, quick to complete and administer
• Scoring: simple, provided promptly and in a useful format
• Interpretation: guidelines available for easy interpretation 
• Intervention: strategies to translate outcome into specifi c interventions 
General discussion
Box 5. Main barriers for the use of HRQoL questionnaires in clinical practice 47-49,68.
Box 6. Requirements to promote HRQoL assessment in clinical practice 9,33,43,47-50,53,70-72.
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Is there proof of clinical relevance?
Th e importance of HRQoL assessment in clinical practice is stressed as it is assumed to 
provide meaningful clinical information. Various suggestions are provided of how HRQoL 
assessment may be of benefi t to individual patient care (Box 7) but clinical relevance is 
not always clear-cut 48,61,62,73,74. Greenhalgh et al. (2005) have described the mechanisms 
between HRQoL intervention and expected outcome in a model, demonstrating its 
complexity 47. Th e challenge is to decide what outcome to measure as several processes 
(communication, treatment response, recognition of problems) can be infl uenced before 
the fi nal outcome of improved HRQoL or patient satisfaction is realized 47,61. 
• Identifying and prioritising problems 
• Assess treatment effi  ciency
• Monitoring disease progression 
• Assisting in informed treatment changes
• Facilitating clinician-patient communication 
• Improving patient satisfaction 
• Allocating health care resources
A number of studies have reported on the impact of HRQoL feedback to clinicians. 
In general there is limited proof of infl uence on medical decisions (referring to others, 
treatment changes, clinical tests), patient satisfaction or HRQoL outcome 47,61-63,73,75. 
Feedback of HRQoL assessment to clinicians does aff ect the extent in which HRQoL 
issues are discussed in a consultation, improves identifi cation of psychological and social 
problems and increases the clinicians' awareness of the patient's HRQoL 47,61,63,73,75,76. 
Only a few studies demonstrated that this increased recognition of HRQoL problems is 
subsequently associated with clinical intervention (follow-up appointments, counselling 
or referral) 48,59,76. Clinicians may not consider HRQoL issues to be important enough 
to adapt their treatment or referrals to it. Th e facilitated communication, resulting from 
the HRQoL feedback, may be suffi  cient for clinicians 47-49,62. Disappointingly there are 
currently no implementation studies available that describe individual HRQoL assessment 
in paediatric care.
What do we gain through HRQoL assessment?
Th ere is a growing awareness that the clinician, parent and child or adolescent diff er in 
their perception of HRQoL, disease severity and treatment expectations (Chapter 4 and 
7) 77-81. Th ese diff erences, together with insuffi  cient clinician-patient communication can 
lead to misunderstandings and dissatisfi ed patients 65. If HRQoL assessment can improve 
the clinician-patient communication and patient health outcome, this may well be a 
suffi  cient reason to implement HRQoL measures 63,65. Although this has not been proven 
in paediatric care, common sense tells us that improved communication can facilitate the 
recognition and acknowledgment of problems and can enable clinicians to improve the 
quality of care of the child and adolescent.
chapter 8
Box 7. Suggested use of HRQoL measures in clinical practice 9,48,51,61,72,75.
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Implementation in asthma care
Th e asthma focus groups and interviews illustrated that there is a considerable impact on 
the life of a child and adolescent with asthma (Chapter 4). Physical limitations, which 
were often linked to social issues, were a dominant theme and non-compliance seemed to 
be linked to insuffi  cient knowledge or denial. Clinicians found it hard to recognise these 
important issues in the life of a child or adolescent with asthma and felt that awareness 
of and familiarity with these problems might assist them in improving the care for their 
patients (Chapter 2 and 4). If children or adolescents feel misunderstood by their clinician, 
or for that matter their parents, this can negatively infl uence their clinician-patient 
relationship and may even aff ect their adherence to treatment. 
Th e DISABKIDS instrument can evaluate a patient's HRQoL and help the clinician to 
focus on areas of particular importance to the child and adolescent. A future prospective 
could be to ask patients to complete the DISABKIDS instrument before consultation, 
preferably on a computer. Th e computerised instrument can be easily administered, save 
time and supply the clinician with immediate feedback of the patient's HRQoL status 
9,73,82,83. If the DISABKIDS computer version is implemented this can give an instant 
readout of the 0-100 score on each domain and compare this to a previous assessment or 
to the population norm data. Th e 37-item chronic generic module can provide general 
data on the impact of living with asthma. Th e 11-item asthma specifi c module can supply 
the clinician with asthma-related issues by concentrating on specifi c limitations and fears 
related to asthma. Any conspicuous scores can then be discussed with the patient. For 
instance if a low score on the medication domain is discussed with the child this could 
make clear that the child is rebelling against the medication because he or she doesn't feel 
it is doing any good. Clinical parameters or regular consultations may not have identifi ed 
this problem. Problematic issues can be discussed, problems can be dealt with or explained 
and if necessary the child or adolescent can be referred to the appropriate health care 
professional (social worker, psychologist). 
Conclusion
While HRQoL may seem ill defi ned and its assessment unscientifi c, to the patient this 
subjective outcome may be more important than biomedical endpoints 45. Although the 
inadequate proof of clinical relevance may currently be the main reason for the limited use 
of HRQoL assessment in clinical practice, the expectation is that in the future a growing 
number of clinicians will incorporate routine HRQoL assessment 62,72. In the mean time 
considerable work needs to be done to prove the benefi t of HRQoL assessment in clinical 
practice and to overcome experienced barriers. 
Th e European DISABKIDS project has come a long way in the development of a new 
cross-national HRQoL instrument for children and adolescents with a chronic me-
dical condition. Th e DISABKIDS instrument can play an important role in future 
paediatric HRQoL assessment. Th e modular build up and cross-national development 
General discussion
141
also off ers advantages for assessment on a national and international level in HRQoL 
evaluation studies and clinical studies. However, further evaluation of the DISABKIDS 
instrument is needed to test its performance as individual measure in clinical practice 
and prove its relevance to clinicians. Th is refi nement can only be achieved through future 
implementation, as understanding how current measures perform in practice facilitates 
improvements 84.
We may need to restrain our expectations of the impact of HRQoL assessment on clinical 
practice. As there is currently insuffi  cient evidence that HRQoL assessment changes the 
treatment and referral plans of the clinician we might need to accept that an improved 
clinician-patient communication is suffi  cient reason to implement HRQoL questionnaires 
47,63. Improved communication can be an important component of the overall HRQoL 
assessment of a patient. Clinicians can benefi t from the information presented to them 
and use it to facilitate communication and discuss problematic areas. Yet, one does need 
to keep in mind that HRQoL assessment will never address all issues that are important to 
the patient and that it can only supplement current clinical measures or communication 
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Th e World Health Organisation Quality of Life (WHOQoL) group defi nes quality of 
life (QoL) as: “an individual's perception of their position in life in the context of the 
culture and value systems in which they live and in relation to their goals, expectations, 
standards and concerns”. QoL has become an increasingly important concept in society as 
well as in research. Social and political questions are raised about the equal distribution of 
QoL in our own society and over the world. In cases where people are in poor health or 
have become ill, improving QoL has become a key issue. Reasons for the importance of 
assessing QoL include the awareness that objective measures of disease severity have shown 
poor correlations with how a patient feels. Of infl uence is also the change, caused by 
improved medical developments, in the impact of certain diseases from potentially lethal 
to chronic which has led to a treatment shift from cure to care. Hence the increased focus 
on health related quality of life (HRQol). In general QoL research is aimed at ensuring 
and improving physical and mental fi tness and wellbeing. Th is has led to the development 
of several questionnaires to assess and describe QoL in various patient groups. In addition 
clinical research projects are increasingly including QoL as outcome measure when 
comparing treatment regimes. Existing QoL questionnaires are still being improved 
and new questionnaires are continuously being developed and tested for specifi c patient 
groups.
Th is thesis generally describes the developmental processes followed within the European 
DISADKIDS project, which was a collaboration of clinicians and investigators from seven 
European countries. Th eir aim was to develop a new European HRQoL instrument for 
children and adolescents with a chronic medical condition. Th e fi rst chapter of this thesis 
begins with an explanation of the general principles related to HRQoL. It decribes the 
increased interest in the assessment of QoL but also shows that the use in clinical practice 
is still limited. Asthma is a main topic in the thesis which is why attention is also given 
to the mental and physical eff ects of asthma on children and adolescents. We decribe 
how questionnaires are generally developed through similar steps including defi ning the 
target group and the aim of the questionnaire, selecting items and testing the validity. Th e 
steps taken in the DISABKIDS project include focus groups in which patients indicate 
how their chronic condition infl uences them in daily life and what QoL aspects they fi nd 
important. Participants were children and adolescents (and their parents) in three age 
groups (4-7, 8-12, 13-16) with the following chronic medical conditions: asthma, juvenile 
idiopathic arthritis, atopic dermatitis, cerebral palsy, cystic fi brosis, diabetes or epilepsy. 
Th e three level modular design, the inclusion of seven chronic medical conditions, the 
wide age range (4-16 years) and the availability of a self-assessment and a proxy version are 
aspects that make the DISABKIDS instrument unique.
As there is little information on the attitude of clinicians towards using QoL measurements 
for patient care the fi rst objective was to learn more about the perspective of paediatric 
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clinicians on implementing QoL assessment in clinical practice. Chapter two describes 
a survey done among the members of the Dutch Paediatric Association. More than half 
of the 303 respondents (57%) believed that it was possible to use QoL questionnaires 
in clinical practice. Th e majority indicated that assessing QoL was benefi cial and that it 
was especially necessary to assess QoL in children with a chronic disease (82%), although 
only a minority (17%) currently used QoL questionnaires. Obstacles that prevent the 
use of QoL questionnaires are the extra time needed for assessment, the unavailability of 
standardized questionnaires and insuffi  cient knowledge about QoL. Th ese are aspects that 
need to be considered when developing a new instrument.
Th e patients were considered the main source of information for the basis of the 
instrument, especially for the development of the included items. Focus groups were 
applied to identify relevant HRQoL statements from the perspective of the patient for 
use as items in the DISABKIDS instrument. Participants included 154 children and 
adolescents with a chronic medical condition, 142 family members and 26 health care 
professionals. A total amount of 3515 HRQoL statements were identifi ed. Th e focus group 
method needed to be adapted for children and adolescents. A number of issues need to be 
considered, including developmental abilities, language skills and attention span. Th ere 
was also the need to create uniformity of the method between countries. Th e third chapter 
describes the applied focus group methodology. 
Th e asthma focus groups and interviews were conducted in four European countries 
(Greece, Italy, the Netherlands and Sweden). A description of discussed topics and 
outcomes is given in chapter four. A total of 43 children and adolescents with asthma, 
33 family members and 7 health care professionals participated in the focus groups and 
interviews. Th e children and adolescents discussed the current limitations they experienced 
which included asthma symptoms, related medical aspects, physical limitations and 
social issues. Parents concentrated more on the consequences for the future, including 
prevention, long-term eff ects of medication and schooling possibilities. Th e focus group 
discussions were found to be a useful tool in generating statements from children and 
adolescents with a chronic condition for use in the development of a questionnaire. 
Th e qualitative data, collected from the cross-national DISABKIDS focus groups and 
interviews, consisted of a total of 3515 HRQoL statements. Th ese included generic QoL 
statements (n=488) not related to any medical condition, chronic generic statements 
(n=1647) related to any chronic medical condition and condition-specifi c statements 
(n=66 to 340) that related to one of the seven included chronic medical conditions. 
Sequential reduction steps were necessary to minimise the vast amount of collected 
statements for the development of the pilot instrument. Th ese included redundancy 
scorings, importance scoring, item writing and card sorting. Th e steps are set out in 
chapter fi ve. After the applied redundancy steps 100 chronic generic items and 26 to 
44 condition-specifi c items were retained for testing in the DISABKIDS pilot study. 
chapter 9
152
It was found that the applied card sorting method was the most comprehensive and 
straightforward method to reduce the statements and divide the items into domain groups.
Th e development of the seven condition-specifi c modules is described in chapter six. Th e 
DISABKIDS condition-specifi c modules were tested in a pilot study of 360 respondents, 
and subsequently in a fi eld test of 1152 respondents in 7 European countries. Th e modules 
were developed through a step-by-step analysis process which included factor analysis, 
correlations and internal consistency. Results from the cognitive interviews and expert 
opinions were also considered. All seven fi nal condition-specifi c modules consist of an 
‘Impact’ domain and an additional domain (e.g. Worry, Stigma, Treatment) with between 
10 to 12 items in total and a Cronbach's alpha varying from 0.71 to 0.90. 
Th e questionnaire’s validation results in the asthma population are presented in chapter 
seven. Th e core chronic generic module (37 items, covering 6 domains) and the asthma 
specifi c module (11 items and 2 domains) were both tested in 7 countries within Europe 
on a total sample of 405 children and adolescents with asthma. Th e internal consistency 
for all the domains was between 0.66 and 0.85 with good retest reproducibility. Th e 
domain scores diff erentiated between asthma severity scores. Th e DISABKIDS HRQoL 
instrument is unique in being developed cross-nationally and in a modular structure. Th e 
psychometric properties of the DISABKIDS chronic generic and asthma-specifi c modules 
are suffi  cient for HRQoL assessment in children and adolescents with asthma.
Th e fi rst results on the psychometric properties of the DISABKIDS chronic generic and 
asthma-specifi c modules are promising, however more work will still need to be done. 
Th e discussion in chapter eight presents remaining limitations, future research suggestions 
and possibilities regarding the implementation of individual HRQoL assessment in 
clinical practice. Overall the European DISABKIDS project has come a long way in the 
development of a new cross-national HRQoL instrument for children and adolescents 
with a chronic medical condition. Th e modular build up and cross-national development 
off er advantages for assessment on a national and international level in HRQoL evaluation 
studies and clinical studies. However, further evaluation of the DISABKIDS instrument 
is needed to test its performance as individual measure in clinical practice and prove its 
relevance to clinicians. In the future, the DISABKIDS instrument may serve as a useful 
tool to assess HRQoL in children and adolescents with a chronic condition to benefi t the 




De defi nitie van de Wereldgezondheidsorganisatie Kwaliteit van Leven (WHOQoL) groep 
defi nieert kwaliteit van leven (KvL) als: “an individual's perception of their position in life 
in the context of the culture and value systems in which they live and in relation to their 
goals, expectations, standards and concerns”. KvL is een steeds belangrijker concept ge-
worden in zowel de maatschappij als in wetenschappelijk onderzoek. In de maatschappij en 
in de politiek is er aandacht voor het vraagstuk van de eerlijke verdeling van KvL in onze 
samenleving en de wereld. Daarnaast is het verbeteren van KvL een kernthema geworden 
voor mensen met een problematische gezondheid of een ziekte. Een van de redenen voor 
het belang van het bepalen van KvL zijn de aanwijzingen dat objectieve bepaling van de 
ernst van een ziekte slechts een zwak verband laat zien met het gevoel van welzijn van de 
patiënt. Van invloed is verder de verandering die is opgetreden als gevolg van medische 
ontwikkelingen in het beloop van bepaalde ziektebeelden van potentieel fataal naar 
chronisch, hetgeen heeft geleid tot een verschuiving van behandeling naar zorg. Vandaar 
de groeiende aandacht voor gezondheidsgerelateerde kwaliteit van leven ofwel ‘health 
related quality of life’ (HRQoL). Over het algemeen heeft onderzoek naar KvL als doel een 
bijdrage te leveren aan het waarborgen en verbeteren van fysieke en mentale gezondheid 
en welzijn. Dit heeft tot gevolg gehad dat er verscheidene vragenlijsten ontwikkeld zijn 
om de KvL van verschillende patiëntengroepen te bepalen en te beschrijven. Daarnaast 
wordt KvL steeds vaker opgenomen als afhankelijke variabele in klinische studies waarin 
verschillende behandelregimes worden vergeleken. Bestaande KvL vragenlijsten worden 
steeds verder verbeterd en nieuwe vragenlijsten worden voortdurend ontwikkeld en getest 
voor specifi eke patiëntengroepen.
Dit proefschrift beschrijft het ontwikkelingsproces dat binnen het Europese DISABKIDS-
project is gevolgd. Het project was een samenwerkingsverband van clinici en onder-
zoekers uit zeven Europese landen. Hun doel was om een nieuw Europees HRQoL 
instrument te ontwikkelen voor kinderen en adolescenten met een chronische ziekte. 
Het eerste hoofdstuk van dit proefschrift start met een schets van de algemene principes 
rondom HRQoL. Het beschrijft dat er een groeiende aandacht is voor het bepalen van 
KvL, maar ook dat het gebruik in de klinische praktijk nog beperkt is. Astma is een 
kernthema in dit proefschrift en daarom wordt in dit hoofdstuk ook aandacht besteed 
aan de psychische en lichamelijke eff ecten van astma op kinderen en adolescenten. We 
beschrijven tevens hoe vragenlijsten in het algemeen ontwikkeld worden in vergelijkbare 
stappen, die het defi niëren van de doelgroep en het doel van de vragenlijst, itemselectie 
en validering omvatten. Het proces dat in het DISABKIDS-project gevolgd is omvat 
tevens het uitvoeren van focusgroepen, waarin patiënten konden aangeven op welke 
manier hun chronische ziekte hun dagelijks leven beïnvloedt en welke aspecten van KvL 
zij belangrijk vinden. Aan de focusgroepen hebben kinderen en adolescenten in drie 
leeftijdcategorieën (4-7, 8-12, 13-16) meegewerkt met de volgende chronische aandoenin-
gen: astma, juveniele idiopathische artritis, atopische dermatitis, cerebrale parese, cystische 
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fi brose, diabetes of epilepsie. De modulaire opzet in drie niveaus, het opnemen van zeven 
chronische aandoeningen, de brede leeftijdsgroep (4-16 jaar) en de beschikbaarheid van 
een kind- en ouderversie zijn aspecten die het DISABKIDS-instrument uniek maken.
Aangezien er weinig informatie beschikbaar is over de attitude van clinici ten opzichte 
van het gebruik van KvL bepaling ten behoeve van de patiëntenzorg, was het eerste doel 
meer te weten te komen over het perspectief van kinderartsen en arts-assistenten op de 
implementatie van KvL bepaling in de klinische praktijk. Hoofdstuk twee beschrijft een 
onderzoek uitgevoerd onder de leden van de Nederlandse Vereniging van Kinderartsen 
(NVK). Meer dan de helft van de 303 respondenten (57%) vonden dat het mogelijk is 
KvL vragenlijsten te gebruiken in de klinische praktijk. De meerderheid gaf aan dat de 
bepaling van KvL nuttig is en dat het in het bijzonder van belang is KvL te bepalen bij 
kinderen met een chronische ziekte (82%). Een minderheid (17%) gebruikte echter op dat 
moment al KvL vragenlijsten. De belemmeringen die het gebruik van KvL vragenlijsten 
in de weg staan zijn vooral: de extra tijd die nodig is voor de KvL bepaling, afwezigheid 
van gestandaardiseerde vragenlijsten en het ontbreken van voldoende kennis over KvL . 
Dit zijn aspecten die bij het ontwikkelen van een nieuw instrument overwogen moeten 
worden.
De patiënten werden gezien als de belangrijkste bron van informatie voor de basis 
van het instrumenten, vooral voor de ontwikkeling van de items. Om de relevante 
uitspraken over HRQol vanuit het perspectief van de patiënt te kunnen identifi ceren 
zijn er focusgroepen toegepast. Deze uitspraken dienden als basis voor de items in het 
DISABKIDS-instrument. Aan de focusgroepen hebben 154 kinderen en adolescenten 
met een chronische aandoening, 142 van hun familieleden en 26 zorgverleners 
meegedaan. In totaal zijn er 3515 uitspraken over HRQol geïdentifi ceerd. De focusgroep-
methodiek moest voor het gebruik met kinderen en adolescenten aangepast worden. Een 
aantal kwesties dienen daarbij overwogen te worden, zoals cognitieve mogelijkheden, 
taalvaardigheid en concentratie. Daarnaast was het noodzakelijk om de methode over 
de verschillende deelnemende landen af te stemmen. Het derde hoofdstuk beschrijft de 
gebruikte methodologie van focusgroepen. 
Astmafocusgroepen en interviews zijn in vier Europese landen uitgevoerd (Griekenland, 
Italië, Nederland en Zweden). Een overzicht van de besproken thema’s en resultaten wordt 
gegeven in hoofdstuk vier. In totaal namen 43 kinderen en adolescenten met astma, 33 
familieleden en 7 zorgverleners deel aan de focusgroepen en interviews. De kinderen 
en adolescenten spraken vooral over de huidige beperkingen die zij ervoeren, zoals 
symptomen van astma, gerelateerde medische aspecten, fysieke beperkingen en sociale 
kwesties. Ouders richtten zich meer op de gevolgen van astma voor de toekomst van hun 
kinderen, zoals preventie, langetermijneff ecten van de medicijnen en onderwijskansen. 
De focusgroepen bleken een bruikbaar instrument om uitspraken van kinderen en 




De kwalitatieve data, verzameld via de DISABKIDS-focusgroepen en interviews in de 
verschillende landen, bestond uit 3515 HRQoL-uitspraken. Deze omvatten generieke KvL 
uitspraken (n=488) niet gerelateerd aan ziekte, chronisch generieke uitspraken (n=1647) 
gerelateerd aan chronische ziekten en ziektespecifi eke uitspraken (n=66 tot 340) gerelateerd 
aan een van de zeven chronische ziekten die het project omvat. Een aantal opeenvol-
gende fasen van datareductie waren noodzakelijk om de grote hoeveelheid verzamelde 
uitspraken te minimaliseren voor gebruik in het pilot-instrument. De datareductie omvatte 
de identifi catie van elkaar overlappende uitspraken, een score op belangrijkheid, het 
schrijven van items en een kaart-sorteermethode. De verschillende stappen zijn beschreven 
in hoofdstuk vijf. Na de datareductie waren er 100 chronisch generieke items en 26 tot 
44 ziektespecifi eke items over om te testen in de DISABKIDS-pilotstudy. Uit dit proces 
kwam naar voren dat de gebruikte kaart-sorteermethode de meest volledige en minst 
gecompliceerde methode was voor het reduceren van de uitspraken en de verdeling van 
items in domeinen.
De ontwikkeling van de zeven ziektespecifi eke modules staat beschreven in hoofdstuk 
zes. De DISABKIDS ziektespecifi eke modules zijn getest in een pilotstudy van 360 
respondenten en vervolgens in een veldstudie van 1152 respondenten in de zeven 
Europese landen. De modules zijn ontwikkeld middels een stapsgewijs analyseproces, 
hetgeen factoranalyse, correlaties en interne consistentie omvatte. De resultaten van de 
interviews en de mening van experts zijn hierbij eveneens betrokken. De uiteindelijke 
zeven ziektespecifi eke modules bevatten een ‘Impact’-domein and een additioneel domein 
(bijvoorbeeld ‘Worry’, ‘Stigma’, ‘Treatment’) met tussen de 10 en 12 items in totaal en een 
Cronbach’s alpha tussen de 0.71 en 0.90.
De resultaten van de validatie van het DISABKIDS-instrument in de astmapopulatie 
worden gepresenteerd in hoofdstuk zeven . De chronisch generieke module (37 items, 
verdeeld over 6 domeinen) en de astmaspecifi eke module (11 items en 2 domeinen) 
zijn beide getest in zeven landen binnen Europa in een steekproef van 405 kinderen en 
adolescenten met astma. De interne consistentie voor alle domeinen was tussen de 0.66 
en 0.85 met een goede test-hertestbetrouwbaarheid. De domeinscores diff erentieerden 
met de ernst van de astma. Het DISABKIDS-instrument voor het bepalen van de 
HRQoL is uniek door zijn crossnationale ontwikkeling en zijn modulaire structuur. 
De psychometrische eigenschappen van de DISABKIDS chronisch generieke en 
astmaspecifi eke modules zijn voldoende voor het gebruik van het instrument voor de 
bepaling van HRQoL in kinderen en adolescenten met astma.
De eerste gegevens over de psychometrische eigenschappen van de DISABKIDS 
chronisch generieke en astmaspecifi eke modules zijn veelbelovend. Er moet echter nog 
meer werk worden verricht. De discussie in hoofdstuk acht geeft een overzicht van de 
resterende beperkingen, suggesties voor toekomstig onderzoeken en mogelijkheden 
voor de implementatie van individuele HRQoL-vragenlijsten in de klinische praktijk. 
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Over het geheel genomen heeft het DISABKIDS-project veel bereikt in de ontwikkeling 
van een nieuw crossnationaal HRQoL-instrument voor kinderen en adolescenten met 
een chronische ziekte. De modulaire opbouw en de crossnationale ontwikkeling biedt 
voordelen voor het meten van HRQoL op een nationaal en internationaal niveau in 
beschrijvende en klinische studies. Het is echter van belang dat het DISABKIDS-
instrument verder wordt onderzocht om te bepalen of het als individueel meetinstrument 
ook in de klinische praktijk te gebruiken is en zijn waarde kan bewijzen voor clinici. We 
verwachten dat het DISABKIDS-instrument in de toekomst een bruikbaar kan zijn voor 
het bepalen van de HRQoL van kinderen en adolescenten met een chronische ziekte en zo 







Th e DISABKIDS chronic generic module





Questionnaire for children and adolescents
Hi, 
We would like to ask you some questions about how you have been feeling during the past 
four weeks. Th ese questions ask about some problems that children like you might have. 
We would like you to answer all the questions below. 
Please
 think back over the past four weeks when answering the questions and
 choose the answer that fi ts you best and tick the appropriate box.
If you play with your friends ‘very often’ you would tick the box as shown in this example:
For example: never seldom quite often very often always
Do you play with your friends? ❏ ❏ ❏ ❏ ❏





Please think back over the last 4 weeks…
never seldom quite often very often always
1. Are you confi dent about your future? ❏ ❏ ❏ ❏ ❏
2. Do you enjoy your life? ❏ ❏ ❏ ❏ ❏
3. Are you able to do everything you want to do even though you have a condition? ❏ ❏ ❏ ❏ ❏
4. Do you feel like everyone else even though you have a condition? ❏ ❏ ❏ ❏ ❏
5. Are you free to lead the life you want even though you have a condition? ❏ ❏ ❏ ❏ ❏
6. Are you able to do things without your parents? ❏ ❏ ❏ ❏ ❏
PHYSICAL
Please think back over the last 4 weeks…
never seldom quite often very often always
7. Are you able to run and move as you like? ❏ ❏ ❏ ❏ ❏
8. Do you feel tired because of your condition? ❏ ❏ ❏ ❏ ❏
9. Is your life ruled by your condition? ❏ ❏ ❏ ❏ ❏
10. Does it bother you that you have to explain to others what you can and can’t do? ❏ ❏ ❏ ❏ ❏
11. Is it diffi  cult to sleep because of your condi-tion? ❏ ❏ ❏ ❏ ❏




Please think back over the last 4 weeks…
never seldom quite often very often always
13. Does your condition make you feel bad about yourself? ❏ ❏ ❏ ❏ ❏
14. Are you unhappy because of your condition? ❏ ❏ ❏ ❏ ❏
15. Do you worry about your condition? ❏ ❏ ❏ ❏ ❏
16. Does your condition make you angry? ❏ ❏ ❏ ❏ ❏
17. Do you have fears about the future because of your condition? ❏ ❏ ❏ ❏ ❏
18. Does your condition get you down? ❏ ❏ ❏ ❏ ❏
19. Does it bother you that your life has to be planned? ❏ ❏ ❏ ❏ ❏
SOCIAL EXCLUSION
Please think back over the last 4 weeks…
never seldom quite often very often always
20. Do you feel lonely because of your condition? ❏ ❏ ❏ ❏ ❏
21. Do your teachers behave diff erently towards you than towards others? ❏ ❏ ❏ ❏ ❏
22. Do you have problems concentrating at school because of your condition? ❏ ❏ ❏ ❏ ❏
23. Do you feel that others have something against you? ❏ ❏ ❏ ❏ ❏
24. Do you think that others stare at you? ❏ ❏ ❏ ❏ ❏




Please think back over the last 4 weeks…
never seldom quite often very often always
26. Do other kids understand your condition? ❏ ❏ ❏ ❏ ❏
27. Do you go out with your friends? ❏ ❏ ❏ ❏ ❏
28. Are you able to play or do things with other children/adolescents (e.g. sports)? ❏ ❏ ❏ ❏ ❏
29. Do you think that you can do most things as well as other children? ❏ ❏ ❏ ❏ ❏
30. Do your friends enjoy being with you? ❏ ❏ ❏ ❏ ❏
31. Do you fi nd it easy to talk about your condi-tion to other people? ❏ ❏ ❏ ❏ ❏
MEDICAL TREATMENT 
Do you take any medication or do you get treatment? 
(e.g. pufs or sprays ) 
❏ yes, then please fi ll in the following questions
❏ no, you may go to the next page   
Th ink about the past four weeks ….
never seldom quite often very often always
32. Does having to get help with medication from others bother you? ❏ ❏ ❏ ❏ ❏
33. Is it annoying for you to have to remember your medication? ❏ ❏ ❏ ❏ ❏
34. Are you worried about your medication? ❏ ❏ ❏ ❏ ❏
35. Does taking medication bother you? ❏ ❏ ❏ ❏ ❏
36. Do you hate taking your medicine? ❏ ❏ ❏ ❏ ❏
37. Does taking medication disrupt everyday life? ❏ ❏ ❏ ❏ ❏
Appendix
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Asthma specifi c module
Now we would like to know some things about your asthma. 
IMPACT
Please think back over the last 4 weeks…
never seldom quite often very often always
1. Do you feel that you get easily exhausted? ❏ ❏ ❏ ❏ ❏
2. Does asthma bother you if you want to go out? ❏ ❏ ❏ ❏ ❏
3. Are you unable to take part in certain sports? ❏ ❏ ❏ ❏ ❏
4. Do you feel short of breath when you do sports? ❏ ❏ ❏ ❏ ❏
5. Are you bothered by the amount of time you spend wheezing? ❏ ❏ ❏ ❏ ❏
6. Do you feel terrible when you are out of breath? ❏ ❏ ❏ ❏ ❏
WORRY
Please think back over the last 4 weeks…
never seldom quite often very often always
7. Are you worried that you might have an asthma attack? ❏ ❏ ❏ ❏ ❏
8. Do you worry that others do not know what to do if you have an attack? ❏ ❏ ❏ ❏ ❏
9. Do you feel scared that you might have dif-fi culty breathing? ❏ ❏ ❏ ❏ ❏
10. Are you scared that you might have to go to the emergency ward? ❏ ❏ ❏ ❏ ❏
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